<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Thyrotropin‐releasing hormone added to corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease - Crowther, CA - 2013 | Cochrane Library</title> <meta content="Thyrotropin‐releasing hormone added to corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease - Crowther, CA - 2013 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000019.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Thyrotropin‐releasing hormone added to corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease - Crowther, CA - 2013 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000019.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD000019.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Thyrotropin‐releasing hormone added to corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease" name="citation_title"/> <meta content="Caroline A Crowther" name="citation_author"/> <meta content="caroline.crowther@adelaide.edu.au" name="citation_author_email"/> <meta content="Zarko Alfirevic" name="citation_author"/> <meta content="The University of Liverpool" name="citation_author_institution"/> <meta content="Shanshan Han" name="citation_author"/> <meta content="The University of Adelaide" name="citation_author_institution"/> <meta content="Ross R Haslam" name="citation_author"/> <meta content="The University of Adelaide" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="11" name="citation_issue"/> <meta content="10.1002/14651858.CD000019.pub3" name="citation_doi"/> <meta content="2013" name="citation_date"/> <meta content="2013/11/21" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000019.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000019.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000019.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Drug Therapy, Combination [methods]; Glucocorticoids [*therapeutic use]; Infant, Premature; *Obstetric Labor, Premature; Randomized Controlled Trials as Topic; Respiratory Distress Syndrome, Newborn [*prevention &amp; control]; Thyrotropin-Releasing Hormone [adverse effects, *therapeutic use]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000019.pub3&amp;doi=10.1002/14651858.CD000019.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000019.pub3&amp;doi=10.1002/14651858.CD000019.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000019.pub3&amp;doi=10.1002/14651858.CD000019.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000019.pub3&amp;doi=10.1002/14651858.CD000019.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000019.pub3&amp;doi=10.1002/14651858.CD000019.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000019.pub3&amp;doi=10.1002/14651858.CD000019.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000019.pub3&amp;doi=10.1002/14651858.CD000019.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000019.pub3&amp;doi=10.1002/14651858.CD000019.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000019.pub3&amp;doi=10.1002/14651858.CD000019.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000019.pub3&amp;doi=10.1002/14651858.CD000019.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000019.pub3&amp;doi=10.1002/14651858.CD000019.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000019.pub3&amp;doi=10.1002/14651858.CD000019.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000019.pub3&amp;doi=10.1002/14651858.CD000019.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000019.pub3&amp;doi=10.1002/14651858.CD000019.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000019.pub3&amp;doi=10.1002/14651858.CD000019.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000019.pub3&amp;doi=10.1002/14651858.CD000019.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000019.pub3&amp;doi=10.1002/14651858.CD000019.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000019.pub3&amp;doi=10.1002/14651858.CD000019.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000019.pub3&amp;doi=10.1002/14651858.CD000019.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000019.pub3&amp;doi=10.1002/14651858.CD000019.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000019.pub3&amp;doi=10.1002/14651858.CD000019.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000019.pub3&amp;doi=10.1002/14651858.CD000019.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000019.pub3&amp;doi=10.1002/14651858.CD000019.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="uYcNEb5O";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD000019\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD000019\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000019\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000019\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","hr","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD000019.pub3",title:"Thyrotropin\\u2010releasing hormone added to corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease",firstPublishedDate:"Nov 21, 2013 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Pregnancy and Childbirth Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=uYcNEb5O&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000019.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD000019.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD000019.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD000019.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000019.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD000019.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD000019.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD000019.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD000019.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD000019.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>702 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD000019.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000019.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000019.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000019.pub3/full#CD000019-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000019.pub3/full#CD000019-sec1-0006"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000019.pub3/full#CD000019-sec1-0001"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000019.pub3/full#CD000019-sec1-0002"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000019.pub3/full#CD000019-sec1-0003"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000019.pub3/full#CD000019-sec1-0004"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000019.pub3/full#CD000019-sec1-0005"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000019.pub3/appendices#CD000019-sec1-0011"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/table_n/CD000019StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/table_n/CD000019StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000019.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000019.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000019.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD000019.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD000019.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD000019.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2013 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Thyrotropin‐releasing hormone added to corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000019.pub3/information#CD000019-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Caroline A Crowther</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000019.pub3/information#CD000019-cr-0003">Zarko Alfirevic</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000019.pub3/information#CD000019-cr-0004">Shanshan Han</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000019.pub3/information#CD000019-cr-0005">Ross R Haslam</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/information/en#CD000019-sec1-0015">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 21 November 2013 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD000019.pub3">https://doi.org/10.1002/14651858.CD000019.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD000019-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD000019-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD000019-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fr#CD000019-abs-0002">Français</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD000019-abs-0001" lang="en"> <section id="CD000019-abs1-0001"> <h3 class="title" id="CD000019-abs1-0001">Background</h3> <p>Thyrotropin‐releasing hormones (TRH) added to prenatal corticosteroids has been suggested as a way to further reduce breathing problems and neonatal lung disease in infants born preterm. </p> </section> <section id="CD000019-abs1-0002"> <h3 class="title" id="CD000019-abs1-0002">Objectives</h3> <p>To assess the effects of giving prenatal TRH in addition to corticosteroids to women at risk of preterm birth for the prevention of neonatal respiratory disease. </p> </section> <section id="CD000019-abs1-0003"> <h3 class="title" id="CD000019-abs1-0003">Search methods</h3> <p>We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (30 June 2013) and reference lists of retrieved studies. We also contacted trial authors. </p> </section> <section id="CD000019-abs1-0004"> <h3 class="title" id="CD000019-abs1-0004">Selection criteria</h3> <p>Randomised controlled trials in women at sufficient risk of preterm birth to warrant the use of prenatal corticosteroids to promote lung maturity. TRH and corticosteroids were compared with corticosteroids, with or without placebo. </p> </section> <section id="CD000019-abs1-0005"> <h3 class="title" id="CD000019-abs1-0005">Data collection and analysis</h3> <p>All assessments of trial eligibility, risk of bias and data extractions were independently carried out by at least two review authors. </p> </section> <section id="CD000019-abs1-0006"> <h3 class="title" id="CD000019-abs1-0006">Main results</h3> <p>Over 4600 women were recruited into the 15 trials included in the review, however two trials did not contribute any outcome data to the review. The trials had a moderate risk of bias. Overall, prenatal TRH, in addition to corticosteroids, did not reduce the risk of death prior to hospital discharge (risk ratio (RR) 1.05, 95% confidence interval (CI) 0.86 to 1.27, six trials, 3694 infants), neonatal respiratory distress syndrome (average RR 1.05, 95% CI 0.91 to 1.22, nine trials, 3833 infants), or chronic lung disease (RR 1.01, 95% CI 0.85 to 1.19, five trials, 2511 infants), and did not improve any of the secondary fetal, neonatal or childhood outcomes assessed by intention‐to‐treat analyses. </p> <p>Indeed, the data showed prenatal TRH to have adverse effects for women and their infants. All side effects reported (nausea, vomiting, light headedness, urgency of micturition, facial flushing) were significantly more likely to occur in women receiving TRH. In the infants, prenatal TRH increased the risk of needing respiratory support (RR 1.16, 95% CI 1.03 to 1.29, three trials, 1969 infants), and of having a low Apgar score at five minutes (RR 1.48, 95% CI 1.14 to 1.92, three trials, 1969 infants). Only three trials provided data on childhood follow‐up, and while one trial suggested poorer outcomes for infants who were exposed to prenatal TRH, the other two trials, that assessed infants using an established developmental instrument, showed no clear differences between groups in follow‐up outcomes. </p> <p>Sensitivity analyses by trial quality, or subgroups with differing times from entry to birth, or different dose regimens of TRH, did not change these findings. </p> </section> <section id="CD000019-abs1-0007"> <h3 class="title" id="CD000019-abs1-0007">Authors' conclusions</h3> <p>Prenatal TRH in addition to corticosteroids, given to women at risk of preterm birth, does not improve infant outcomes and can cause maternal side effects. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD000019-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD000019-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD000019-abs-0008">Español</a> </li> <li class="section-language"> <a class="" href="full/fr#CD000019-abs-0007">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD000019-abs-0006">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD000019-abs-0005">Русский</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD000019-abs-0004" lang="en"> <h3>Thyrotropin‐releasing hormone added to corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease </h3> <p>Thyrotropin‐releasing hormone (TRH) given with corticosteroids does not improve the benefit of corticosteroids on the lungs of babies born too early, and may increase harm. </p> <p>Babies born preterm (before 37 weeks of pregnancy) are at risk of breathing difficulties (such as respiratory distress syndrome). TRH increases thyroid hormones in the baby and it has been thought that adding TRH to corticosteroids for women giving birth early may increase the benefit of corticosteroids on the baby's lungs. </p> <p>This review included 15 trials, of a moderate risk of bias, that involved over 4600 women and their babies. In this review, TRH, given with corticosteroids to women at risk of early birth, was not shown to further reduce the breathing difficulties for the babies. Babies born to mothers who had received TRH with corticosteroids, were more likely to require support for breathing than babies born to mothers who received only corticosteroids. Women receiving TRH were more likely to experience adverse side effects, such as nausea, vomiting and flushing than women who only received corticosteroids. </p> <p>Therefore, based on the current available evidence, TRH is not recommended to be given to women at risk of preterm birth for preventing neonatal respiratory disease. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD000019-sec1-0006" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD000019-sec1-0006"></div> <h3 class="title" id="CD000019-sec1-0007">Implications for practice</h3> <section id="CD000019-sec1-0007"> <p>Based on the current available evidence, TRH should not be given to pregnant women at risk of preterm birth in an attempt to prevent neonatal respiratory disease. </p> <p>This review found that prenatal TRH in addition to corticosteroids given to women at risk of preterm birth does not reduce the risk or severity of neonatal lung disease, may increase the chances of the infant needing respiratory support, and is associated with adverse side effects for the mother. </p> </section> <h3 class="title" id="CD000019-sec1-0008">Implications for research</h3> <section id="CD000019-sec1-0008"> <p>In the light of the evidence reviewed, no further randomised controlled trials are warranted. </p> <p>Given the trend to adverse neonatal findings in babies who were born 10 days or more after trial entry, trials should aim to provide outcome and follow‐up data on all babies recruited. Those trials that reported data on only minority subgroups of babies should consider retrieving outcome data on the other babies, in particular on mortality and longer‐term morbidity. </p> <p>Adverse maternal side effects of therapy were significant for women receiving prenatal TRH. The duration of the adverse effects, their clinical significance and the consumers' feelings about these have not been assessed. </p> <p>Five of the trials included in this review have only been reported in abstract form (<a href="./references#CD000019-bbs2-0001" title="AbuhamadA , GreenG , HeylP , deVecianaM . The combined use of corticosteroids and thyrotropin releasing hormone in pregnancies with preterm rupture of membranes: a randomised double blind controlled trial. American Journal of Obstetrics and Gynecology1999;180(1 Pt 2):S96. ">Abuhamad 1999</a>; <a href="./references#CD000019-bbs2-0006" title="CarlanSJ , ParsonsM , O'BrienWF , KrammerJ . Pharmacologic pulmonary maturation in preterm premature rupture of membranes. American Journal of Obstetrics and Gynecology1991;164:371. ">Carlan 1991</a>; <a href="./references#CD000019-bbs2-0007" title="AlthabeF , FustiharaC , AlthabeO , CernadesJMC . Controlled trial of prenatal betamethasone plus TRH vs betamethasone plus placebo for prevention of RDS in preterm infants. Pediatric Research1991;29:200A. Ceriani CernadasJ , FustiharaC , AlthabeF , AlthabeO . Controlled trial of prenatal betamethasone (B) plus TRH for prevention of respiratory distress syndrome (RDS) in preterm infants. Pediatric Research1992;32:738. ">Ceriani 1992</a>; <a href="./references#CD000019-bbs2-0011" title="JikiharaH , SawadaY , ImaiS , MorishigeK , TaniguchiT , NoharaA , et al. Maternal administration of thyrotropin‐releasing hormone for prevention of neonatal respiratory distress syndrome. Proceedings of 6th Congress of the Federation of the Asia‐Oceania Perinatal Societies; 1990 Oct 22‐26; Perth, Western Australia. 1990:87. ">Jikihara 1990</a>; <a href="./references#CD000019-bbs2-0012" title="KimEA , ParkSJ , YoonHS , KimKS , WonHS , LeeIS , et al. Antenatal thyrotropin‐releasing hormone to prevent respiratory distress syndrome in Korean preterm. Pediatric Academic Societies Annual Meeting; 2000 May 12‐16; Boston, MA, USA. 2000. KimEA , ParkSJ , YoonHS , KimKS , WonHS , LeeIS , et al. Antenatal thyrotropin‐releasing hormone to prevent respiratory distress syndrome in Korean preterm. Pediatric Research2000;47:407A. ">Kim 2000</a>). One trial using 400 μg TRH treatment dosage was planned in the USA in 1997 and stopped without enrolling (<a href="./references#CD000019-bbs2-0021" title="YoderBA . Trial to compare antenatal steroids alone, TRH alone, steroids + TRH and placebo in infants &lt;32 weeks' gestation. Personal communication1997. ">Yoder 1997</a>). Another trial of TRH administration after prelabour rupture of membranes preterm was reported as planned in 1997 (<a href="./references#CD000019-bbs2-0022" title="PearlmanSA . Trial to compare steroids vs steroids + TRH to mothers at 23‐28 weeks with PROM. Personal communication March 6 1997. ">Pearlman 1997</a>). </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD000019-sec1-0001" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD000019-sec1-0001"></div> <p>Preterm birth remains the leading cause of early neonatal death and infant mortality, often from respiratory distress syndrome as a consequence of immature lung development (<a href="./references#CD000019-bbs2-0031" title="NassarN , SullivanEA . Australia's Mothers and Babies 1999. Vol. AIHW Cat. No. PER 19 (Perinatal Statistics Series no. 11). Sydney: Australian Institiute of Health and Welfare, National Perinatal Statistics Unit, 2001. ">Nassar 2001</a>). Between 5% and 9% of pregnant women will give birth before 37 weeks' gestation, with higher rates in developing countries (<a href="./references#CD000019-bbs2-0027" title="LiZ , ZekiR , HilderL , SullivanEA . Australia's Mothers and Babies 2010. Perinatal statistics series no. 27. Cat. no. PER 57. Canberra: AIHW National Perinatal Epidemiology and Statistics Unit, 2012. ">Li 2012</a>). Preterm babies who survive the early weeks of life are at risk of long‐term neurological disability (<a href="./references#CD000019-bbs2-0030" title="MooreT , HennessyEM , MylesJ , JohnsonSJ , DraperES , CosteloeKL , et al. Neurological and developmental outcome in extremely preterm children born in England in 1995 and 2006: the EPICure studies. British Medical Journal2012;345:e7961. ">Moore 2012</a>; <a href="./references#CD000019-bbs2-0035" title="SaigalS , DoyleLW . An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet2008;371(9608):261‐9. ">Saigal 2008</a>; <a href="./references#CD000019-bbs2-0037" title="SereniusF , KällénK , BlennowM , EwaldU , FellmanV , HolmströmG , et al. Neurodevelopmental outcome in extremely preterm infants at 2.5 years after active perinatal care in Sweden. JAMA2013;309(17):1810‐20. ">Serenius 2013</a>). Parents are understandably worried and distressed when their baby is born preterm. Strategies to reduce the risk of preterm birth and, in particular, neonatal respiratory disease receive considerable attention (<a href="./references#CD000019-bbs2-0024" title="CrowtherCA , McKinlayCJD , MiddletonP , HardingJE . Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes. Cochrane Database of Systematic Reviews2011, Issue 6. [DOI: 10.1002/14651858.CD003935.pub3] ">Crowther 2011</a>; <a href="./references#CD000019-bbs2-0033" title="RobertsD , DalzielS . Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews2006, Issue 3. [DOI: 10.1002/14651858.CD004454.pub2] ">Roberts 2006</a>; <a href="./references#CD000019-bbs2-0038" title="StevensTP , BlennowM , MyersEH , SollR . Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database of Systematic Reviews2007, Issue 4. [DOI: 10.1002/14651858.CD003063.pub3] ">Stevens 2007</a>). </p> <p>The first report of a trial of prenatal thyrotropin‐releasing hormone (TRH) given with antenatal corticosteroids to women threatening to give birth preterm with the aim of enhancing lung development was presented, in abstract form, by Liggins and his co‐workers in 1988 (<a href="./references#CD000019-bbs2-0029" title="LigginsGC , SchellenbergJC , ManzaiM , KittermanJA , LeeCC . Synergisms of cortisol and thyrotropin releasing hormone in lung maturation in fetal sheep. Journal of Applied Physiology1988;65:1880‐4. ">Liggins 1988</a>). The rationale for the use of TRH was based on previous research by Liggins' group (<a href="./references#CD000019-bbs2-0036" title="SchellenbergJC , LigginsGC , ManzaiM , KittermanJA , LeeC . Synergistic hormonal effects on lung maturation in fetal sheep. Journal of Applied Physiology1988;65:94‐100. ">Schellenberg 1988</a>). In an elegant series of experiments in preterm lambs they showed both an increase in lung fluid phospholipids and an increase in lung distensibility when thyroid hormones were used in combination with corticosteroids. TRH and glucocorticoids showed similar synergism (<a href="./references#CD000019-bbs2-0029" title="LigginsGC , SchellenbergJC , ManzaiM , KittermanJA , LeeCC . Synergisms of cortisol and thyrotropin releasing hormone in lung maturation in fetal sheep. Journal of Applied Physiology1988;65:1880‐4. ">Liggins 1988</a>). </p> <p>Thyroid hormones (T3 and T4) given antenatally to the mother do not readily reach the fetal circulation due to metabolism by the placenta and membranes. However, TRH given to the mother elevates thyroid stimulating hormone (TSH) and thyroid hormones concentrations in the fetus (<a href="./references#CD000019-bbs2-0034" title="RotiE , GnudiA , BravermanL , RobuschiG , EmanueleR , BandiniP , et al. Human cord blood concentrations of thyrotropin, thyroglobulin and iodothyronines after maternal administration of thyrotropin releasing hormone. Journal of Clinical Endocrinology and Metabolism1981;53:813‐7. ">Roti 1981</a>). The exact action of TRH on the fetal lung is not known and it is possible that any action may be mediated via non‐hormonal pathways. </p> <p>In adults, intravenous TRH administration is associated with side effects, which are often transient, of nausea, vomiting, light headedness, facial flushing, metallic taste, and a rise in blood pressure (<a href="./references#CD000019-bbs2-0026" title="JacksonI . Thyrotropin‐releasing hormone. New England Journal of Medicine1982;306:145‐50. ">Jackson 1982</a>). </p> <p>Since the initial abstract reported by <a href="./references#CD000019-bbs2-0029" title="LigginsGC , SchellenbergJC , ManzaiM , KittermanJA , LeeCC . Synergisms of cortisol and thyrotropin releasing hormone in lung maturation in fetal sheep. Journal of Applied Physiology1988;65:1880‐4. ">Liggins 1988</a>, the use of prenatal TRH as an intervention strategy to reduce the risk of neonatal lung disease and its sequelae has been evaluated in several randomised trials. </p> <p>This review updates a previously published Cochrane review on TRH added to corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease (<a href="./references#CD000019-bbs2-0043" title="CrowtherCA , AlfirevicZ , HanS , HaslamRR . Thyrotropin‐releasing hormone added to corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease. Cochrane Database of Systematic Reviews2004, Issue 2. [DOI: 10.1002/14651858.CD000019.pub2] ">Crowther 2004</a>). The previous version of this review was able to include 13 trials, and concluded that prenatal TRH in addition to corticosteroids does not improve infants outcomes, and can be associated with maternal side effects. </p> <p>This review assesses the current available evidence regarding the effectiveness and safety of prenatal TRH given in addition to corticosteroids to women at risk of preterm birth. </p> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD000019-sec1-0002" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD000019-sec1-0002"></div> <p>To assess the effects of TRH administered in addition to corticosteroids to women at risk of preterm birth on fetal and infant mortality and morbidity, and on maternal side effects. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD000019-sec1-0003" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD000019-sec1-0003"></div> <section id="CD000019-sec2-0001"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD000019-sec3-0001"> <h4 class="title">Types of studies</h4> <p>All published, unpublished and ongoing randomised controlled trials and quasi‐randomised controlled trials with reported data that compare outcomes in women and babies exposed to prenatal thyrotropin‐releasing hormone (TRH) and corticosteroids with outcomes in controls receiving corticosteroids alone, with or without placebo. We planned to include cluster‐randomised trials, and exclude cross‐over trials. We planned to include studies published as abstracts only. </p> </section> <section id="CD000019-sec3-0002"> <h4 class="title">Types of participants</h4> <p>Women at sufficiently high risk of preterm birth to warrant administration of prenatal corticosteroids to promote fetal lung maturity. High‐risk groups were those women showing signs of threatening to give birth preterm, or needing early delivery because of maternal or fetal complications. </p> </section> <section id="CD000019-sec3-0003"> <h4 class="title">Types of interventions</h4> <p>TRH (any dosage) administered to the women intravenously and corticosteroids, compared with corticosteroids with either placebo or no placebo. </p> </section> <section id="CD000019-sec3-0004"> <h4 class="title">Types of outcome measures</h4> <p>Pre‐specified clinical measures of outcome related to fetal and neonatal mortality, neonatal morbidity, childhood development and maternal morbidity. </p> <section id="CD000019-sec4-0001"> <h5 class="title">Primary outcomes</h5> <p>Primary outcomes were chosen to be most representative of the clinically important measures of effectiveness and safety for the infants. </p> <p> <ol id="CD000019-lst1-0001"> <li> <p>Death prior to hospital discharge;</p> </li> <li> <p>chronic lung disease (variously defined by authors);</p> </li> <li> <p>respiratory distress syndrome (RDS).</p> </li> </ol> </p> </section> <section id="CD000019-sec4-0002"> <h5 class="title">Secondary outcomes</h5> <p>Secondary outcomes included other measures of effectiveness, complications and health services use. </p> <section id="CD000019-sec5-0001"> <h6 class="title">For the infant</h6> <p> <ol id="CD000019-lst1-0002"> <li> <p>Chronic lung disease (variously defined by authors) or death;</p> </li> <li> <p>need for oxygen therapy;</p> </li> <li> <p>severe RDS (variously defined by authors);</p> </li> <li> <p>use of respiratory support (mechanical ventilation or continuous positive airway pressure, or both); </p> </li> <li> <p>admission to neonatal intensive care unit;</p> </li> <li> <p>intraventricular haemorrhage;</p> </li> <li> <p>intraventricular haemorrhage grade three or four;</p> </li> <li> <p>periventricular leucomalacia;</p> </li> <li> <p>air leak syndrome;</p> </li> <li> <p>pulmonary haemorrhage;</p> </li> <li> <p>necrotising enterocolitis;</p> </li> <li> <p>patent ductus arteriosus;</p> </li> <li> <p>low Apgar score at five minutes;</p> </li> <li> <p>gestational age at birth;</p> </li> <li> <p>use of surfactant;</p> </li> <li> <p>neurodevelopmental abnormality at follow‐up (variously defined by authors);</p> </li> <li> <p>visual impairment at follow‐up (variously defined by authors);</p> </li> <li> <p>hearing impairment at follow‐up (variously defined by authors);</p> </li> <li> <p>motor delay at follow‐up (variously defined by authors);</p> </li> <li> <p>motor impairment at follow‐up (variously defined by authors);</p> </li> <li> <p>fine motor delay at follow‐up (variously defined by authors);</p> </li> <li> <p>sensory impairment at follow‐up (variously defined by authors);</p> </li> <li> <p>language development delay at follow‐up (variously defined by authors);</p> </li> <li> <p>social delay at follow‐up (variously defined by authors);</p> </li> <li> <p>Bayley Mental Development Index (variously defined by authors);</p> </li> <li> <p>Bayley Psychomotor Developmental Index (variously defined by authors).</p> </li> </ol> </p> </section> <section id="CD000019-sec5-0002"> <h6 class="title">For the mother</h6> <p> <ol id="CD000019-lst1-0003"> <li> <p>Nausea;</p> </li> <li> <p>vomiting;</p> </li> <li> <p>light headedness;</p> </li> <li> <p>urgency of micturition;</p> </li> <li> <p>facial flushing;</p> </li> <li> <p>systolic blood pressure rise during treatment (variously defined by authors);</p> </li> <li> <p>diastolic blood pressure rise during treatment (variously defined by authors).</p> </li> </ol> </p> </section> </section> </section> </section> <section id="CD000019-sec2-0002"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD000019-sec3-0005"> <h4 class="title">Electronic searches</h4> <p>We searched the Cochrane Pregnancy and Childbirth Group’s Trials Register by contacting the Trials Search Co‐ordinator (30 June 2013).  </p> <p>The Cochrane Pregnancy and Childbirth Group’s Trials Register is maintained by the Trials Search Co‐ordinator and contains trials identified from:  </p> <p> <ol id="CD000019-lst1-0004"> <li> <p>monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</p> </li> <li> <p>weekly searches of MEDLINE;</p> </li> <li> <p>weekly searches of Embase;</p> </li> <li> <p>handsearches of 30 journals and the proceedings of major conferences;</p> </li> <li> <p>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts. </p> </li> </ol> </p> <p>Details of the search strategies for CENTRAL, MEDLINE and Embase, the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service can be found in the ‘Specialized Register’ section within the editorial information about the <a href="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PREG/frame.html" target="_blank">Cochrane Pregnancy and Childbirth Group</a>.  </p> <p>Trials identified through the searching activities described above are each assigned to a review topic (or topics). The Trials Search Co‐ordinator searches the register for each review using the topic list rather than keywords.   </p> <p>[For details of additional searching carried out in the previous version of the review (<a href="./references#CD000019-bbs2-0043" title="CrowtherCA , AlfirevicZ , HanS , HaslamRR . Thyrotropin‐releasing hormone added to corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease. Cochrane Database of Systematic Reviews2004, Issue 2. [DOI: 10.1002/14651858.CD000019.pub2] ">Crowther 2004</a>), please s<i>ee:</i><a href="./appendices#CD000019-sec2-0007">Appendix 1</a>.] </p> </section> <section id="CD000019-sec3-0006"> <h4 class="title">Searching other resources</h4> <p>We searched reference lists of trials and other review articles and contacted researchers. We contacted authors of <a href="./references#CD000019-bbs2-0022" title="PearlmanSA . Trial to compare steroids vs steroids + TRH to mothers at 23‐28 weeks with PROM. Personal communication March 6 1997. ">Pearlman 1997</a> and <a href="./references#CD000019-bbs2-0021" title="YoderBA . Trial to compare antenatal steroids alone, TRH alone, steroids + TRH and placebo in infants &lt;32 weeks' gestation. Personal communication1997. ">Yoder 1997</a> for further information. </p> <p>We did not apply any language restrictions.</p> </section> </section> <section id="CD000019-sec2-0003"> <h3 class="title" id="CD000019-sec2-0003">Data collection and analysis</h3> <p>The following methods were used for this update.</p> <p>Please see <a href="./references#CD000019-bbs2-0043" title="CrowtherCA , AlfirevicZ , HanS , HaslamRR . Thyrotropin‐releasing hormone added to corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease. Cochrane Database of Systematic Reviews2004, Issue 2. [DOI: 10.1002/14651858.CD000019.pub2] ">Crowther 2004</a> for methods used in the previous version of this review. </p> <section id="CD000019-sec3-0007"> <h4 class="title">Selection of studies</h4> <p>Two review authors independently assessed for inclusion all the potential studies we identified as a result of the search strategy. We resolved any disagreement through discussion, or if required we consulted a third review author. </p> </section> <section id="CD000019-sec3-0008"> <h4 class="title">Data extraction and management</h4> <p>We designed a form to extract data. At least two review authors extracted the data using the agreed form. We resolved discrepancies through discussion, or if required we consulted a third review author. Data were entered into Review Manager software (<a href="./references#CD000019-bbs2-0032" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 2012</a>) and checked for accuracy. </p> <p>When information regarding any of the above was unclear, we attempted to contact authors of the original reports to provide further details. </p> </section> <section id="CD000019-sec3-0009"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors independently assessed risk of bias for each study using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD009021.pub2/full#CD009021-bbs2-0053" target="_blank">Higgins 2011</a>). We resolved any disagreement by discussion or by involving a third assessor. </p> <section id="CD000019-sec4-0003"> <h5 class="title">(1) Sequence generation (checking for possible selection bias)</h5> <p>We described for each included study the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups. </p> <p>We assessed the method as:</p> <p> <ul id="CD000019-lst1-0005"> <li> <p>low risk of bias (any truly random process, e.g. random number table; computer random number generator); </p> </li> <li> <p>high risk of bias (any non‐random process, e.g. odd or even date of birth; hospital or clinic record number); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD000019-sec4-0004"> <h5 class="title">(2) Allocation concealment (checking for possible selection bias)</h5> <p>We described for each included study the method used to conceal the allocation sequence and determine whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment. </p> <p>We assessed the methods as:</p> <p> <ul id="CD000019-lst1-0006"> <li> <p>low risk of bias (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes); </p> </li> <li> <p>high risk of bias (open random allocation; unsealed or non‐opaque envelopes, alternation; date of birth); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD000019-sec4-0005"> <h5 class="title">(3.1) Blinding of participants and personnel (checking for possible performance bias)</h5> <p>We described for each included study the methods used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. We considered that studies are at low risk of bias if they were blinded, or if we judged that the lack of blinding would be unlikely to affect results. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed the methods as:</p> <p> <ul id="CD000019-lst1-0007"> <li> <p>low, high or unclear risk of bias for participants;</p> </li> <li> <p>low, high or unclear risk of bias for personnel.</p> </li> </ul> </p> </section> <section id="CD000019-sec4-0006"> <h5 class="title">(3.2) Blinding of outcome assessment (checking for possible detection bias)</h5> <p>We described for each included study the methods used, if any, to blind outcome assessors from knowledge of which intervention a participant received. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed methods used to blind outcome assessment as:</p> <p> <ul id="CD000019-lst1-0008"> <li> <p>low, high or unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD000019-sec4-0007"> <h5 class="title">(4) Incomplete outcome data (checking for possible attrition bias through withdrawals, dropouts, protocol deviations) </h5> <p>We described for each included study, and for each outcome or class of outcomes, the completeness of data including attrition and exclusions from the analysis. We stated whether attrition and exclusions were reported, the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. Where sufficient information was reported, or could be supplied by the trial authors, we re‐included missing data in the analyses which we undertook. </p> <p>We assessed methods as:</p> <p> <ul id="CD000019-lst1-0009"> <li> <p>low risk of bias (e.g. no missing outcome data; missing outcome data balanced across groups); </p> </li> <li> <p>high risk of bias (e.g. numbers or reasons for missing data imbalanced across groups; ‘as treated’ analysis done with substantial departure of intervention received from that assigned at randomisation); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD000019-sec4-0008"> <h5 class="title">(5) Selective reporting bias</h5> <p>We described for each included study how we investigated the possibility of selective outcome reporting bias and what we found. </p> <p>We assessed the methods as:</p> <p> <ul id="CD000019-lst1-0010"> <li> <p>low risk of bias (where it was clear that all of the study’s pre‐specified outcomes and all expected outcomes of interest to the review had been reported); </p> </li> <li> <p>high risk of bias (where not all the study’s pre‐specified outcomes had been reported; one or more reported primary outcomes were not pre‐specified; outcomes of interest were reported incompletely and so could not be used; study fails to include results of a key outcome that would have been expected to have been reported); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD000019-sec4-0009"> <h5 class="title">(6) Other sources of bias</h5> <p>We described for each included study any important concerns we had about other possible sources of bias. </p> <p>We assessed whether each study was free of other problems that could put it at risk of bias: </p> <p> <ul id="CD000019-lst1-0011"> <li> <p>low risk of other bias;</p> </li> <li> <p>high risk of other bias;</p> </li> <li> <p>unclear whether there is risk of other bias.</p> </li> </ul> </p> </section> <section id="CD000019-sec4-0010"> <h5 class="title">(7) Overall risk of bias</h5> <p>We made explicit judgements about whether studies were at high risk of bias, according to the criteria given in the <i>Cochrane Handbook</i> (<a href="http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD009021.pub2/full#CD009021-bbs2-0053" target="_blank">Higgins 2011</a>). With reference to (1) to (6) above, we assessed the likely magnitude and direction of the bias and whether we considered it was likely to impact on the findings. We planned to explore the impact of the level of bias through undertaking sensitivity analyses ‐ see <a href="http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD009021.pub2/full#CD009021-sec3-0022" target="_blank">Sensitivity analysis</a>. </p> </section> </section> <section id="CD000019-sec3-0010"> <h4 class="title">Measures of treatment effect</h4> <section id="CD000019-sec4-0011"> <h5 class="title">Dichotomous data</h5> <p>For dichotomous data, we presented results as summary risk ratio with 95% confidence intervals. </p> </section> <section id="CD000019-sec4-0012"> <h5 class="title">Continuous data</h5> <p>For continuous data, we used the mean difference when outcomes were measured in the same way between trials. If necessary, we would have used the standardised mean difference to combine trials that measured the same outcome, but used different methods. </p> </section> </section> <section id="CD000019-sec3-0011"> <h4 class="title">Unit of analysis issues</h4> <section id="CD000019-sec4-0013"> <h5 class="title">Cluster‐randomised trials</h5> <p>We did not identify any cluster‐randomised trials for inclusion. In future updates of this review, if we identify cluster‐randomised trials, we plan to include them in the analyses along with individually‐randomised trials. We will adjust their sample sizes using the methods described in the <i>Cochrane Handbook</i> using an estimate of the intracluster correlation co‐efficient (ICC) derived from the trial (if possible), from a similar trial or from a study of a similar population (<a href="./references#CD000019-bbs2-0025" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). If we use ICCs from other sources, we will report this and conduct sensitivity analyses to investigate the effect of variation in the ICC. If we identify both cluster‐randomised trials and individually‐randomised trials, we plan to synthesise the relevant information. We will consider it reasonable to combine the results from both if there is little heterogeneity between the study designs and the interaction between the effect of intervention and the choice of randomisation unit is considered to be unlikely. </p> <p>We also plan to acknowledge heterogeneity in the randomisation unit and perform a sensitivity analysis to investigate the effects of the randomisation unit. </p> </section> <section id="CD000019-sec4-0014"> <h5 class="title">Cross‐over trials</h5> <p>We considered cross‐over trials as inappropriate for inclusion in this review.</p> </section> </section> <section id="CD000019-sec3-0012"> <h4 class="title">Dealing with missing data</h4> <p>For included studies, we noted levels of attrition. We planned to explore the impact of including studies with high levels of missing data in the overall assessment of treatment effect by using sensitivity analysis. </p> <p>For all outcomes, we carried out analyses, as far as possible, on an intention‐to‐treat basis, i.e. we attempted to include all participants randomised to each group in the analyses, and all participants were analysed in the group to which they were allocated, regardless of whether or not they received the allocated intervention. The denominator for each outcome in each trial was the number randomised minus any participants whose outcomes were known to be missing. </p> </section> <section id="CD000019-sec3-0013"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed statistical heterogeneity in each meta‐analysis using the Tau², I² and Chi² statistics. We regarded heterogeneity as substantial if an I² was greater than 30% and either a Tau² was greater than zero, or there was a low P value (less than 0.10) in the Chi² test for heterogeneity.  </p> </section> <section id="CD000019-sec3-0014"> <h4 class="title">Assessment of reporting biases</h4> <p>In future updates of this review, if there are 10 or more studies in a meta‐analysis, we will investigate reporting biases (such as publication bias) using funnel plots. We will assess funnel plot asymmetry visually. If asymmetry is suggested by a visual assessment, we will perform exploratory analyses to investigate it. </p> </section> <section id="CD000019-sec3-0015"> <h4 class="title">Data synthesis</h4> <p>We carried out statistical analysis using Review Manager software (<a href="./references#CD000019-bbs2-0032" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 2012</a>). We used fixed‐effect meta‐analysis for combining data where it was reasonable to assume that studies were estimating the same underlying treatment effect: i.e. where trials were examining the same intervention, and the trials’ populations and methods were judged sufficiently similar. Where there was clinical heterogeneity sufficient to expect that the underlying treatment effects differed between trials, or where substantial statistical heterogeneity was detected, we used random‐effects meta‐analysis to produce an overall summary if an average treatment effect across trials was considered clinically meaningful. The random‐effects summary has been treated as the average range of possible treatment effects and we have discussed the clinical implications of treatment effects differing between trials. If the average treatment effect was not clinically meaningful, we would not have combined trials. </p> <p>Where we used random‐effects analyses, we have presented the results as the average treatment effect with its 95% confidence interval, and the estimates of  Tau² and I². </p> </section> <section id="CD000019-sec3-0016"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Where we identified substantial heterogeneity, we investigated it using subgroup analyses and sensitivity analyses. We considered whether an overall summary was meaningful, and if it was, we used random‐effects analysis. </p> <p>We planned subgroup analyses to examine separately the primary outcomes for infants based on: </p> <p> <ul id="CD000019-lst1-0012"> <li> <p>the reasons the women were considered at risk of preterm birth;</p> </li> <li> <p>the number of infants <i>in utero</i> (singleton, twins or higher order multiple pregnancy); </p> </li> <li> <p>the gestational age TRH treatment was given;</p> </li> <li> <p>the dose of TRH given;</p> </li> <li> <p>the outcome for optimally treated infants, which was variously defined by the authors.</p> </li> </ul> </p> <p>These analyses were only possible for the dose of TRH given, and the outcome for optimally treated infants. </p> <p>The greatest beneficial effect of antenatal corticosteroids was observed in the group of infants delivered 24 hours or more and 10 days or less after start of therapy (<a href="./references#CD000019-bbs2-0028" title="LigginsGC , HowieRN . A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics1972;50:515‐25. ">Liggins 1972</a>). An expectation that this may be the case for the combination of prenatal TRH and corticosteroids prompted the secondary timed analysis as follows: </p> <p> <ol id="CD000019-lst1-0013"> <li> <p>birth less than 24 hours after first dose;</p> </li> <li> <p>birth between 24 hours and 10 days, inclusive, after first dose;</p> </li> <li> <p>birth more than 10 days after first dose.</p> </li> </ol> </p> <p>Initial analyses were limited to the pre‐specified outcomes and sensitivity and secondary analyses to the pre‐specified primary outcomes, and the secondary outcomes: </p> <p> <ul id="CD000019-lst1-0014"> <li> <p>chronic lung disease (variously defined by authors) or death;</p> </li> <li> <p>need for oxygen therapy;</p> </li> <li> <p>severe RDS (variously defined by authors);</p> </li> <li> <p>use of respiratory support (mechanical ventilation or continuous positive airway pressure, or both). </p> </li> </ul> </p> <p>We assessed subgroup differences by interaction tests available within RevMan (<a href="./references#CD000019-bbs2-0032" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 2012</a>). We have reported the results of subgroup analyses quoting the Chi² statistic and P value, and the interaction test I² value. </p> </section> <section id="CD000019-sec3-0017"> <h4 class="title">Sensitivity analysis</h4> <p>We carried out a sensitivity analysis to explore the effects of trial quality assessed by sequence generation, allocation concealment, blinding, incomplete outcome data and selective reporting, by omitting studies rated as 'unclear risk of bias' or 'high risk of bias' for these components. The sensitivity analysis has been restricted to those pre‐specified outcomes listed above. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD000019-sec1-0004" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD000019-sec1-0004"></div> <section id="CD000019-sec2-0004"> <h3 class="title">Description of studies</h3> <p><i>See</i><a href="./references#CD000019-sec2-0010" title="">Characteristics of included studies</a>, <a href="./references#CD000019-sec2-0011" title="">Characteristics of excluded studies</a>, and <a href="./references#CD000019-sec2-0012" title="">Characteristics of ongoing studies</a>. </p> <section id="CD000019-sec3-0018"> <h4 class="title">Results of the search</h4> <p>The updated search of the Pregnancy and Childbirth Group's Specialist Register identified four reports that have been added as additional references under previously included trials (<a href="./references#CD000019-bbs2-0008" title="Collaborative Santiago Surfactant Group. Collaborative trial of prenatal thyrotropin‐releasing hormone and corticosteroids for prevention of respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178:33‐9. MaturanaA , TorresJ , SalinasR , MoyaF , for the Collaborative Group. Controlled trial of prenatal thyrotropin‐releasing hormone (TRH) and betamethasone (B) for prevention of respiratory distress syndrome (RDS). Pediatric Research1997;41:163A. ReyesG , GonzalezAR , GomezG , BlasiniI , RiveraCE . Comparative study of the effectiveness of thyroxine and steroids on reduction of neonatal morbidity: outcome at 20 months follow‐up. Puerto Rico Health Sciences Journal2004;23(1):9‐12. SantiagoR , RomagueraJ . Steroids vs steroids and thyroxine to accelerate fetal maturation of patients in arrested preterm labor. Puerto Rico Health Sciences Journal1999;18:156. ">Chile 1998</a>; <a href="./references#CD000019-bbs2-0012" title="KimEA , ParkSJ , YoonHS , KimKS , WonHS , LeeIS , et al. Antenatal thyrotropin‐releasing hormone to prevent respiratory distress syndrome in Korean preterm. Pediatric Academic Societies Annual Meeting; 2000 May 12‐16; Boston, MA, USA. 2000. KimEA , ParkSJ , YoonHS , KimKS , WonHS , LeeIS , et al. Antenatal thyrotropin‐releasing hormone to prevent respiratory distress syndrome in Korean preterm. Pediatric Research2000;47:407A. ">Kim 2000</a>; <a href="./references#CD000019-bbs2-0013" title="KnightDB , LigginsGC , Wealthall SR. A randomised controlled trial of the effect of thyrotropin‐releasing hormone with betamethasone in mothers likely to deliver prematurely on neonatal outcome. Proceedings of the Australian Perinatal Society; 1992; Queensland, Australia. 1992:A9. KnightDB , LigginsGC , Wealthall SR. A randomized, controlled trial of antepartum thyrotropin‐releasing hormone and betamethasone in the prevention of respiratory disease in preterm infants. American Journal of Obstetrics and Gynecology1994;171:11‐6. KnightDB , Wealthall SR, LigginsGC , HowieRN . A randomised double blind controlled trial of antepartum TRH with betamethasone in the prevention of neonatal respiratory disease. New Zealand Medical Journal1989;102:195. LigginsGC , KnightDB , Wealthall SR, HowieRN . A randomized double‐blind trial of antepartum TRH and steroids in the prevention of neonatal respiratory disease. Clinical reproductive medicine ‐ the Liggins years; 1988 July 29‐30; Auckland, New Zealand. 1988. ">Knight 1994</a>). We have included two additional trials in this update that were previously excluded, due to not reporting any relevant outcome data (<a href="./references#CD000019-bbs2-0009" title="CrowtherC , HaslamR , HillerJ , McGeeT , RyallR , RobinsonJ . Thyrotropin‐releasing hormone: Does two hundred micrograms provide effective stimulation to the preterm fetal pituitary gland compared with four hundred micrograms?. American Journal of Obstetrics and Gynecology1995;173:719‐23. CrowtherCA , HaslamRR , HillerJE , McGeeT , RobinsonJS . Thyrotrophin releasing hormone (TRH) and lung maturation: does 200mcg TRH provide effective stimulation to the preterm fetal pituitary gland compared with 400mcg TRH?. International Journal of Gynecology and Obstetrics1991;36 Suppl:32. ">Crowther 1995</a>; <a href="./references#CD000019-bbs2-0015" title="VotoL , LedeR , ScagliaH , ZylbersteinC , ZapasterioJ , OrtiJ , et al. Effects of maternal administration of betamethasone, with and without TRH, on serum PRL, TSH and iodothyronine levels in Rh‐isoimmunized fetuses: a randomized clinical trial. Prenatal and Neonatal Medicine1998;3:447‐51. ">Voto 1998</a>). </p> <p>Therefore, of the 22 studies that were identified, 15 met our inclusion criteria (<a href="./references#CD000019-bbs2-0001" title="AbuhamadA , GreenG , HeylP , deVecianaM . The combined use of corticosteroids and thyrotropin releasing hormone in pregnancies with preterm rupture of membranes: a randomised double blind controlled trial. American Journal of Obstetrics and Gynecology1999;180(1 Pt 2):S96. ">Abuhamad 1999</a>; <a href="./references#CD000019-bbs2-0002" title="CrowtherC , HillerJ , HaslamR , RobinsonJ , the ACTOBAT Study Group. Australian Collaborative Trial of Betamethasone and TRH for the prevention of neonatal respiratory disease (ACTOBAT). International Journal of Gynecology and Obstetrics1994;46:59. CrowtherCA , HillerJE , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial of antenatal thyrotropin‐releasing hormone: Adverse effects at 12‐month follow‐up. Pediatrics1997;99:311‐7. HillerJE , CrowtherCA , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial af antenatal thyrotropin‐releasing hormone (ACTOBAT): 12 month follow‐up. 4th Annual Congress of the Perinatal Society of Australia &amp; New Zealand; 1998 March 30‐April 4; Alice Springs, Australia. Alice Springs, 1998:77. The ACTOBAT Study Group. Australian collaborative trial of betamethasone and thyrotropin releasing hormone (ACTOBAT) for the prevention of neonatal respiratory disease. Lancet1995;345:877‐82. ">ACTOBAT 1995</a>; <a href="./references#CD000019-bbs2-0003" title="BallardPL , BallardRA , CreasyRK , PadburyJ , PolkDH , BrackenM , et al. Plasma thyroid hormones and prolactin in premature infants and their mothers after treatment with thyrotropin‐releasing hormone. Pediatric Research1992;32(6):673‐8. BallardRA , BallardPL , CreasyR , GrossI , MainD , PadburyJF , et al. Prenatal treatment with thyrotropin releasing hormone plus corticosteroid: absence of maternal, fetal or neonatal side effects. Clinical Research1990;38:192A. BallardRA , BallardPL , CreasyR , GrossI , MainD , PadburyJF , et al. Prenatal treatment with thyrotropin releasing hormone plus corticosteroid: absence of maternal, fetal or neonatal side effects. Pediatric Research1991;29:202A. BallardRA , BallardPL , CreasyR , GrossI , PadburyJF , TRH Study Group. Thyrotropin releasing hormone plus corticosteroids decreases chronic lung disease in very low birth weight infants. Pediatric Research1991;29(4):1828A. BallardRA , BallardPL , CreasyR , PadburyJ , PolkDH , BrackenM , et al. Respiratory disease in very‐low birthweight infants after prenatal thyrotropin‐releasing hormone and glucocorticoid. Lancet1992;339:510‐5. ">Ballard 1992b</a>; <a href="./references#CD000019-bbs2-0004" title="BallardPL , BallardRA , NingY , CnannA , BoardmanC , Pinto‐MartinJ , et al. Plasma thyroid hormones in premature infants: effect of gestational age and antenatal thyrotropin‐releasing hormone treatment. Pediatric Research1998;44:642‐9. BallardRA , BallardPL , BoardmanC , CnaanA , DavisDJ , HartMC , et al. Antenatal thyrotropin releasing hormone (TRH) for the prevention of chronic lung disease (CLD) in the preterm infant. Pediatric Research1997;41:246A. BallardRA , BallardPL , CnaanA , Pinto‐MartinJ , DavisDJ , PadburyJF , et al. Antenatal thyrotropin‐releasing hormone to prevention lung disease in preterm infants. New England Journal of Medicine1998;338:493‐8. ">Ballard 1998</a>; <a href="./references#CD000019-bbs2-0005" title="CamposG , HerrmanF , DornerM . Combined hormonal therapy for the prevention of respiratory distress syndrome and its consequences. Seminars in Perinatology1993;17(4):267‐74. ">Campos 1993</a>; <a href="./references#CD000019-bbs2-0006" title="CarlanSJ , ParsonsM , O'BrienWF , KrammerJ . Pharmacologic pulmonary maturation in preterm premature rupture of membranes. American Journal of Obstetrics and Gynecology1991;164:371. ">Carlan 1991</a>; <a href="./references#CD000019-bbs2-0007" title="AlthabeF , FustiharaC , AlthabeO , CernadesJMC . Controlled trial of prenatal betamethasone plus TRH vs betamethasone plus placebo for prevention of RDS in preterm infants. Pediatric Research1991;29:200A. Ceriani CernadasJ , FustiharaC , AlthabeF , AlthabeO . Controlled trial of prenatal betamethasone (B) plus TRH for prevention of respiratory distress syndrome (RDS) in preterm infants. Pediatric Research1992;32:738. ">Ceriani 1992</a>; <a href="./references#CD000019-bbs2-0008" title="Collaborative Santiago Surfactant Group. Collaborative trial of prenatal thyrotropin‐releasing hormone and corticosteroids for prevention of respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178:33‐9. MaturanaA , TorresJ , SalinasR , MoyaF , for the Collaborative Group. Controlled trial of prenatal thyrotropin‐releasing hormone (TRH) and betamethasone (B) for prevention of respiratory distress syndrome (RDS). Pediatric Research1997;41:163A. ReyesG , GonzalezAR , GomezG , BlasiniI , RiveraCE . Comparative study of the effectiveness of thyroxine and steroids on reduction of neonatal morbidity: outcome at 20 months follow‐up. Puerto Rico Health Sciences Journal2004;23(1):9‐12. SantiagoR , RomagueraJ . Steroids vs steroids and thyroxine to accelerate fetal maturation of patients in arrested preterm labor. Puerto Rico Health Sciences Journal1999;18:156. ">Chile 1998</a>; <a href="./references#CD000019-bbs2-0009" title="CrowtherC , HaslamR , HillerJ , McGeeT , RyallR , RobinsonJ . Thyrotropin‐releasing hormone: Does two hundred micrograms provide effective stimulation to the preterm fetal pituitary gland compared with four hundred micrograms?. American Journal of Obstetrics and Gynecology1995;173:719‐23. CrowtherCA , HaslamRR , HillerJE , McGeeT , RobinsonJS . Thyrotrophin releasing hormone (TRH) and lung maturation: does 200mcg TRH provide effective stimulation to the preterm fetal pituitary gland compared with 400mcg TRH?. International Journal of Gynecology and Obstetrics1991;36 Suppl:32. ">Crowther 1995</a>; <a href="./references#CD000019-bbs2-0010" title="AlfirevicZ , BoerK , BrocklehurstP , BuimerM , ElbourneD , KokJ , et al. Two trials of antenatal thyrotrophin‐releasing hormone for fetal maturation: stopping before the due date. British Journal of Obstetrics and Gynaecology1999;106:898‐906. AlfirevicZ , ElbourneD , BrocklehurstP , TruesdaleA , NeilsonJ . Randomised controlled trial of antenatal administration of thyrotropin releasing hormone (TRH) to women at risk of premature delivery. Prenatal and Neonatal Medicine1996;1(1):10. BrietJM , vanSonderenL , BuimerM , BoerK , KokJH . Neurodevelopmental outcome of children treated with antenatal thyrotropin‐releasing hormone. Pediatrics2002;110(2 Pt 1):249‐53. BrocklehurstP . Antenatal thyrotropin‐releasing hormone for fetal maturity: two concurrent randomised controlled trials (The Antenatal TRH Trial and the Thyroneth Trial). British Journal of Obstetrics and Gynaecology1998;105:81. ">Europe 1999</a>; <a href="./references#CD000019-bbs2-0011" title="JikiharaH , SawadaY , ImaiS , MorishigeK , TaniguchiT , NoharaA , et al. Maternal administration of thyrotropin‐releasing hormone for prevention of neonatal respiratory distress syndrome. Proceedings of 6th Congress of the Federation of the Asia‐Oceania Perinatal Societies; 1990 Oct 22‐26; Perth, Western Australia. 1990:87. ">Jikihara 1990</a>; <a href="./references#CD000019-bbs2-0012" title="KimEA , ParkSJ , YoonHS , KimKS , WonHS , LeeIS , et al. Antenatal thyrotropin‐releasing hormone to prevent respiratory distress syndrome in Korean preterm. Pediatric Academic Societies Annual Meeting; 2000 May 12‐16; Boston, MA, USA. 2000. KimEA , ParkSJ , YoonHS , KimKS , WonHS , LeeIS , et al. Antenatal thyrotropin‐releasing hormone to prevent respiratory distress syndrome in Korean preterm. Pediatric Research2000;47:407A. ">Kim 2000</a>; <a href="./references#CD000019-bbs2-0013" title="KnightDB , LigginsGC , Wealthall SR. A randomised controlled trial of the effect of thyrotropin‐releasing hormone with betamethasone in mothers likely to deliver prematurely on neonatal outcome. Proceedings of the Australian Perinatal Society; 1992; Queensland, Australia. 1992:A9. KnightDB , LigginsGC , Wealthall SR. A randomized, controlled trial of antepartum thyrotropin‐releasing hormone and betamethasone in the prevention of respiratory disease in preterm infants. American Journal of Obstetrics and Gynecology1994;171:11‐6. KnightDB , Wealthall SR, LigginsGC , HowieRN . A randomised double blind controlled trial of antepartum TRH with betamethasone in the prevention of neonatal respiratory disease. New Zealand Medical Journal1989;102:195. LigginsGC , KnightDB , Wealthall SR, HowieRN . A randomized double‐blind trial of antepartum TRH and steroids in the prevention of neonatal respiratory disease. Clinical reproductive medicine ‐ the Liggins years; 1988 July 29‐30; Auckland, New Zealand. 1988. ">Knight 1994</a>; <a href="./references#CD000019-bbs2-0014" title="MoralesWJ , O'BrienWF , AngelJL , KnuppelRA , SawaiS . Fetal lung maturation: the combined use of corticosteroids and thyrotropin‐releasing hormone. Obstetrics and Gynecology1989;73:111‐6. ">Morales 1989</a>; <a href="./references#CD000019-bbs2-0015" title="VotoL , LedeR , ScagliaH , ZylbersteinC , ZapasterioJ , OrtiJ , et al. Effects of maternal administration of betamethasone, with and without TRH, on serum PRL, TSH and iodothyronine levels in Rh‐isoimmunized fetuses: a randomized clinical trial. Prenatal and Neonatal Medicine1998;3:447‐51. ">Voto 1998</a>). </p> <p>We excluded six trials (<a href="./references#CD000019-bbs2-0016" title="DevliegerR , VanderlindenS , deZegherF , VanAsscheFA , SpitzB . Effect of antenatal thyrotropin‐releasing hormone on uterine contractility, blood pressure, and maternal heart rate. American Journal of Obstetrics and Gynecology1997;177(2):431‐3. SpitzB , DevliegerR , VanAsscheFA . Antenatal TRH‐treatment: effects on uterine contractions, blood pressure and maternal heart rate. 10th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1996 August 4‐8; Seattle, Washington, USA. 1996:191. ">Devlieger 1997</a>; <a href="./references#CD000019-bbs2-0017" title="DolaC , NageotteP , RumneyP , TowersC , AsratT , FreemanR , et al. The effects of antenatal treatment with betamethasone and thyrotropin‐releasing hormone (TRH) in patients with preterm premature rupture of the membrane (PPROM). American Journal of Obstetrics and Gynecology1997;176:549. JacksonD , NageotteM , TowersC , AsratT , FreemanR , GardnerK , et al. Thyroid‐releasing hormone (TRH) versus betamethasone or placebo in preterm premature ruptured membranes: a prospective randomised study. American Journal of Obstetrics and Gynecology1991;170:383. ">Dola 1997</a>; <a href="./references#CD000019-bbs2-0018" title="RotiE , GardiniE , MinelliR , BianconiL , AlboniA , BravermanLE . Thyrotropin releasing hormone does not stimulate prolactin release in the preterm human fetus. Acta Endocrinologica1990;122(4):462‐6. ">Roti 1990</a>; <a href="./references#CD000019-bbs2-0019" title="TorresBA , StromquistCI , MoyaFR , DeClueT . Prenatal administration of thyrotropin‐releasing hormone and postnatal thyroxine values. Lancet1994;343:730. ">Torres 1994</a>; <a href="./references#CD000019-bbs2-0020" title="TorresJ , ForadoriA , SalinasR , PobleteJP , MaturanaA , RomanA , et al. Dose related response of the fetal pituitary‐thyroid axis to maternal administration of thyrotropin‐releasing hormone (TRH). Pediatric Research1995;2:241A. ">Torres 1995</a>; <a href="./references#CD000019-bbs2-0021" title="YoderBA . Trial to compare antenatal steroids alone, TRH alone, steroids + TRH and placebo in infants &lt;32 weeks' gestation. Personal communication1997. ">Yoder 1997</a>), and one study is classified as ongoing (reported as 'planned') (<a href="./references#CD000019-bbs2-0022" title="PearlmanSA . Trial to compare steroids vs steroids + TRH to mothers at 23‐28 weeks with PROM. Personal communication March 6 1997. ">Pearlman 1997</a>). </p> </section> <section id="CD000019-sec3-0019"> <h4 class="title">Included studies</h4> <p>Over 4600 women were recruited into the 15 trials that met the pre‐specified criteria for inclusion in this review (<a href="./references#CD000019-bbs2-0001" title="AbuhamadA , GreenG , HeylP , deVecianaM . The combined use of corticosteroids and thyrotropin releasing hormone in pregnancies with preterm rupture of membranes: a randomised double blind controlled trial. American Journal of Obstetrics and Gynecology1999;180(1 Pt 2):S96. ">Abuhamad 1999</a>; <a href="./references#CD000019-bbs2-0002" title="CrowtherC , HillerJ , HaslamR , RobinsonJ , the ACTOBAT Study Group. Australian Collaborative Trial of Betamethasone and TRH for the prevention of neonatal respiratory disease (ACTOBAT). International Journal of Gynecology and Obstetrics1994;46:59. CrowtherCA , HillerJE , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial of antenatal thyrotropin‐releasing hormone: Adverse effects at 12‐month follow‐up. Pediatrics1997;99:311‐7. HillerJE , CrowtherCA , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial af antenatal thyrotropin‐releasing hormone (ACTOBAT): 12 month follow‐up. 4th Annual Congress of the Perinatal Society of Australia &amp; New Zealand; 1998 March 30‐April 4; Alice Springs, Australia. Alice Springs, 1998:77. The ACTOBAT Study Group. Australian collaborative trial of betamethasone and thyrotropin releasing hormone (ACTOBAT) for the prevention of neonatal respiratory disease. Lancet1995;345:877‐82. ">ACTOBAT 1995</a>; <a href="./references#CD000019-bbs2-0003" title="BallardPL , BallardRA , CreasyRK , PadburyJ , PolkDH , BrackenM , et al. Plasma thyroid hormones and prolactin in premature infants and their mothers after treatment with thyrotropin‐releasing hormone. Pediatric Research1992;32(6):673‐8. BallardRA , BallardPL , CreasyR , GrossI , MainD , PadburyJF , et al. Prenatal treatment with thyrotropin releasing hormone plus corticosteroid: absence of maternal, fetal or neonatal side effects. Clinical Research1990;38:192A. BallardRA , BallardPL , CreasyR , GrossI , MainD , PadburyJF , et al. Prenatal treatment with thyrotropin releasing hormone plus corticosteroid: absence of maternal, fetal or neonatal side effects. Pediatric Research1991;29:202A. BallardRA , BallardPL , CreasyR , GrossI , PadburyJF , TRH Study Group. Thyrotropin releasing hormone plus corticosteroids decreases chronic lung disease in very low birth weight infants. Pediatric Research1991;29(4):1828A. BallardRA , BallardPL , CreasyR , PadburyJ , PolkDH , BrackenM , et al. Respiratory disease in very‐low birthweight infants after prenatal thyrotropin‐releasing hormone and glucocorticoid. Lancet1992;339:510‐5. ">Ballard 1992b</a>; <a href="./references#CD000019-bbs2-0004" title="BallardPL , BallardRA , NingY , CnannA , BoardmanC , Pinto‐MartinJ , et al. Plasma thyroid hormones in premature infants: effect of gestational age and antenatal thyrotropin‐releasing hormone treatment. Pediatric Research1998;44:642‐9. BallardRA , BallardPL , BoardmanC , CnaanA , DavisDJ , HartMC , et al. Antenatal thyrotropin releasing hormone (TRH) for the prevention of chronic lung disease (CLD) in the preterm infant. Pediatric Research1997;41:246A. BallardRA , BallardPL , CnaanA , Pinto‐MartinJ , DavisDJ , PadburyJF , et al. Antenatal thyrotropin‐releasing hormone to prevention lung disease in preterm infants. New England Journal of Medicine1998;338:493‐8. ">Ballard 1998</a>; <a href="./references#CD000019-bbs2-0005" title="CamposG , HerrmanF , DornerM . Combined hormonal therapy for the prevention of respiratory distress syndrome and its consequences. Seminars in Perinatology1993;17(4):267‐74. ">Campos 1993</a>; <a href="./references#CD000019-bbs2-0006" title="CarlanSJ , ParsonsM , O'BrienWF , KrammerJ . Pharmacologic pulmonary maturation in preterm premature rupture of membranes. American Journal of Obstetrics and Gynecology1991;164:371. ">Carlan 1991</a>; <a href="./references#CD000019-bbs2-0007" title="AlthabeF , FustiharaC , AlthabeO , CernadesJMC . Controlled trial of prenatal betamethasone plus TRH vs betamethasone plus placebo for prevention of RDS in preterm infants. Pediatric Research1991;29:200A. Ceriani CernadasJ , FustiharaC , AlthabeF , AlthabeO . Controlled trial of prenatal betamethasone (B) plus TRH for prevention of respiratory distress syndrome (RDS) in preterm infants. Pediatric Research1992;32:738. ">Ceriani 1992</a>; <a href="./references#CD000019-bbs2-0008" title="Collaborative Santiago Surfactant Group. Collaborative trial of prenatal thyrotropin‐releasing hormone and corticosteroids for prevention of respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178:33‐9. MaturanaA , TorresJ , SalinasR , MoyaF , for the Collaborative Group. Controlled trial of prenatal thyrotropin‐releasing hormone (TRH) and betamethasone (B) for prevention of respiratory distress syndrome (RDS). Pediatric Research1997;41:163A. ReyesG , GonzalezAR , GomezG , BlasiniI , RiveraCE . Comparative study of the effectiveness of thyroxine and steroids on reduction of neonatal morbidity: outcome at 20 months follow‐up. Puerto Rico Health Sciences Journal2004;23(1):9‐12. SantiagoR , RomagueraJ . Steroids vs steroids and thyroxine to accelerate fetal maturation of patients in arrested preterm labor. Puerto Rico Health Sciences Journal1999;18:156. ">Chile 1998</a>; <a href="./references#CD000019-bbs2-0009" title="CrowtherC , HaslamR , HillerJ , McGeeT , RyallR , RobinsonJ . Thyrotropin‐releasing hormone: Does two hundred micrograms provide effective stimulation to the preterm fetal pituitary gland compared with four hundred micrograms?. American Journal of Obstetrics and Gynecology1995;173:719‐23. CrowtherCA , HaslamRR , HillerJE , McGeeT , RobinsonJS . Thyrotrophin releasing hormone (TRH) and lung maturation: does 200mcg TRH provide effective stimulation to the preterm fetal pituitary gland compared with 400mcg TRH?. International Journal of Gynecology and Obstetrics1991;36 Suppl:32. ">Crowther 1995</a>; <a href="./references#CD000019-bbs2-0010" title="AlfirevicZ , BoerK , BrocklehurstP , BuimerM , ElbourneD , KokJ , et al. Two trials of antenatal thyrotrophin‐releasing hormone for fetal maturation: stopping before the due date. British Journal of Obstetrics and Gynaecology1999;106:898‐906. AlfirevicZ , ElbourneD , BrocklehurstP , TruesdaleA , NeilsonJ . Randomised controlled trial of antenatal administration of thyrotropin releasing hormone (TRH) to women at risk of premature delivery. Prenatal and Neonatal Medicine1996;1(1):10. BrietJM , vanSonderenL , BuimerM , BoerK , KokJH . Neurodevelopmental outcome of children treated with antenatal thyrotropin‐releasing hormone. Pediatrics2002;110(2 Pt 1):249‐53. BrocklehurstP . Antenatal thyrotropin‐releasing hormone for fetal maturity: two concurrent randomised controlled trials (The Antenatal TRH Trial and the Thyroneth Trial). British Journal of Obstetrics and Gynaecology1998;105:81. ">Europe 1999</a>; <a href="./references#CD000019-bbs2-0011" title="JikiharaH , SawadaY , ImaiS , MorishigeK , TaniguchiT , NoharaA , et al. Maternal administration of thyrotropin‐releasing hormone for prevention of neonatal respiratory distress syndrome. Proceedings of 6th Congress of the Federation of the Asia‐Oceania Perinatal Societies; 1990 Oct 22‐26; Perth, Western Australia. 1990:87. ">Jikihara 1990</a>; <a href="./references#CD000019-bbs2-0012" title="KimEA , ParkSJ , YoonHS , KimKS , WonHS , LeeIS , et al. Antenatal thyrotropin‐releasing hormone to prevent respiratory distress syndrome in Korean preterm. Pediatric Academic Societies Annual Meeting; 2000 May 12‐16; Boston, MA, USA. 2000. KimEA , ParkSJ , YoonHS , KimKS , WonHS , LeeIS , et al. Antenatal thyrotropin‐releasing hormone to prevent respiratory distress syndrome in Korean preterm. Pediatric Research2000;47:407A. ">Kim 2000</a>; <a href="./references#CD000019-bbs2-0013" title="KnightDB , LigginsGC , Wealthall SR. A randomised controlled trial of the effect of thyrotropin‐releasing hormone with betamethasone in mothers likely to deliver prematurely on neonatal outcome. Proceedings of the Australian Perinatal Society; 1992; Queensland, Australia. 1992:A9. KnightDB , LigginsGC , Wealthall SR. A randomized, controlled trial of antepartum thyrotropin‐releasing hormone and betamethasone in the prevention of respiratory disease in preterm infants. American Journal of Obstetrics and Gynecology1994;171:11‐6. KnightDB , Wealthall SR, LigginsGC , HowieRN . A randomised double blind controlled trial of antepartum TRH with betamethasone in the prevention of neonatal respiratory disease. New Zealand Medical Journal1989;102:195. LigginsGC , KnightDB , Wealthall SR, HowieRN . A randomized double‐blind trial of antepartum TRH and steroids in the prevention of neonatal respiratory disease. Clinical reproductive medicine ‐ the Liggins years; 1988 July 29‐30; Auckland, New Zealand. 1988. ">Knight 1994</a>; <a href="./references#CD000019-bbs2-0014" title="MoralesWJ , O'BrienWF , AngelJL , KnuppelRA , SawaiS . Fetal lung maturation: the combined use of corticosteroids and thyrotropin‐releasing hormone. Obstetrics and Gynecology1989;73:111‐6. ">Morales 1989</a>; <a href="./references#CD000019-bbs2-0015" title="VotoL , LedeR , ScagliaH , ZylbersteinC , ZapasterioJ , OrtiJ , et al. Effects of maternal administration of betamethasone, with and without TRH, on serum PRL, TSH and iodothyronine levels in Rh‐isoimmunized fetuses: a randomized clinical trial. Prenatal and Neonatal Medicine1998;3:447‐51. ">Voto 1998</a>). </p> <p>Gestational age at trial entry varied between 24 to 33 completed weeks: 24 to 31 completed weeks in <a href="./references#CD000019-bbs2-0002" title="CrowtherC , HillerJ , HaslamR , RobinsonJ , the ACTOBAT Study Group. Australian Collaborative Trial of Betamethasone and TRH for the prevention of neonatal respiratory disease (ACTOBAT). International Journal of Gynecology and Obstetrics1994;46:59. CrowtherCA , HillerJE , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial of antenatal thyrotropin‐releasing hormone: Adverse effects at 12‐month follow‐up. Pediatrics1997;99:311‐7. HillerJE , CrowtherCA , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial af antenatal thyrotropin‐releasing hormone (ACTOBAT): 12 month follow‐up. 4th Annual Congress of the Perinatal Society of Australia &amp; New Zealand; 1998 March 30‐April 4; Alice Springs, Australia. Alice Springs, 1998:77. The ACTOBAT Study Group. Australian collaborative trial of betamethasone and thyrotropin releasing hormone (ACTOBAT) for the prevention of neonatal respiratory disease. Lancet1995;345:877‐82. ">ACTOBAT 1995</a>, <a href="./references#CD000019-bbs2-0003" title="BallardPL , BallardRA , CreasyRK , PadburyJ , PolkDH , BrackenM , et al. Plasma thyroid hormones and prolactin in premature infants and their mothers after treatment with thyrotropin‐releasing hormone. Pediatric Research1992;32(6):673‐8. BallardRA , BallardPL , CreasyR , GrossI , MainD , PadburyJF , et al. Prenatal treatment with thyrotropin releasing hormone plus corticosteroid: absence of maternal, fetal or neonatal side effects. Clinical Research1990;38:192A. BallardRA , BallardPL , CreasyR , GrossI , MainD , PadburyJF , et al. Prenatal treatment with thyrotropin releasing hormone plus corticosteroid: absence of maternal, fetal or neonatal side effects. Pediatric Research1991;29:202A. BallardRA , BallardPL , CreasyR , GrossI , PadburyJF , TRH Study Group. Thyrotropin releasing hormone plus corticosteroids decreases chronic lung disease in very low birth weight infants. Pediatric Research1991;29(4):1828A. BallardRA , BallardPL , CreasyR , PadburyJ , PolkDH , BrackenM , et al. Respiratory disease in very‐low birthweight infants after prenatal thyrotropin‐releasing hormone and glucocorticoid. Lancet1992;339:510‐5. ">Ballard 1992b</a> and <a href="./references#CD000019-bbs2-0005" title="CamposG , HerrmanF , DornerM . Combined hormonal therapy for the prevention of respiratory distress syndrome and its consequences. Seminars in Perinatology1993;17(4):267‐74. ">Campos 1993</a>; 24 to less than 30 weeks in <a href="./references#CD000019-bbs2-0004" title="BallardPL , BallardRA , NingY , CnannA , BoardmanC , Pinto‐MartinJ , et al. Plasma thyroid hormones in premature infants: effect of gestational age and antenatal thyrotropin‐releasing hormone treatment. Pediatric Research1998;44:642‐9. BallardRA , BallardPL , BoardmanC , CnaanA , DavisDJ , HartMC , et al. Antenatal thyrotropin releasing hormone (TRH) for the prevention of chronic lung disease (CLD) in the preterm infant. Pediatric Research1997;41:246A. BallardRA , BallardPL , CnaanA , Pinto‐MartinJ , DavisDJ , PadburyJF , et al. Antenatal thyrotropin‐releasing hormone to prevention lung disease in preterm infants. New England Journal of Medicine1998;338:493‐8. ">Ballard 1998</a>; 24 to less than 33 weeks in <a href="./references#CD000019-bbs2-0008" title="Collaborative Santiago Surfactant Group. Collaborative trial of prenatal thyrotropin‐releasing hormone and corticosteroids for prevention of respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178:33‐9. MaturanaA , TorresJ , SalinasR , MoyaF , for the Collaborative Group. Controlled trial of prenatal thyrotropin‐releasing hormone (TRH) and betamethasone (B) for prevention of respiratory distress syndrome (RDS). Pediatric Research1997;41:163A. ReyesG , GonzalezAR , GomezG , BlasiniI , RiveraCE . Comparative study of the effectiveness of thyroxine and steroids on reduction of neonatal morbidity: outcome at 20 months follow‐up. Puerto Rico Health Sciences Journal2004;23(1):9‐12. SantiagoR , RomagueraJ . Steroids vs steroids and thyroxine to accelerate fetal maturation of patients in arrested preterm labor. Puerto Rico Health Sciences Journal1999;18:156. ">Chile 1998</a> and <a href="./references#CD000019-bbs2-0013" title="KnightDB , LigginsGC , Wealthall SR. A randomised controlled trial of the effect of thyrotropin‐releasing hormone with betamethasone in mothers likely to deliver prematurely on neonatal outcome. Proceedings of the Australian Perinatal Society; 1992; Queensland, Australia. 1992:A9. KnightDB , LigginsGC , Wealthall SR. A randomized, controlled trial of antepartum thyrotropin‐releasing hormone and betamethasone in the prevention of respiratory disease in preterm infants. American Journal of Obstetrics and Gynecology1994;171:11‐6. KnightDB , Wealthall SR, LigginsGC , HowieRN . A randomised double blind controlled trial of antepartum TRH with betamethasone in the prevention of neonatal respiratory disease. New Zealand Medical Journal1989;102:195. LigginsGC , KnightDB , Wealthall SR, HowieRN . A randomized double‐blind trial of antepartum TRH and steroids in the prevention of neonatal respiratory disease. Clinical reproductive medicine ‐ the Liggins years; 1988 July 29‐30; Auckland, New Zealand. 1988. ">Knight 1994</a>; 24 to less than 34 weeks in <a href="./references#CD000019-bbs2-0006" title="CarlanSJ , ParsonsM , O'BrienWF , KrammerJ . Pharmacologic pulmonary maturation in preterm premature rupture of membranes. American Journal of Obstetrics and Gynecology1991;164:371. ">Carlan 1991</a> and <a href="./references#CD000019-bbs2-0009" title="CrowtherC , HaslamR , HillerJ , McGeeT , RyallR , RobinsonJ . Thyrotropin‐releasing hormone: Does two hundred micrograms provide effective stimulation to the preterm fetal pituitary gland compared with four hundred micrograms?. American Journal of Obstetrics and Gynecology1995;173:719‐23. CrowtherCA , HaslamRR , HillerJE , McGeeT , RobinsonJS . Thyrotrophin releasing hormone (TRH) and lung maturation: does 200mcg TRH provide effective stimulation to the preterm fetal pituitary gland compared with 400mcg TRH?. International Journal of Gynecology and Obstetrics1991;36 Suppl:32. ">Crowther 1995</a>; 24 to 34 weeks in <a href="./references#CD000019-bbs2-0001" title="AbuhamadA , GreenG , HeylP , deVecianaM . The combined use of corticosteroids and thyrotropin releasing hormone in pregnancies with preterm rupture of membranes: a randomised double blind controlled trial. American Journal of Obstetrics and Gynecology1999;180(1 Pt 2):S96. ">Abuhamad 1999</a>; less than 32 weeks in <a href="./references#CD000019-bbs2-0010" title="AlfirevicZ , BoerK , BrocklehurstP , BuimerM , ElbourneD , KokJ , et al. Two trials of antenatal thyrotrophin‐releasing hormone for fetal maturation: stopping before the due date. British Journal of Obstetrics and Gynaecology1999;106:898‐906. AlfirevicZ , ElbourneD , BrocklehurstP , TruesdaleA , NeilsonJ . Randomised controlled trial of antenatal administration of thyrotropin releasing hormone (TRH) to women at risk of premature delivery. Prenatal and Neonatal Medicine1996;1(1):10. BrietJM , vanSonderenL , BuimerM , BoerK , KokJH . Neurodevelopmental outcome of children treated with antenatal thyrotropin‐releasing hormone. Pediatrics2002;110(2 Pt 1):249‐53. BrocklehurstP . Antenatal thyrotropin‐releasing hormone for fetal maturity: two concurrent randomised controlled trials (The Antenatal TRH Trial and the Thyroneth Trial). British Journal of Obstetrics and Gynaecology1998;105:81. ">Europe 1999</a>; less than 34 weeks in <a href="./references#CD000019-bbs2-0014" title="MoralesWJ , O'BrienWF , AngelJL , KnuppelRA , SawaiS . Fetal lung maturation: the combined use of corticosteroids and thyrotropin‐releasing hormone. Obstetrics and Gynecology1989;73:111‐6. ">Morales 1989</a>; 23 to 29 completed weeks in <a href="./references#CD000019-bbs2-0011" title="JikiharaH , SawadaY , ImaiS , MorishigeK , TaniguchiT , NoharaA , et al. Maternal administration of thyrotropin‐releasing hormone for prevention of neonatal respiratory distress syndrome. Proceedings of 6th Congress of the Federation of the Asia‐Oceania Perinatal Societies; 1990 Oct 22‐26; Perth, Western Australia. 1990:87. ">Jikihara 1990</a>; 26 to 31 weeks in <a href="./references#CD000019-bbs2-0007" title="AlthabeF , FustiharaC , AlthabeO , CernadesJMC . Controlled trial of prenatal betamethasone plus TRH vs betamethasone plus placebo for prevention of RDS in preterm infants. Pediatric Research1991;29:200A. Ceriani CernadasJ , FustiharaC , AlthabeF , AlthabeO . Controlled trial of prenatal betamethasone (B) plus TRH for prevention of respiratory distress syndrome (RDS) in preterm infants. Pediatric Research1992;32:738. ">Ceriani 1992</a>; and 26 to 34 weeks in <a href="./references#CD000019-bbs2-0012" title="KimEA , ParkSJ , YoonHS , KimKS , WonHS , LeeIS , et al. Antenatal thyrotropin‐releasing hormone to prevent respiratory distress syndrome in Korean preterm. Pediatric Academic Societies Annual Meeting; 2000 May 12‐16; Boston, MA, USA. 2000. KimEA , ParkSJ , YoonHS , KimKS , WonHS , LeeIS , et al. Antenatal thyrotropin‐releasing hormone to prevent respiratory distress syndrome in Korean preterm. Pediatric Research2000;47:407A. ">Kim 2000</a>. </p> <p>All trials used the administration of antenatal corticosteroids as an inclusion criterion. The thyrotropin‐releasing hormone (TRH) regimens varied as follows. </p> <p> <ul id="CD000019-lst1-0015"> <li> <p><a href="./references#CD000019-bbs2-0007" title="AlthabeF , FustiharaC , AlthabeO , CernadesJMC . Controlled trial of prenatal betamethasone plus TRH vs betamethasone plus placebo for prevention of RDS in preterm infants. Pediatric Research1991;29:200A. Ceriani CernadasJ , FustiharaC , AlthabeF , AlthabeO . Controlled trial of prenatal betamethasone (B) plus TRH for prevention of respiratory distress syndrome (RDS) in preterm infants. Pediatric Research1992;32:738. ">Ceriani 1992</a> used 200 μg TRH, 12‐hourly, given twice and <a href="./references#CD000019-bbs2-0002" title="CrowtherC , HillerJ , HaslamR , RobinsonJ , the ACTOBAT Study Group. Australian Collaborative Trial of Betamethasone and TRH for the prevention of neonatal respiratory disease (ACTOBAT). International Journal of Gynecology and Obstetrics1994;46:59. CrowtherCA , HillerJE , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial of antenatal thyrotropin‐releasing hormone: Adverse effects at 12‐month follow‐up. Pediatrics1997;99:311‐7. HillerJE , CrowtherCA , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial af antenatal thyrotropin‐releasing hormone (ACTOBAT): 12 month follow‐up. 4th Annual Congress of the Perinatal Society of Australia &amp; New Zealand; 1998 March 30‐April 4; Alice Springs, Australia. Alice Springs, 1998:77. The ACTOBAT Study Group. Australian collaborative trial of betamethasone and thyrotropin releasing hormone (ACTOBAT) for the prevention of neonatal respiratory disease. Lancet1995;345:877‐82. ">ACTOBAT 1995</a> used 200 μg TRH, 12‐hourly, given up to a maximum of four doses. </p> </li> <li> <p><a href="./references#CD000019-bbs2-0003" title="BallardPL , BallardRA , CreasyRK , PadburyJ , PolkDH , BrackenM , et al. Plasma thyroid hormones and prolactin in premature infants and their mothers after treatment with thyrotropin‐releasing hormone. Pediatric Research1992;32(6):673‐8. BallardRA , BallardPL , CreasyR , GrossI , MainD , PadburyJF , et al. Prenatal treatment with thyrotropin releasing hormone plus corticosteroid: absence of maternal, fetal or neonatal side effects. Clinical Research1990;38:192A. BallardRA , BallardPL , CreasyR , GrossI , MainD , PadburyJF , et al. Prenatal treatment with thyrotropin releasing hormone plus corticosteroid: absence of maternal, fetal or neonatal side effects. Pediatric Research1991;29:202A. BallardRA , BallardPL , CreasyR , GrossI , PadburyJF , TRH Study Group. Thyrotropin releasing hormone plus corticosteroids decreases chronic lung disease in very low birth weight infants. Pediatric Research1991;29(4):1828A. BallardRA , BallardPL , CreasyR , PadburyJ , PolkDH , BrackenM , et al. Respiratory disease in very‐low birthweight infants after prenatal thyrotropin‐releasing hormone and glucocorticoid. Lancet1992;339:510‐5. ">Ballard 1992b</a>, <a href="./references#CD000019-bbs2-0004" title="BallardPL , BallardRA , NingY , CnannA , BoardmanC , Pinto‐MartinJ , et al. Plasma thyroid hormones in premature infants: effect of gestational age and antenatal thyrotropin‐releasing hormone treatment. Pediatric Research1998;44:642‐9. BallardRA , BallardPL , BoardmanC , CnaanA , DavisDJ , HartMC , et al. Antenatal thyrotropin releasing hormone (TRH) for the prevention of chronic lung disease (CLD) in the preterm infant. Pediatric Research1997;41:246A. BallardRA , BallardPL , CnaanA , Pinto‐MartinJ , DavisDJ , PadburyJF , et al. Antenatal thyrotropin‐releasing hormone to prevention lung disease in preterm infants. New England Journal of Medicine1998;338:493‐8. ">Ballard 1998</a>, <a href="./references#CD000019-bbs2-0005" title="CamposG , HerrmanF , DornerM . Combined hormonal therapy for the prevention of respiratory distress syndrome and its consequences. Seminars in Perinatology1993;17(4):267‐74. ">Campos 1993</a>, <a href="./references#CD000019-bbs2-0008" title="Collaborative Santiago Surfactant Group. Collaborative trial of prenatal thyrotropin‐releasing hormone and corticosteroids for prevention of respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178:33‐9. MaturanaA , TorresJ , SalinasR , MoyaF , for the Collaborative Group. Controlled trial of prenatal thyrotropin‐releasing hormone (TRH) and betamethasone (B) for prevention of respiratory distress syndrome (RDS). Pediatric Research1997;41:163A. ReyesG , GonzalezAR , GomezG , BlasiniI , RiveraCE . Comparative study of the effectiveness of thyroxine and steroids on reduction of neonatal morbidity: outcome at 20 months follow‐up. Puerto Rico Health Sciences Journal2004;23(1):9‐12. SantiagoR , RomagueraJ . Steroids vs steroids and thyroxine to accelerate fetal maturation of patients in arrested preterm labor. Puerto Rico Health Sciences Journal1999;18:156. ">Chile 1998</a>, <a href="./references#CD000019-bbs2-0010" title="AlfirevicZ , BoerK , BrocklehurstP , BuimerM , ElbourneD , KokJ , et al. Two trials of antenatal thyrotrophin‐releasing hormone for fetal maturation: stopping before the due date. British Journal of Obstetrics and Gynaecology1999;106:898‐906. AlfirevicZ , ElbourneD , BrocklehurstP , TruesdaleA , NeilsonJ . Randomised controlled trial of antenatal administration of thyrotropin releasing hormone (TRH) to women at risk of premature delivery. Prenatal and Neonatal Medicine1996;1(1):10. BrietJM , vanSonderenL , BuimerM , BoerK , KokJH . Neurodevelopmental outcome of children treated with antenatal thyrotropin‐releasing hormone. Pediatrics2002;110(2 Pt 1):249‐53. BrocklehurstP . Antenatal thyrotropin‐releasing hormone for fetal maturity: two concurrent randomised controlled trials (The Antenatal TRH Trial and the Thyroneth Trial). British Journal of Obstetrics and Gynaecology1998;105:81. ">Europe 1999</a> and <a href="./references#CD000019-bbs2-0011" title="JikiharaH , SawadaY , ImaiS , MorishigeK , TaniguchiT , NoharaA , et al. Maternal administration of thyrotropin‐releasing hormone for prevention of neonatal respiratory distress syndrome. Proceedings of 6th Congress of the Federation of the Asia‐Oceania Perinatal Societies; 1990 Oct 22‐26; Perth, Western Australia. 1990:87. ">Jikihara 1990</a> used 400 μg TRH every eight hours up to a maximum of four doses. </p> </li> <li> <p><a href="./references#CD000019-bbs2-0015" title="VotoL , LedeR , ScagliaH , ZylbersteinC , ZapasterioJ , OrtiJ , et al. Effects of maternal administration of betamethasone, with and without TRH, on serum PRL, TSH and iodothyronine levels in Rh‐isoimmunized fetuses: a randomized clinical trial. Prenatal and Neonatal Medicine1998;3:447‐51. ">Voto 1998</a> used 400 μg TRH every six hours for four doses. </p> </li> <li> <p><a href="./references#CD000019-bbs2-0013" title="KnightDB , LigginsGC , Wealthall SR. A randomised controlled trial of the effect of thyrotropin‐releasing hormone with betamethasone in mothers likely to deliver prematurely on neonatal outcome. Proceedings of the Australian Perinatal Society; 1992; Queensland, Australia. 1992:A9. KnightDB , LigginsGC , Wealthall SR. A randomized, controlled trial of antepartum thyrotropin‐releasing hormone and betamethasone in the prevention of respiratory disease in preterm infants. American Journal of Obstetrics and Gynecology1994;171:11‐6. KnightDB , Wealthall SR, LigginsGC , HowieRN . A randomised double blind controlled trial of antepartum TRH with betamethasone in the prevention of neonatal respiratory disease. New Zealand Medical Journal1989;102:195. LigginsGC , KnightDB , Wealthall SR, HowieRN . A randomized double‐blind trial of antepartum TRH and steroids in the prevention of neonatal respiratory disease. Clinical reproductive medicine ‐ the Liggins years; 1988 July 29‐30; Auckland, New Zealand. 1988. ">Knight 1994</a> used 400 μg TRH every 12 hours for a maximum of four doses. </p> </li> <li> <p><a href="./references#CD000019-bbs2-0006" title="CarlanSJ , ParsonsM , O'BrienWF , KrammerJ . Pharmacologic pulmonary maturation in preterm premature rupture of membranes. American Journal of Obstetrics and Gynecology1991;164:371. ">Carlan 1991</a>, <a href="./references#CD000019-bbs2-0012" title="KimEA , ParkSJ , YoonHS , KimKS , WonHS , LeeIS , et al. Antenatal thyrotropin‐releasing hormone to prevent respiratory distress syndrome in Korean preterm. Pediatric Academic Societies Annual Meeting; 2000 May 12‐16; Boston, MA, USA. 2000. KimEA , ParkSJ , YoonHS , KimKS , WonHS , LeeIS , et al. Antenatal thyrotropin‐releasing hormone to prevent respiratory distress syndrome in Korean preterm. Pediatric Research2000;47:407A. ">Kim 2000</a> and <a href="./references#CD000019-bbs2-0014" title="MoralesWJ , O'BrienWF , AngelJL , KnuppelRA , SawaiS . Fetal lung maturation: the combined use of corticosteroids and thyrotropin‐releasing hormone. Obstetrics and Gynecology1989;73:111‐6. ">Morales 1989</a> used 400 μg TRH every eight hours for up to six doses. </p> </li> <li> <p><a href="./references#CD000019-bbs2-0001" title="AbuhamadA , GreenG , HeylP , deVecianaM . The combined use of corticosteroids and thyrotropin releasing hormone in pregnancies with preterm rupture of membranes: a randomised double blind controlled trial. American Journal of Obstetrics and Gynecology1999;180(1 Pt 2):S96. ">Abuhamad 1999</a> used 500 μg TRH every eight hours up to a maximum of four doses, repeated weekly for a maximum of four weeks or until delivery. </p> </li> <li> <p>In <a href="./references#CD000019-bbs2-0009" title="CrowtherC , HaslamR , HillerJ , McGeeT , RyallR , RobinsonJ . Thyrotropin‐releasing hormone: Does two hundred micrograms provide effective stimulation to the preterm fetal pituitary gland compared with four hundred micrograms?. American Journal of Obstetrics and Gynecology1995;173:719‐23. CrowtherCA , HaslamRR , HillerJE , McGeeT , RobinsonJS . Thyrotrophin releasing hormone (TRH) and lung maturation: does 200mcg TRH provide effective stimulation to the preterm fetal pituitary gland compared with 400mcg TRH?. International Journal of Gynecology and Obstetrics1991;36 Suppl:32. ">Crowther 1995</a>, two treatment groups received either 200 μg TRH or 400 μg TRH over 30 minutes. </p> </li> </ul> </p> <p>For further details see: <a href="./references#CD000019-sec2-0010" title="">Characteristics of included studies</a>. </p> </section> <section id="CD000019-sec3-0020"> <h4 class="title">Excluded studies</h4> <p>We excluded six trials (<a href="./references#CD000019-bbs2-0016" title="DevliegerR , VanderlindenS , deZegherF , VanAsscheFA , SpitzB . Effect of antenatal thyrotropin‐releasing hormone on uterine contractility, blood pressure, and maternal heart rate. American Journal of Obstetrics and Gynecology1997;177(2):431‐3. SpitzB , DevliegerR , VanAsscheFA . Antenatal TRH‐treatment: effects on uterine contractions, blood pressure and maternal heart rate. 10th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1996 August 4‐8; Seattle, Washington, USA. 1996:191. ">Devlieger 1997</a>; <a href="./references#CD000019-bbs2-0017" title="DolaC , NageotteP , RumneyP , TowersC , AsratT , FreemanR , et al. The effects of antenatal treatment with betamethasone and thyrotropin‐releasing hormone (TRH) in patients with preterm premature rupture of the membrane (PPROM). American Journal of Obstetrics and Gynecology1997;176:549. JacksonD , NageotteM , TowersC , AsratT , FreemanR , GardnerK , et al. Thyroid‐releasing hormone (TRH) versus betamethasone or placebo in preterm premature ruptured membranes: a prospective randomised study. American Journal of Obstetrics and Gynecology1991;170:383. ">Dola 1997</a>; <a href="./references#CD000019-bbs2-0018" title="RotiE , GardiniE , MinelliR , BianconiL , AlboniA , BravermanLE . Thyrotropin releasing hormone does not stimulate prolactin release in the preterm human fetus. Acta Endocrinologica1990;122(4):462‐6. ">Roti 1990</a>; <a href="./references#CD000019-bbs2-0019" title="TorresBA , StromquistCI , MoyaFR , DeClueT . Prenatal administration of thyrotropin‐releasing hormone and postnatal thyroxine values. Lancet1994;343:730. ">Torres 1994</a>; <a href="./references#CD000019-bbs2-0020" title="TorresJ , ForadoriA , SalinasR , PobleteJP , MaturanaA , RomanA , et al. Dose related response of the fetal pituitary‐thyroid axis to maternal administration of thyrotropin‐releasing hormone (TRH). Pediatric Research1995;2:241A. ">Torres 1995</a>; <a href="./references#CD000019-bbs2-0021" title="YoderBA . Trial to compare antenatal steroids alone, TRH alone, steroids + TRH and placebo in infants &lt;32 weeks' gestation. Personal communication1997. ">Yoder 1997</a>) for a variety of reasons. In four trials it was unclear as to whether all women (including those in the control group) received corticosteroids (<a href="./references#CD000019-bbs2-0016" title="DevliegerR , VanderlindenS , deZegherF , VanAsscheFA , SpitzB . Effect of antenatal thyrotropin‐releasing hormone on uterine contractility, blood pressure, and maternal heart rate. American Journal of Obstetrics and Gynecology1997;177(2):431‐3. SpitzB , DevliegerR , VanAsscheFA . Antenatal TRH‐treatment: effects on uterine contractions, blood pressure and maternal heart rate. 10th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1996 August 4‐8; Seattle, Washington, USA. 1996:191. ">Devlieger 1997</a>; <a href="./references#CD000019-bbs2-0017" title="DolaC , NageotteP , RumneyP , TowersC , AsratT , FreemanR , et al. The effects of antenatal treatment with betamethasone and thyrotropin‐releasing hormone (TRH) in patients with preterm premature rupture of the membrane (PPROM). American Journal of Obstetrics and Gynecology1997;176:549. JacksonD , NageotteM , TowersC , AsratT , FreemanR , GardnerK , et al. Thyroid‐releasing hormone (TRH) versus betamethasone or placebo in preterm premature ruptured membranes: a prospective randomised study. American Journal of Obstetrics and Gynecology1991;170:383. ">Dola 1997</a>; <a href="./references#CD000019-bbs2-0018" title="RotiE , GardiniE , MinelliR , BianconiL , AlboniA , BravermanLE . Thyrotropin releasing hormone does not stimulate prolactin release in the preterm human fetus. Acta Endocrinologica1990;122(4):462‐6. ">Roti 1990</a>; <a href="./references#CD000019-bbs2-0020" title="TorresJ , ForadoriA , SalinasR , PobleteJP , MaturanaA , RomanA , et al. Dose related response of the fetal pituitary‐thyroid axis to maternal administration of thyrotropin‐releasing hormone (TRH). Pediatric Research1995;2:241A. ">Torres 1995</a>); in one trial a cross‐over design was used (<a href="./references#CD000019-bbs2-0016" title="DevliegerR , VanderlindenS , deZegherF , VanAsscheFA , SpitzB . Effect of antenatal thyrotropin‐releasing hormone on uterine contractility, blood pressure, and maternal heart rate. American Journal of Obstetrics and Gynecology1997;177(2):431‐3. SpitzB , DevliegerR , VanAsscheFA . Antenatal TRH‐treatment: effects on uterine contractions, blood pressure and maternal heart rate. 10th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1996 August 4‐8; Seattle, Washington, USA. 1996:191. ">Devlieger 1997</a>); for one trial it was unclear as to whether it was randomised (<a href="./references#CD000019-bbs2-0019" title="TorresBA , StromquistCI , MoyaFR , DeClueT . Prenatal administration of thyrotropin‐releasing hormone and postnatal thyroxine values. Lancet1994;343:730. ">Torres 1994</a>); and one trial stopped without enrolling any women (<a href="./references#CD000019-bbs2-0021" title="YoderBA . Trial to compare antenatal steroids alone, TRH alone, steroids + TRH and placebo in infants &lt;32 weeks' gestation. Personal communication1997. ">Yoder 1997</a>). </p> <p>For further details see: <a href="./references#CD000019-sec2-0011" title="">Characteristics of excluded studies</a>. </p> </section> </section> <section id="CD000019-sec2-0005"> <h3 class="title">Risk of bias in included studies</h3> <p><i>See</i><a href="./references#CD000019-sec2-0010" title="">Characteristics of included studies</a>, <a href="#CD000019-fig-0001">Figure 1</a> and <a href="#CD000019-fig-0002">Figure 2</a> for further information on the risk of bias in the included studies. Overall, the risk of bias in the 15 included trials was judged to be moderate. </p> <div class="figure" id="CD000019-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD000019-fig-0001" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD000019-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD000019-fig-0002" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD000019-sec3-0021"> <h4 class="title">Allocation</h4> <p>Six of the 15 included trials used adequate methods for sequence generation. Four trials (<a href="./references#CD000019-bbs2-0002" title="CrowtherC , HillerJ , HaslamR , RobinsonJ , the ACTOBAT Study Group. Australian Collaborative Trial of Betamethasone and TRH for the prevention of neonatal respiratory disease (ACTOBAT). International Journal of Gynecology and Obstetrics1994;46:59. CrowtherCA , HillerJE , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial of antenatal thyrotropin‐releasing hormone: Adverse effects at 12‐month follow‐up. Pediatrics1997;99:311‐7. HillerJE , CrowtherCA , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial af antenatal thyrotropin‐releasing hormone (ACTOBAT): 12 month follow‐up. 4th Annual Congress of the Perinatal Society of Australia &amp; New Zealand; 1998 March 30‐April 4; Alice Springs, Australia. Alice Springs, 1998:77. The ACTOBAT Study Group. Australian collaborative trial of betamethasone and thyrotropin releasing hormone (ACTOBAT) for the prevention of neonatal respiratory disease. Lancet1995;345:877‐82. ">ACTOBAT 1995</a>; <a href="./references#CD000019-bbs2-0008" title="Collaborative Santiago Surfactant Group. Collaborative trial of prenatal thyrotropin‐releasing hormone and corticosteroids for prevention of respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178:33‐9. MaturanaA , TorresJ , SalinasR , MoyaF , for the Collaborative Group. Controlled trial of prenatal thyrotropin‐releasing hormone (TRH) and betamethasone (B) for prevention of respiratory distress syndrome (RDS). Pediatric Research1997;41:163A. ReyesG , GonzalezAR , GomezG , BlasiniI , RiveraCE . Comparative study of the effectiveness of thyroxine and steroids on reduction of neonatal morbidity: outcome at 20 months follow‐up. Puerto Rico Health Sciences Journal2004;23(1):9‐12. SantiagoR , RomagueraJ . Steroids vs steroids and thyroxine to accelerate fetal maturation of patients in arrested preterm labor. Puerto Rico Health Sciences Journal1999;18:156. ">Chile 1998</a>; <a href="./references#CD000019-bbs2-0010" title="AlfirevicZ , BoerK , BrocklehurstP , BuimerM , ElbourneD , KokJ , et al. Two trials of antenatal thyrotrophin‐releasing hormone for fetal maturation: stopping before the due date. British Journal of Obstetrics and Gynaecology1999;106:898‐906. AlfirevicZ , ElbourneD , BrocklehurstP , TruesdaleA , NeilsonJ . Randomised controlled trial of antenatal administration of thyrotropin releasing hormone (TRH) to women at risk of premature delivery. Prenatal and Neonatal Medicine1996;1(1):10. BrietJM , vanSonderenL , BuimerM , BoerK , KokJH . Neurodevelopmental outcome of children treated with antenatal thyrotropin‐releasing hormone. Pediatrics2002;110(2 Pt 1):249‐53. BrocklehurstP . Antenatal thyrotropin‐releasing hormone for fetal maturity: two concurrent randomised controlled trials (The Antenatal TRH Trial and the Thyroneth Trial). British Journal of Obstetrics and Gynaecology1998;105:81. ">Europe 1999</a>; <a href="./references#CD000019-bbs2-0015" title="VotoL , LedeR , ScagliaH , ZylbersteinC , ZapasterioJ , OrtiJ , et al. Effects of maternal administration of betamethasone, with and without TRH, on serum PRL, TSH and iodothyronine levels in Rh‐isoimmunized fetuses: a randomized clinical trial. Prenatal and Neonatal Medicine1998;3:447‐51. ">Voto 1998</a>) used central telephone randomisation, and two trials (<a href="./references#CD000019-bbs2-0003" title="BallardPL , BallardRA , CreasyRK , PadburyJ , PolkDH , BrackenM , et al. Plasma thyroid hormones and prolactin in premature infants and their mothers after treatment with thyrotropin‐releasing hormone. Pediatric Research1992;32(6):673‐8. BallardRA , BallardPL , CreasyR , GrossI , MainD , PadburyJF , et al. Prenatal treatment with thyrotropin releasing hormone plus corticosteroid: absence of maternal, fetal or neonatal side effects. Clinical Research1990;38:192A. BallardRA , BallardPL , CreasyR , GrossI , MainD , PadburyJF , et al. Prenatal treatment with thyrotropin releasing hormone plus corticosteroid: absence of maternal, fetal or neonatal side effects. Pediatric Research1991;29:202A. BallardRA , BallardPL , CreasyR , GrossI , PadburyJF , TRH Study Group. Thyrotropin releasing hormone plus corticosteroids decreases chronic lung disease in very low birth weight infants. Pediatric Research1991;29(4):1828A. BallardRA , BallardPL , CreasyR , PadburyJ , PolkDH , BrackenM , et al. Respiratory disease in very‐low birthweight infants after prenatal thyrotropin‐releasing hormone and glucocorticoid. Lancet1992;339:510‐5. ">Ballard 1992b</a>; <a href="./references#CD000019-bbs2-0013" title="KnightDB , LigginsGC , Wealthall SR. A randomised controlled trial of the effect of thyrotropin‐releasing hormone with betamethasone in mothers likely to deliver prematurely on neonatal outcome. Proceedings of the Australian Perinatal Society; 1992; Queensland, Australia. 1992:A9. KnightDB , LigginsGC , Wealthall SR. A randomized, controlled trial of antepartum thyrotropin‐releasing hormone and betamethasone in the prevention of respiratory disease in preterm infants. American Journal of Obstetrics and Gynecology1994;171:11‐6. KnightDB , Wealthall SR, LigginsGC , HowieRN . A randomised double blind controlled trial of antepartum TRH with betamethasone in the prevention of neonatal respiratory disease. New Zealand Medical Journal1989;102:195. LigginsGC , KnightDB , Wealthall SR, HowieRN . A randomized double‐blind trial of antepartum TRH and steroids in the prevention of neonatal respiratory disease. Clinical reproductive medicine ‐ the Liggins years; 1988 July 29‐30; Auckland, New Zealand. 1988. ">Knight 1994</a>) used random number tables. Sequence generation was unclear for the remaining trials (<a href="./references#CD000019-bbs2-0001" title="AbuhamadA , GreenG , HeylP , deVecianaM . The combined use of corticosteroids and thyrotropin releasing hormone in pregnancies with preterm rupture of membranes: a randomised double blind controlled trial. American Journal of Obstetrics and Gynecology1999;180(1 Pt 2):S96. ">Abuhamad 1999</a>; <a href="./references#CD000019-bbs2-0004" title="BallardPL , BallardRA , NingY , CnannA , BoardmanC , Pinto‐MartinJ , et al. Plasma thyroid hormones in premature infants: effect of gestational age and antenatal thyrotropin‐releasing hormone treatment. Pediatric Research1998;44:642‐9. BallardRA , BallardPL , BoardmanC , CnaanA , DavisDJ , HartMC , et al. Antenatal thyrotropin releasing hormone (TRH) for the prevention of chronic lung disease (CLD) in the preterm infant. Pediatric Research1997;41:246A. BallardRA , BallardPL , CnaanA , Pinto‐MartinJ , DavisDJ , PadburyJF , et al. Antenatal thyrotropin‐releasing hormone to prevention lung disease in preterm infants. New England Journal of Medicine1998;338:493‐8. ">Ballard 1998;</a><a href="./references#CD000019-bbs2-0005" title="CamposG , HerrmanF , DornerM . Combined hormonal therapy for the prevention of respiratory distress syndrome and its consequences. Seminars in Perinatology1993;17(4):267‐74. ">Campos 1993</a>; <a href="./references#CD000019-bbs2-0006" title="CarlanSJ , ParsonsM , O'BrienWF , KrammerJ . Pharmacologic pulmonary maturation in preterm premature rupture of membranes. American Journal of Obstetrics and Gynecology1991;164:371. ">Carlan 1991</a>; <a href="./references#CD000019-bbs2-0007" title="AlthabeF , FustiharaC , AlthabeO , CernadesJMC . Controlled trial of prenatal betamethasone plus TRH vs betamethasone plus placebo for prevention of RDS in preterm infants. Pediatric Research1991;29:200A. Ceriani CernadasJ , FustiharaC , AlthabeF , AlthabeO . Controlled trial of prenatal betamethasone (B) plus TRH for prevention of respiratory distress syndrome (RDS) in preterm infants. Pediatric Research1992;32:738. ">Ceriani 1992</a>; <a href="./references#CD000019-bbs2-0009" title="CrowtherC , HaslamR , HillerJ , McGeeT , RyallR , RobinsonJ . Thyrotropin‐releasing hormone: Does two hundred micrograms provide effective stimulation to the preterm fetal pituitary gland compared with four hundred micrograms?. American Journal of Obstetrics and Gynecology1995;173:719‐23. CrowtherCA , HaslamRR , HillerJE , McGeeT , RobinsonJS . Thyrotrophin releasing hormone (TRH) and lung maturation: does 200mcg TRH provide effective stimulation to the preterm fetal pituitary gland compared with 400mcg TRH?. International Journal of Gynecology and Obstetrics1991;36 Suppl:32. ">Crowther 1995</a>; <a href="./references#CD000019-bbs2-0011" title="JikiharaH , SawadaY , ImaiS , MorishigeK , TaniguchiT , NoharaA , et al. Maternal administration of thyrotropin‐releasing hormone for prevention of neonatal respiratory distress syndrome. Proceedings of 6th Congress of the Federation of the Asia‐Oceania Perinatal Societies; 1990 Oct 22‐26; Perth, Western Australia. 1990:87. ">Jikihara 1990</a>; <a href="./references#CD000019-bbs2-0012" title="KimEA , ParkSJ , YoonHS , KimKS , WonHS , LeeIS , et al. Antenatal thyrotropin‐releasing hormone to prevent respiratory distress syndrome in Korean preterm. Pediatric Academic Societies Annual Meeting; 2000 May 12‐16; Boston, MA, USA. 2000. KimEA , ParkSJ , YoonHS , KimKS , WonHS , LeeIS , et al. Antenatal thyrotropin‐releasing hormone to prevent respiratory distress syndrome in Korean preterm. Pediatric Research2000;47:407A. ">Kim 2000</a>; <a href="./references#CD000019-bbs2-0014" title="MoralesWJ , O'BrienWF , AngelJL , KnuppelRA , SawaiS . Fetal lung maturation: the combined use of corticosteroids and thyrotropin‐releasing hormone. Obstetrics and Gynecology1989;73:111‐6. ">Morales 1989</a>). </p> <p>Eight of the 15 trials (<a href="./references#CD000019-bbs2-0001" title="AbuhamadA , GreenG , HeylP , deVecianaM . The combined use of corticosteroids and thyrotropin releasing hormone in pregnancies with preterm rupture of membranes: a randomised double blind controlled trial. American Journal of Obstetrics and Gynecology1999;180(1 Pt 2):S96. ">Abuhamad 1999</a>; <a href="./references#CD000019-bbs2-0002" title="CrowtherC , HillerJ , HaslamR , RobinsonJ , the ACTOBAT Study Group. Australian Collaborative Trial of Betamethasone and TRH for the prevention of neonatal respiratory disease (ACTOBAT). International Journal of Gynecology and Obstetrics1994;46:59. CrowtherCA , HillerJE , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial of antenatal thyrotropin‐releasing hormone: Adverse effects at 12‐month follow‐up. Pediatrics1997;99:311‐7. HillerJE , CrowtherCA , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial af antenatal thyrotropin‐releasing hormone (ACTOBAT): 12 month follow‐up. 4th Annual Congress of the Perinatal Society of Australia &amp; New Zealand; 1998 March 30‐April 4; Alice Springs, Australia. Alice Springs, 1998:77. The ACTOBAT Study Group. Australian collaborative trial of betamethasone and thyrotropin releasing hormone (ACTOBAT) for the prevention of neonatal respiratory disease. Lancet1995;345:877‐82. ">ACTOBAT 1995</a>; <a href="./references#CD000019-bbs2-0003" title="BallardPL , BallardRA , CreasyRK , PadburyJ , PolkDH , BrackenM , et al. Plasma thyroid hormones and prolactin in premature infants and their mothers after treatment with thyrotropin‐releasing hormone. Pediatric Research1992;32(6):673‐8. BallardRA , BallardPL , CreasyR , GrossI , MainD , PadburyJF , et al. Prenatal treatment with thyrotropin releasing hormone plus corticosteroid: absence of maternal, fetal or neonatal side effects. Clinical Research1990;38:192A. BallardRA , BallardPL , CreasyR , GrossI , MainD , PadburyJF , et al. Prenatal treatment with thyrotropin releasing hormone plus corticosteroid: absence of maternal, fetal or neonatal side effects. Pediatric Research1991;29:202A. BallardRA , BallardPL , CreasyR , GrossI , PadburyJF , TRH Study Group. Thyrotropin releasing hormone plus corticosteroids decreases chronic lung disease in very low birth weight infants. Pediatric Research1991;29(4):1828A. BallardRA , BallardPL , CreasyR , PadburyJ , PolkDH , BrackenM , et al. Respiratory disease in very‐low birthweight infants after prenatal thyrotropin‐releasing hormone and glucocorticoid. Lancet1992;339:510‐5. ">Ballard 1992b</a>; <a href="./references#CD000019-bbs2-0004" title="BallardPL , BallardRA , NingY , CnannA , BoardmanC , Pinto‐MartinJ , et al. Plasma thyroid hormones in premature infants: effect of gestational age and antenatal thyrotropin‐releasing hormone treatment. Pediatric Research1998;44:642‐9. BallardRA , BallardPL , BoardmanC , CnaanA , DavisDJ , HartMC , et al. Antenatal thyrotropin releasing hormone (TRH) for the prevention of chronic lung disease (CLD) in the preterm infant. Pediatric Research1997;41:246A. BallardRA , BallardPL , CnaanA , Pinto‐MartinJ , DavisDJ , PadburyJF , et al. Antenatal thyrotropin‐releasing hormone to prevention lung disease in preterm infants. New England Journal of Medicine1998;338:493‐8. ">Ballard 1998</a>; <a href="./references#CD000019-bbs2-0008" title="Collaborative Santiago Surfactant Group. Collaborative trial of prenatal thyrotropin‐releasing hormone and corticosteroids for prevention of respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178:33‐9. MaturanaA , TorresJ , SalinasR , MoyaF , for the Collaborative Group. Controlled trial of prenatal thyrotropin‐releasing hormone (TRH) and betamethasone (B) for prevention of respiratory distress syndrome (RDS). Pediatric Research1997;41:163A. ReyesG , GonzalezAR , GomezG , BlasiniI , RiveraCE . Comparative study of the effectiveness of thyroxine and steroids on reduction of neonatal morbidity: outcome at 20 months follow‐up. Puerto Rico Health Sciences Journal2004;23(1):9‐12. SantiagoR , RomagueraJ . Steroids vs steroids and thyroxine to accelerate fetal maturation of patients in arrested preterm labor. Puerto Rico Health Sciences Journal1999;18:156. ">Chile 1998</a>; <a href="./references#CD000019-bbs2-0010" title="AlfirevicZ , BoerK , BrocklehurstP , BuimerM , ElbourneD , KokJ , et al. Two trials of antenatal thyrotrophin‐releasing hormone for fetal maturation: stopping before the due date. British Journal of Obstetrics and Gynaecology1999;106:898‐906. AlfirevicZ , ElbourneD , BrocklehurstP , TruesdaleA , NeilsonJ . Randomised controlled trial of antenatal administration of thyrotropin releasing hormone (TRH) to women at risk of premature delivery. Prenatal and Neonatal Medicine1996;1(1):10. BrietJM , vanSonderenL , BuimerM , BoerK , KokJH . Neurodevelopmental outcome of children treated with antenatal thyrotropin‐releasing hormone. Pediatrics2002;110(2 Pt 1):249‐53. BrocklehurstP . Antenatal thyrotropin‐releasing hormone for fetal maturity: two concurrent randomised controlled trials (The Antenatal TRH Trial and the Thyroneth Trial). British Journal of Obstetrics and Gynaecology1998;105:81. ">Europe 1999</a>; <a href="./references#CD000019-bbs2-0013" title="KnightDB , LigginsGC , Wealthall SR. A randomised controlled trial of the effect of thyrotropin‐releasing hormone with betamethasone in mothers likely to deliver prematurely on neonatal outcome. Proceedings of the Australian Perinatal Society; 1992; Queensland, Australia. 1992:A9. KnightDB , LigginsGC , Wealthall SR. A randomized, controlled trial of antepartum thyrotropin‐releasing hormone and betamethasone in the prevention of respiratory disease in preterm infants. American Journal of Obstetrics and Gynecology1994;171:11‐6. KnightDB , Wealthall SR, LigginsGC , HowieRN . A randomised double blind controlled trial of antepartum TRH with betamethasone in the prevention of neonatal respiratory disease. New Zealand Medical Journal1989;102:195. LigginsGC , KnightDB , Wealthall SR, HowieRN . A randomized double‐blind trial of antepartum TRH and steroids in the prevention of neonatal respiratory disease. Clinical reproductive medicine ‐ the Liggins years; 1988 July 29‐30; Auckland, New Zealand. 1988. ">Knight 1994</a>; <a href="./references#CD000019-bbs2-0015" title="VotoL , LedeR , ScagliaH , ZylbersteinC , ZapasterioJ , OrtiJ , et al. Effects of maternal administration of betamethasone, with and without TRH, on serum PRL, TSH and iodothyronine levels in Rh‐isoimmunized fetuses: a randomized clinical trial. Prenatal and Neonatal Medicine1998;3:447‐51. ">Voto 1998</a>) reported an adequate method for concealing allocation. Four trials (<a href="./references#CD000019-bbs2-0001" title="AbuhamadA , GreenG , HeylP , deVecianaM . The combined use of corticosteroids and thyrotropin releasing hormone in pregnancies with preterm rupture of membranes: a randomised double blind controlled trial. American Journal of Obstetrics and Gynecology1999;180(1 Pt 2):S96. ">Abuhamad 1999</a>; <a href="./references#CD000019-bbs2-0003" title="BallardPL , BallardRA , CreasyRK , PadburyJ , PolkDH , BrackenM , et al. Plasma thyroid hormones and prolactin in premature infants and their mothers after treatment with thyrotropin‐releasing hormone. Pediatric Research1992;32(6):673‐8. BallardRA , BallardPL , CreasyR , GrossI , MainD , PadburyJF , et al. Prenatal treatment with thyrotropin releasing hormone plus corticosteroid: absence of maternal, fetal or neonatal side effects. Clinical Research1990;38:192A. BallardRA , BallardPL , CreasyR , GrossI , MainD , PadburyJF , et al. Prenatal treatment with thyrotropin releasing hormone plus corticosteroid: absence of maternal, fetal or neonatal side effects. Pediatric Research1991;29:202A. BallardRA , BallardPL , CreasyR , GrossI , PadburyJF , TRH Study Group. Thyrotropin releasing hormone plus corticosteroids decreases chronic lung disease in very low birth weight infants. Pediatric Research1991;29(4):1828A. BallardRA , BallardPL , CreasyR , PadburyJ , PolkDH , BrackenM , et al. Respiratory disease in very‐low birthweight infants after prenatal thyrotropin‐releasing hormone and glucocorticoid. Lancet1992;339:510‐5. ">Ballard 1992b</a>; <a href="./references#CD000019-bbs2-0004" title="BallardPL , BallardRA , NingY , CnannA , BoardmanC , Pinto‐MartinJ , et al. Plasma thyroid hormones in premature infants: effect of gestational age and antenatal thyrotropin‐releasing hormone treatment. Pediatric Research1998;44:642‐9. BallardRA , BallardPL , BoardmanC , CnaanA , DavisDJ , HartMC , et al. Antenatal thyrotropin releasing hormone (TRH) for the prevention of chronic lung disease (CLD) in the preterm infant. Pediatric Research1997;41:246A. BallardRA , BallardPL , CnaanA , Pinto‐MartinJ , DavisDJ , PadburyJF , et al. Antenatal thyrotropin‐releasing hormone to prevention lung disease in preterm infants. New England Journal of Medicine1998;338:493‐8. ">Ballard 1998;</a><a href="./references#CD000019-bbs2-0013" title="KnightDB , LigginsGC , Wealthall SR. A randomised controlled trial of the effect of thyrotropin‐releasing hormone with betamethasone in mothers likely to deliver prematurely on neonatal outcome. Proceedings of the Australian Perinatal Society; 1992; Queensland, Australia. 1992:A9. KnightDB , LigginsGC , Wealthall SR. A randomized, controlled trial of antepartum thyrotropin‐releasing hormone and betamethasone in the prevention of respiratory disease in preterm infants. American Journal of Obstetrics and Gynecology1994;171:11‐6. KnightDB , Wealthall SR, LigginsGC , HowieRN . A randomised double blind controlled trial of antepartum TRH with betamethasone in the prevention of neonatal respiratory disease. New Zealand Medical Journal1989;102:195. LigginsGC , KnightDB , Wealthall SR, HowieRN . A randomized double‐blind trial of antepartum TRH and steroids in the prevention of neonatal respiratory disease. Clinical reproductive medicine ‐ the Liggins years; 1988 July 29‐30; Auckland, New Zealand. 1988. ">Knight 1994</a>) used a central allocation (pharmacy‐controlled), and three trials (<a href="./references#CD000019-bbs2-0002" title="CrowtherC , HillerJ , HaslamR , RobinsonJ , the ACTOBAT Study Group. Australian Collaborative Trial of Betamethasone and TRH for the prevention of neonatal respiratory disease (ACTOBAT). International Journal of Gynecology and Obstetrics1994;46:59. CrowtherCA , HillerJE , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial of antenatal thyrotropin‐releasing hormone: Adverse effects at 12‐month follow‐up. Pediatrics1997;99:311‐7. HillerJE , CrowtherCA , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial af antenatal thyrotropin‐releasing hormone (ACTOBAT): 12 month follow‐up. 4th Annual Congress of the Perinatal Society of Australia &amp; New Zealand; 1998 March 30‐April 4; Alice Springs, Australia. Alice Springs, 1998:77. The ACTOBAT Study Group. Australian collaborative trial of betamethasone and thyrotropin releasing hormone (ACTOBAT) for the prevention of neonatal respiratory disease. Lancet1995;345:877‐82. ">ACTOBAT 1995</a>; <a href="./references#CD000019-bbs2-0008" title="Collaborative Santiago Surfactant Group. Collaborative trial of prenatal thyrotropin‐releasing hormone and corticosteroids for prevention of respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178:33‐9. MaturanaA , TorresJ , SalinasR , MoyaF , for the Collaborative Group. Controlled trial of prenatal thyrotropin‐releasing hormone (TRH) and betamethasone (B) for prevention of respiratory distress syndrome (RDS). Pediatric Research1997;41:163A. ReyesG , GonzalezAR , GomezG , BlasiniI , RiveraCE . Comparative study of the effectiveness of thyroxine and steroids on reduction of neonatal morbidity: outcome at 20 months follow‐up. Puerto Rico Health Sciences Journal2004;23(1):9‐12. SantiagoR , RomagueraJ . Steroids vs steroids and thyroxine to accelerate fetal maturation of patients in arrested preterm labor. Puerto Rico Health Sciences Journal1999;18:156. ">Chile 1998</a>; <a href="./references#CD000019-bbs2-0010" title="AlfirevicZ , BoerK , BrocklehurstP , BuimerM , ElbourneD , KokJ , et al. Two trials of antenatal thyrotrophin‐releasing hormone for fetal maturation: stopping before the due date. British Journal of Obstetrics and Gynaecology1999;106:898‐906. AlfirevicZ , ElbourneD , BrocklehurstP , TruesdaleA , NeilsonJ . Randomised controlled trial of antenatal administration of thyrotropin releasing hormone (TRH) to women at risk of premature delivery. Prenatal and Neonatal Medicine1996;1(1):10. BrietJM , vanSonderenL , BuimerM , BoerK , KokJH . Neurodevelopmental outcome of children treated with antenatal thyrotropin‐releasing hormone. Pediatrics2002;110(2 Pt 1):249‐53. BrocklehurstP . Antenatal thyrotropin‐releasing hormone for fetal maturity: two concurrent randomised controlled trials (The Antenatal TRH Trial and the Thyroneth Trial). British Journal of Obstetrics and Gynaecology1998;105:81. ">Europe 1999</a>) used central telephone randomisation service. <a href="./references#CD000019-bbs2-0015" title="VotoL , LedeR , ScagliaH , ZylbersteinC , ZapasterioJ , OrtiJ , et al. Effects of maternal administration of betamethasone, with and without TRH, on serum PRL, TSH and iodothyronine levels in Rh‐isoimmunized fetuses: a randomized clinical trial. Prenatal and Neonatal Medicine1998;3:447‐51. ">Voto 1998</a> used sequentially numbered drug containers of identical appearance. Allocation concealment was unclear in the remaining seven trials (<a href="./references#CD000019-bbs2-0005" title="CamposG , HerrmanF , DornerM . Combined hormonal therapy for the prevention of respiratory distress syndrome and its consequences. Seminars in Perinatology1993;17(4):267‐74. ">Campos 1993</a>; <a href="./references#CD000019-bbs2-0006" title="CarlanSJ , ParsonsM , O'BrienWF , KrammerJ . Pharmacologic pulmonary maturation in preterm premature rupture of membranes. American Journal of Obstetrics and Gynecology1991;164:371. ">Carlan 1991</a>; <a href="./references#CD000019-bbs2-0007" title="AlthabeF , FustiharaC , AlthabeO , CernadesJMC . Controlled trial of prenatal betamethasone plus TRH vs betamethasone plus placebo for prevention of RDS in preterm infants. Pediatric Research1991;29:200A. Ceriani CernadasJ , FustiharaC , AlthabeF , AlthabeO . Controlled trial of prenatal betamethasone (B) plus TRH for prevention of respiratory distress syndrome (RDS) in preterm infants. Pediatric Research1992;32:738. ">Ceriani 1992</a>; <a href="./references#CD000019-bbs2-0009" title="CrowtherC , HaslamR , HillerJ , McGeeT , RyallR , RobinsonJ . Thyrotropin‐releasing hormone: Does two hundred micrograms provide effective stimulation to the preterm fetal pituitary gland compared with four hundred micrograms?. American Journal of Obstetrics and Gynecology1995;173:719‐23. CrowtherCA , HaslamRR , HillerJE , McGeeT , RobinsonJS . Thyrotrophin releasing hormone (TRH) and lung maturation: does 200mcg TRH provide effective stimulation to the preterm fetal pituitary gland compared with 400mcg TRH?. International Journal of Gynecology and Obstetrics1991;36 Suppl:32. ">Crowther 1995</a>; <a href="./references#CD000019-bbs2-0011" title="JikiharaH , SawadaY , ImaiS , MorishigeK , TaniguchiT , NoharaA , et al. Maternal administration of thyrotropin‐releasing hormone for prevention of neonatal respiratory distress syndrome. Proceedings of 6th Congress of the Federation of the Asia‐Oceania Perinatal Societies; 1990 Oct 22‐26; Perth, Western Australia. 1990:87. ">Jikihara 1990</a>; <a href="./references#CD000019-bbs2-0012" title="KimEA , ParkSJ , YoonHS , KimKS , WonHS , LeeIS , et al. Antenatal thyrotropin‐releasing hormone to prevent respiratory distress syndrome in Korean preterm. Pediatric Academic Societies Annual Meeting; 2000 May 12‐16; Boston, MA, USA. 2000. KimEA , ParkSJ , YoonHS , KimKS , WonHS , LeeIS , et al. Antenatal thyrotropin‐releasing hormone to prevent respiratory distress syndrome in Korean preterm. Pediatric Research2000;47:407A. ">Kim 2000</a>; <a href="./references#CD000019-bbs2-0014" title="MoralesWJ , O'BrienWF , AngelJL , KnuppelRA , SawaiS . Fetal lung maturation: the combined use of corticosteroids and thyrotropin‐releasing hormone. Obstetrics and Gynecology1989;73:111‐6. ">Morales 1989</a>). </p> </section> <section id="CD000019-sec3-0022"> <h4 class="title">Blinding</h4> <p>Seven of the 15 included trials (<a href="./references#CD000019-bbs2-0002" title="CrowtherC , HillerJ , HaslamR , RobinsonJ , the ACTOBAT Study Group. Australian Collaborative Trial of Betamethasone and TRH for the prevention of neonatal respiratory disease (ACTOBAT). International Journal of Gynecology and Obstetrics1994;46:59. CrowtherCA , HillerJE , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial of antenatal thyrotropin‐releasing hormone: Adverse effects at 12‐month follow‐up. Pediatrics1997;99:311‐7. HillerJE , CrowtherCA , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial af antenatal thyrotropin‐releasing hormone (ACTOBAT): 12 month follow‐up. 4th Annual Congress of the Perinatal Society of Australia &amp; New Zealand; 1998 March 30‐April 4; Alice Springs, Australia. Alice Springs, 1998:77. The ACTOBAT Study Group. Australian collaborative trial of betamethasone and thyrotropin releasing hormone (ACTOBAT) for the prevention of neonatal respiratory disease. Lancet1995;345:877‐82. ">ACTOBAT 1995</a>; <a href="./references#CD000019-bbs2-0003" title="BallardPL , BallardRA , CreasyRK , PadburyJ , PolkDH , BrackenM , et al. Plasma thyroid hormones and prolactin in premature infants and their mothers after treatment with thyrotropin‐releasing hormone. Pediatric Research1992;32(6):673‐8. BallardRA , BallardPL , CreasyR , GrossI , MainD , PadburyJF , et al. Prenatal treatment with thyrotropin releasing hormone plus corticosteroid: absence of maternal, fetal or neonatal side effects. Clinical Research1990;38:192A. BallardRA , BallardPL , CreasyR , GrossI , MainD , PadburyJF , et al. Prenatal treatment with thyrotropin releasing hormone plus corticosteroid: absence of maternal, fetal or neonatal side effects. Pediatric Research1991;29:202A. BallardRA , BallardPL , CreasyR , GrossI , PadburyJF , TRH Study Group. Thyrotropin releasing hormone plus corticosteroids decreases chronic lung disease in very low birth weight infants. Pediatric Research1991;29(4):1828A. BallardRA , BallardPL , CreasyR , PadburyJ , PolkDH , BrackenM , et al. Respiratory disease in very‐low birthweight infants after prenatal thyrotropin‐releasing hormone and glucocorticoid. Lancet1992;339:510‐5. ">Ballard 1992b</a>; <a href="./references#CD000019-bbs2-0004" title="BallardPL , BallardRA , NingY , CnannA , BoardmanC , Pinto‐MartinJ , et al. Plasma thyroid hormones in premature infants: effect of gestational age and antenatal thyrotropin‐releasing hormone treatment. Pediatric Research1998;44:642‐9. BallardRA , BallardPL , BoardmanC , CnaanA , DavisDJ , HartMC , et al. Antenatal thyrotropin releasing hormone (TRH) for the prevention of chronic lung disease (CLD) in the preterm infant. Pediatric Research1997;41:246A. BallardRA , BallardPL , CnaanA , Pinto‐MartinJ , DavisDJ , PadburyJF , et al. Antenatal thyrotropin‐releasing hormone to prevention lung disease in preterm infants. New England Journal of Medicine1998;338:493‐8. ">Ballard 1998</a>; <a href="./references#CD000019-bbs2-0008" title="Collaborative Santiago Surfactant Group. Collaborative trial of prenatal thyrotropin‐releasing hormone and corticosteroids for prevention of respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178:33‐9. MaturanaA , TorresJ , SalinasR , MoyaF , for the Collaborative Group. Controlled trial of prenatal thyrotropin‐releasing hormone (TRH) and betamethasone (B) for prevention of respiratory distress syndrome (RDS). Pediatric Research1997;41:163A. ReyesG , GonzalezAR , GomezG , BlasiniI , RiveraCE . Comparative study of the effectiveness of thyroxine and steroids on reduction of neonatal morbidity: outcome at 20 months follow‐up. Puerto Rico Health Sciences Journal2004;23(1):9‐12. SantiagoR , RomagueraJ . Steroids vs steroids and thyroxine to accelerate fetal maturation of patients in arrested preterm labor. Puerto Rico Health Sciences Journal1999;18:156. ">Chile 1998</a>; <a href="./references#CD000019-bbs2-0010" title="AlfirevicZ , BoerK , BrocklehurstP , BuimerM , ElbourneD , KokJ , et al. Two trials of antenatal thyrotrophin‐releasing hormone for fetal maturation: stopping before the due date. British Journal of Obstetrics and Gynaecology1999;106:898‐906. AlfirevicZ , ElbourneD , BrocklehurstP , TruesdaleA , NeilsonJ . Randomised controlled trial of antenatal administration of thyrotropin releasing hormone (TRH) to women at risk of premature delivery. Prenatal and Neonatal Medicine1996;1(1):10. BrietJM , vanSonderenL , BuimerM , BoerK , KokJH . Neurodevelopmental outcome of children treated with antenatal thyrotropin‐releasing hormone. Pediatrics2002;110(2 Pt 1):249‐53. BrocklehurstP . Antenatal thyrotropin‐releasing hormone for fetal maturity: two concurrent randomised controlled trials (The Antenatal TRH Trial and the Thyroneth Trial). British Journal of Obstetrics and Gynaecology1998;105:81. ">Europe 1999</a>; <a href="./references#CD000019-bbs2-0013" title="KnightDB , LigginsGC , Wealthall SR. A randomised controlled trial of the effect of thyrotropin‐releasing hormone with betamethasone in mothers likely to deliver prematurely on neonatal outcome. Proceedings of the Australian Perinatal Society; 1992; Queensland, Australia. 1992:A9. KnightDB , LigginsGC , Wealthall SR. A randomized, controlled trial of antepartum thyrotropin‐releasing hormone and betamethasone in the prevention of respiratory disease in preterm infants. American Journal of Obstetrics and Gynecology1994;171:11‐6. KnightDB , Wealthall SR, LigginsGC , HowieRN . A randomised double blind controlled trial of antepartum TRH with betamethasone in the prevention of neonatal respiratory disease. New Zealand Medical Journal1989;102:195. LigginsGC , KnightDB , Wealthall SR, HowieRN . A randomized double‐blind trial of antepartum TRH and steroids in the prevention of neonatal respiratory disease. Clinical reproductive medicine ‐ the Liggins years; 1988 July 29‐30; Auckland, New Zealand. 1988. ">Knight 1994</a>; <a href="./references#CD000019-bbs2-0015" title="VotoL , LedeR , ScagliaH , ZylbersteinC , ZapasterioJ , OrtiJ , et al. Effects of maternal administration of betamethasone, with and without TRH, on serum PRL, TSH and iodothyronine levels in Rh‐isoimmunized fetuses: a randomized clinical trial. Prenatal and Neonatal Medicine1998;3:447‐51. ">Voto 1998</a>) were blinded throughout the study. In <a href="./references#CD000019-bbs2-0002" title="CrowtherC , HillerJ , HaslamR , RobinsonJ , the ACTOBAT Study Group. Australian Collaborative Trial of Betamethasone and TRH for the prevention of neonatal respiratory disease (ACTOBAT). International Journal of Gynecology and Obstetrics1994;46:59. CrowtherCA , HillerJE , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial of antenatal thyrotropin‐releasing hormone: Adverse effects at 12‐month follow‐up. Pediatrics1997;99:311‐7. HillerJE , CrowtherCA , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial af antenatal thyrotropin‐releasing hormone (ACTOBAT): 12 month follow‐up. 4th Annual Congress of the Perinatal Society of Australia &amp; New Zealand; 1998 March 30‐April 4; Alice Springs, Australia. Alice Springs, 1998:77. The ACTOBAT Study Group. Australian collaborative trial of betamethasone and thyrotropin releasing hormone (ACTOBAT) for the prevention of neonatal respiratory disease. Lancet1995;345:877‐82. ">ACTOBAT 1995</a>, assessment of neonatal outcomes was blinded, and a placebo was used except for with the first 198 women recruited. In the other six studies, all women, investigators, clinicians and pregnancy outcome assessors were blinded, and a placebo was used (<a href="./references#CD000019-bbs2-0003" title="BallardPL , BallardRA , CreasyRK , PadburyJ , PolkDH , BrackenM , et al. Plasma thyroid hormones and prolactin in premature infants and their mothers after treatment with thyrotropin‐releasing hormone. Pediatric Research1992;32(6):673‐8. BallardRA , BallardPL , CreasyR , GrossI , MainD , PadburyJF , et al. Prenatal treatment with thyrotropin releasing hormone plus corticosteroid: absence of maternal, fetal or neonatal side effects. Clinical Research1990;38:192A. BallardRA , BallardPL , CreasyR , GrossI , MainD , PadburyJF , et al. Prenatal treatment with thyrotropin releasing hormone plus corticosteroid: absence of maternal, fetal or neonatal side effects. Pediatric Research1991;29:202A. BallardRA , BallardPL , CreasyR , GrossI , PadburyJF , TRH Study Group. Thyrotropin releasing hormone plus corticosteroids decreases chronic lung disease in very low birth weight infants. Pediatric Research1991;29(4):1828A. BallardRA , BallardPL , CreasyR , PadburyJ , PolkDH , BrackenM , et al. Respiratory disease in very‐low birthweight infants after prenatal thyrotropin‐releasing hormone and glucocorticoid. Lancet1992;339:510‐5. ">Ballard 1992b</a>; <a href="./references#CD000019-bbs2-0004" title="BallardPL , BallardRA , NingY , CnannA , BoardmanC , Pinto‐MartinJ , et al. Plasma thyroid hormones in premature infants: effect of gestational age and antenatal thyrotropin‐releasing hormone treatment. Pediatric Research1998;44:642‐9. BallardRA , BallardPL , BoardmanC , CnaanA , DavisDJ , HartMC , et al. Antenatal thyrotropin releasing hormone (TRH) for the prevention of chronic lung disease (CLD) in the preterm infant. Pediatric Research1997;41:246A. BallardRA , BallardPL , CnaanA , Pinto‐MartinJ , DavisDJ , PadburyJF , et al. Antenatal thyrotropin‐releasing hormone to prevention lung disease in preterm infants. New England Journal of Medicine1998;338:493‐8. ">Ballard 1998</a>; <a href="./references#CD000019-bbs2-0008" title="Collaborative Santiago Surfactant Group. Collaborative trial of prenatal thyrotropin‐releasing hormone and corticosteroids for prevention of respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178:33‐9. MaturanaA , TorresJ , SalinasR , MoyaF , for the Collaborative Group. Controlled trial of prenatal thyrotropin‐releasing hormone (TRH) and betamethasone (B) for prevention of respiratory distress syndrome (RDS). Pediatric Research1997;41:163A. ReyesG , GonzalezAR , GomezG , BlasiniI , RiveraCE . Comparative study of the effectiveness of thyroxine and steroids on reduction of neonatal morbidity: outcome at 20 months follow‐up. Puerto Rico Health Sciences Journal2004;23(1):9‐12. SantiagoR , RomagueraJ . Steroids vs steroids and thyroxine to accelerate fetal maturation of patients in arrested preterm labor. Puerto Rico Health Sciences Journal1999;18:156. ">Chile 1998</a>; <a href="./references#CD000019-bbs2-0010" title="AlfirevicZ , BoerK , BrocklehurstP , BuimerM , ElbourneD , KokJ , et al. Two trials of antenatal thyrotrophin‐releasing hormone for fetal maturation: stopping before the due date. British Journal of Obstetrics and Gynaecology1999;106:898‐906. AlfirevicZ , ElbourneD , BrocklehurstP , TruesdaleA , NeilsonJ . Randomised controlled trial of antenatal administration of thyrotropin releasing hormone (TRH) to women at risk of premature delivery. Prenatal and Neonatal Medicine1996;1(1):10. BrietJM , vanSonderenL , BuimerM , BoerK , KokJH . Neurodevelopmental outcome of children treated with antenatal thyrotropin‐releasing hormone. Pediatrics2002;110(2 Pt 1):249‐53. BrocklehurstP . Antenatal thyrotropin‐releasing hormone for fetal maturity: two concurrent randomised controlled trials (The Antenatal TRH Trial and the Thyroneth Trial). British Journal of Obstetrics and Gynaecology1998;105:81. ">Europe 1999</a>; <a href="./references#CD000019-bbs2-0013" title="KnightDB , LigginsGC , Wealthall SR. A randomised controlled trial of the effect of thyrotropin‐releasing hormone with betamethasone in mothers likely to deliver prematurely on neonatal outcome. Proceedings of the Australian Perinatal Society; 1992; Queensland, Australia. 1992:A9. KnightDB , LigginsGC , Wealthall SR. A randomized, controlled trial of antepartum thyrotropin‐releasing hormone and betamethasone in the prevention of respiratory disease in preterm infants. American Journal of Obstetrics and Gynecology1994;171:11‐6. KnightDB , Wealthall SR, LigginsGC , HowieRN . A randomised double blind controlled trial of antepartum TRH with betamethasone in the prevention of neonatal respiratory disease. New Zealand Medical Journal1989;102:195. LigginsGC , KnightDB , Wealthall SR, HowieRN . A randomized double‐blind trial of antepartum TRH and steroids in the prevention of neonatal respiratory disease. Clinical reproductive medicine ‐ the Liggins years; 1988 July 29‐30; Auckland, New Zealand. 1988. ">Knight 1994</a>; <a href="./references#CD000019-bbs2-0015" title="VotoL , LedeR , ScagliaH , ZylbersteinC , ZapasterioJ , OrtiJ , et al. Effects of maternal administration of betamethasone, with and without TRH, on serum PRL, TSH and iodothyronine levels in Rh‐isoimmunized fetuses: a randomized clinical trial. Prenatal and Neonatal Medicine1998;3:447‐51. ">Voto 1998</a>). </p> <p>In <a href="./references#CD000019-bbs2-0001" title="AbuhamadA , GreenG , HeylP , deVecianaM . The combined use of corticosteroids and thyrotropin releasing hormone in pregnancies with preterm rupture of membranes: a randomised double blind controlled trial. American Journal of Obstetrics and Gynecology1999;180(1 Pt 2):S96. ">Abuhamad 1999</a>, while a placebo was used and women and personnel were blinded, the blinding of outcome assessors was not detailed. Similarly, in <a href="./references#CD000019-bbs2-0007" title="AlthabeF , FustiharaC , AlthabeO , CernadesJMC . Controlled trial of prenatal betamethasone plus TRH vs betamethasone plus placebo for prevention of RDS in preterm infants. Pediatric Research1991;29:200A. Ceriani CernadasJ , FustiharaC , AlthabeF , AlthabeO . Controlled trial of prenatal betamethasone (B) plus TRH for prevention of respiratory distress syndrome (RDS) in preterm infants. Pediatric Research1992;32:738. ">Ceriani 1992</a>, while a placebo was used, and the trial was described as "double‐blind", no detail regarding blinding of outcome assessors was provided. In <a href="./references#CD000019-bbs2-0014" title="MoralesWJ , O'BrienWF , AngelJL , KnuppelRA , SawaiS . Fetal lung maturation: the combined use of corticosteroids and thyrotropin‐releasing hormone. Obstetrics and Gynecology1989;73:111‐6. ">Morales 1989</a>, neonate outcome recorders and neonatal respiratory distress assessors were blinded, however a placebo was not used (and thus women and other study personnel were not blinded). </p> <p>Blinding was unclear in six trials (<a href="./references#CD000019-bbs2-0005" title="CamposG , HerrmanF , DornerM . Combined hormonal therapy for the prevention of respiratory distress syndrome and its consequences. Seminars in Perinatology1993;17(4):267‐74. ">Campos 1993</a>; <a href="./references#CD000019-bbs2-0006" title="CarlanSJ , ParsonsM , O'BrienWF , KrammerJ . Pharmacologic pulmonary maturation in preterm premature rupture of membranes. American Journal of Obstetrics and Gynecology1991;164:371. ">Carlan 1991</a>; <a href="./references#CD000019-bbs2-0009" title="CrowtherC , HaslamR , HillerJ , McGeeT , RyallR , RobinsonJ . Thyrotropin‐releasing hormone: Does two hundred micrograms provide effective stimulation to the preterm fetal pituitary gland compared with four hundred micrograms?. American Journal of Obstetrics and Gynecology1995;173:719‐23. CrowtherCA , HaslamRR , HillerJE , McGeeT , RobinsonJS . Thyrotrophin releasing hormone (TRH) and lung maturation: does 200mcg TRH provide effective stimulation to the preterm fetal pituitary gland compared with 400mcg TRH?. International Journal of Gynecology and Obstetrics1991;36 Suppl:32. ">Crowther 1995</a>; <a href="./references#CD000019-bbs2-0011" title="JikiharaH , SawadaY , ImaiS , MorishigeK , TaniguchiT , NoharaA , et al. Maternal administration of thyrotropin‐releasing hormone for prevention of neonatal respiratory distress syndrome. Proceedings of 6th Congress of the Federation of the Asia‐Oceania Perinatal Societies; 1990 Oct 22‐26; Perth, Western Australia. 1990:87. ">Jikihara 1990</a>; <a href="./references#CD000019-bbs2-0012" title="KimEA , ParkSJ , YoonHS , KimKS , WonHS , LeeIS , et al. Antenatal thyrotropin‐releasing hormone to prevent respiratory distress syndrome in Korean preterm. Pediatric Academic Societies Annual Meeting; 2000 May 12‐16; Boston, MA, USA. 2000. KimEA , ParkSJ , YoonHS , KimKS , WonHS , LeeIS , et al. Antenatal thyrotropin‐releasing hormone to prevent respiratory distress syndrome in Korean preterm. Pediatric Research2000;47:407A. ">Kim 2000</a>) due to limited information available. </p> </section> <section id="CD000019-sec3-0023"> <h4 class="title">Incomplete outcome data</h4> <p>Losses to follow‐up in six trials (<a href="./references#CD000019-bbs2-0001" title="AbuhamadA , GreenG , HeylP , deVecianaM . The combined use of corticosteroids and thyrotropin releasing hormone in pregnancies with preterm rupture of membranes: a randomised double blind controlled trial. American Journal of Obstetrics and Gynecology1999;180(1 Pt 2):S96. ">Abuhamad 1999</a>; <a href="./references#CD000019-bbs2-0002" title="CrowtherC , HillerJ , HaslamR , RobinsonJ , the ACTOBAT Study Group. Australian Collaborative Trial of Betamethasone and TRH for the prevention of neonatal respiratory disease (ACTOBAT). International Journal of Gynecology and Obstetrics1994;46:59. CrowtherCA , HillerJE , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial of antenatal thyrotropin‐releasing hormone: Adverse effects at 12‐month follow‐up. Pediatrics1997;99:311‐7. HillerJE , CrowtherCA , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial af antenatal thyrotropin‐releasing hormone (ACTOBAT): 12 month follow‐up. 4th Annual Congress of the Perinatal Society of Australia &amp; New Zealand; 1998 March 30‐April 4; Alice Springs, Australia. Alice Springs, 1998:77. The ACTOBAT Study Group. Australian collaborative trial of betamethasone and thyrotropin releasing hormone (ACTOBAT) for the prevention of neonatal respiratory disease. Lancet1995;345:877‐82. ">ACTOBAT 1995</a>; <a href="./references#CD000019-bbs2-0004" title="BallardPL , BallardRA , NingY , CnannA , BoardmanC , Pinto‐MartinJ , et al. Plasma thyroid hormones in premature infants: effect of gestational age and antenatal thyrotropin‐releasing hormone treatment. Pediatric Research1998;44:642‐9. BallardRA , BallardPL , BoardmanC , CnaanA , DavisDJ , HartMC , et al. Antenatal thyrotropin releasing hormone (TRH) for the prevention of chronic lung disease (CLD) in the preterm infant. Pediatric Research1997;41:246A. BallardRA , BallardPL , CnaanA , Pinto‐MartinJ , DavisDJ , PadburyJF , et al. Antenatal thyrotropin‐releasing hormone to prevention lung disease in preterm infants. New England Journal of Medicine1998;338:493‐8. ">Ballard 1998</a>; <a href="./references#CD000019-bbs2-0009" title="CrowtherC , HaslamR , HillerJ , McGeeT , RyallR , RobinsonJ . Thyrotropin‐releasing hormone: Does two hundred micrograms provide effective stimulation to the preterm fetal pituitary gland compared with four hundred micrograms?. American Journal of Obstetrics and Gynecology1995;173:719‐23. CrowtherCA , HaslamRR , HillerJE , McGeeT , RobinsonJS . Thyrotrophin releasing hormone (TRH) and lung maturation: does 200mcg TRH provide effective stimulation to the preterm fetal pituitary gland compared with 400mcg TRH?. International Journal of Gynecology and Obstetrics1991;36 Suppl:32. ">Crowther 1995</a>; <a href="./references#CD000019-bbs2-0010" title="AlfirevicZ , BoerK , BrocklehurstP , BuimerM , ElbourneD , KokJ , et al. Two trials of antenatal thyrotrophin‐releasing hormone for fetal maturation: stopping before the due date. British Journal of Obstetrics and Gynaecology1999;106:898‐906. AlfirevicZ , ElbourneD , BrocklehurstP , TruesdaleA , NeilsonJ . Randomised controlled trial of antenatal administration of thyrotropin releasing hormone (TRH) to women at risk of premature delivery. Prenatal and Neonatal Medicine1996;1(1):10. BrietJM , vanSonderenL , BuimerM , BoerK , KokJH . Neurodevelopmental outcome of children treated with antenatal thyrotropin‐releasing hormone. Pediatrics2002;110(2 Pt 1):249‐53. BrocklehurstP . Antenatal thyrotropin‐releasing hormone for fetal maturity: two concurrent randomised controlled trials (The Antenatal TRH Trial and the Thyroneth Trial). British Journal of Obstetrics and Gynaecology1998;105:81. ">Europe 1999;</a><a href="./references#CD000019-bbs2-0013" title="KnightDB , LigginsGC , Wealthall SR. A randomised controlled trial of the effect of thyrotropin‐releasing hormone with betamethasone in mothers likely to deliver prematurely on neonatal outcome. Proceedings of the Australian Perinatal Society; 1992; Queensland, Australia. 1992:A9. KnightDB , LigginsGC , Wealthall SR. A randomized, controlled trial of antepartum thyrotropin‐releasing hormone and betamethasone in the prevention of respiratory disease in preterm infants. American Journal of Obstetrics and Gynecology1994;171:11‐6. KnightDB , Wealthall SR, LigginsGC , HowieRN . A randomised double blind controlled trial of antepartum TRH with betamethasone in the prevention of neonatal respiratory disease. New Zealand Medical Journal1989;102:195. LigginsGC , KnightDB , Wealthall SR, HowieRN . A randomized double‐blind trial of antepartum TRH and steroids in the prevention of neonatal respiratory disease. Clinical reproductive medicine ‐ the Liggins years; 1988 July 29‐30; Auckland, New Zealand. 1988. ">Knight 1994</a>) were less than 3%. In <a href="./references#CD000019-bbs2-0008" title="Collaborative Santiago Surfactant Group. Collaborative trial of prenatal thyrotropin‐releasing hormone and corticosteroids for prevention of respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178:33‐9. MaturanaA , TorresJ , SalinasR , MoyaF , for the Collaborative Group. Controlled trial of prenatal thyrotropin‐releasing hormone (TRH) and betamethasone (B) for prevention of respiratory distress syndrome (RDS). Pediatric Research1997;41:163A. ReyesG , GonzalezAR , GomezG , BlasiniI , RiveraCE . Comparative study of the effectiveness of thyroxine and steroids on reduction of neonatal morbidity: outcome at 20 months follow‐up. Puerto Rico Health Sciences Journal2004;23(1):9‐12. SantiagoR , RomagueraJ . Steroids vs steroids and thyroxine to accelerate fetal maturation of patients in arrested preterm labor. Puerto Rico Health Sciences Journal1999;18:156. ">Chile 1998</a>, losses to follow‐up were 21/370 (5.7%) for the main trial; however for the follow‐up, losses were over 50%. In <a href="./references#CD000019-bbs2-0015" title="VotoL , LedeR , ScagliaH , ZylbersteinC , ZapasterioJ , OrtiJ , et al. Effects of maternal administration of betamethasone, with and without TRH, on serum PRL, TSH and iodothyronine levels in Rh‐isoimmunized fetuses: a randomized clinical trial. Prenatal and Neonatal Medicine1998;3:447‐51. ">Voto 1998</a> data were missing for 4/35 (11.4%) of women; and in <a href="./references#CD000019-bbs2-0006" title="CarlanSJ , ParsonsM , O'BrienWF , KrammerJ . Pharmacologic pulmonary maturation in preterm premature rupture of membranes. American Journal of Obstetrics and Gynecology1991;164:371. ">Carlan 1991</a>, losses to follow‐up were 7/44 (15.9%). No information was available on losses to follow‐up in two trials (<a href="./references#CD000019-bbs2-0011" title="JikiharaH , SawadaY , ImaiS , MorishigeK , TaniguchiT , NoharaA , et al. Maternal administration of thyrotropin‐releasing hormone for prevention of neonatal respiratory distress syndrome. Proceedings of 6th Congress of the Federation of the Asia‐Oceania Perinatal Societies; 1990 Oct 22‐26; Perth, Western Australia. 1990:87. ">Jikihara 1990</a>; <a href="./references#CD000019-bbs2-0012" title="KimEA , ParkSJ , YoonHS , KimKS , WonHS , LeeIS , et al. Antenatal thyrotropin‐releasing hormone to prevent respiratory distress syndrome in Korean preterm. Pediatric Academic Societies Annual Meeting; 2000 May 12‐16; Boston, MA, USA. 2000. KimEA , ParkSJ , YoonHS , KimKS , WonHS , LeeIS , et al. Antenatal thyrotropin‐releasing hormone to prevent respiratory distress syndrome in Korean preterm. Pediatric Research2000;47:407A. ">Kim 2000</a>). </p> <p>In <a href="./references#CD000019-bbs2-0003" title="BallardPL , BallardRA , CreasyRK , PadburyJ , PolkDH , BrackenM , et al. Plasma thyroid hormones and prolactin in premature infants and their mothers after treatment with thyrotropin‐releasing hormone. Pediatric Research1992;32(6):673‐8. BallardRA , BallardPL , CreasyR , GrossI , MainD , PadburyJF , et al. Prenatal treatment with thyrotropin releasing hormone plus corticosteroid: absence of maternal, fetal or neonatal side effects. Clinical Research1990;38:192A. BallardRA , BallardPL , CreasyR , GrossI , MainD , PadburyJF , et al. Prenatal treatment with thyrotropin releasing hormone plus corticosteroid: absence of maternal, fetal or neonatal side effects. Pediatric Research1991;29:202A. BallardRA , BallardPL , CreasyR , GrossI , PadburyJF , TRH Study Group. Thyrotropin releasing hormone plus corticosteroids decreases chronic lung disease in very low birth weight infants. Pediatric Research1991;29(4):1828A. BallardRA , BallardPL , CreasyR , PadburyJ , PolkDH , BrackenM , et al. Respiratory disease in very‐low birthweight infants after prenatal thyrotropin‐releasing hormone and glucocorticoid. Lancet1992;339:510‐5. ">Ballard 1992b</a>; <a href="./references#CD000019-bbs2-0005" title="CamposG , HerrmanF , DornerM . Combined hormonal therapy for the prevention of respiratory distress syndrome and its consequences. Seminars in Perinatology1993;17(4):267‐74. ">Campos 1993</a>; <a href="./references#CD000019-bbs2-0006" title="CarlanSJ , ParsonsM , O'BrienWF , KrammerJ . Pharmacologic pulmonary maturation in preterm premature rupture of membranes. American Journal of Obstetrics and Gynecology1991;164:371. ">Carlan 1991</a> and <a href="./references#CD000019-bbs2-0014" title="MoralesWJ , O'BrienWF , AngelJL , KnuppelRA , SawaiS . Fetal lung maturation: the combined use of corticosteroids and thyrotropin‐releasing hormone. Obstetrics and Gynecology1989;73:111‐6. ">Morales 1989</a>, outcome data were only available for a subgroup of participants expected to benefit most from the exposure to prenatal TRH. </p> <p>An intention‐to‐treat analysis (with data analysed from all women randomised) was reported as being used in six trials (<a href="./references#CD000019-bbs2-0001" title="AbuhamadA , GreenG , HeylP , deVecianaM . The combined use of corticosteroids and thyrotropin releasing hormone in pregnancies with preterm rupture of membranes: a randomised double blind controlled trial. American Journal of Obstetrics and Gynecology1999;180(1 Pt 2):S96. ">Abuhamad 1999</a>; <a href="./references#CD000019-bbs2-0002" title="CrowtherC , HillerJ , HaslamR , RobinsonJ , the ACTOBAT Study Group. Australian Collaborative Trial of Betamethasone and TRH for the prevention of neonatal respiratory disease (ACTOBAT). International Journal of Gynecology and Obstetrics1994;46:59. CrowtherCA , HillerJE , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial of antenatal thyrotropin‐releasing hormone: Adverse effects at 12‐month follow‐up. Pediatrics1997;99:311‐7. HillerJE , CrowtherCA , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial af antenatal thyrotropin‐releasing hormone (ACTOBAT): 12 month follow‐up. 4th Annual Congress of the Perinatal Society of Australia &amp; New Zealand; 1998 March 30‐April 4; Alice Springs, Australia. Alice Springs, 1998:77. The ACTOBAT Study Group. Australian collaborative trial of betamethasone and thyrotropin releasing hormone (ACTOBAT) for the prevention of neonatal respiratory disease. Lancet1995;345:877‐82. ">ACTOBAT 1995</a>; <a href="./references#CD000019-bbs2-0004" title="BallardPL , BallardRA , NingY , CnannA , BoardmanC , Pinto‐MartinJ , et al. Plasma thyroid hormones in premature infants: effect of gestational age and antenatal thyrotropin‐releasing hormone treatment. Pediatric Research1998;44:642‐9. BallardRA , BallardPL , BoardmanC , CnaanA , DavisDJ , HartMC , et al. Antenatal thyrotropin releasing hormone (TRH) for the prevention of chronic lung disease (CLD) in the preterm infant. Pediatric Research1997;41:246A. BallardRA , BallardPL , CnaanA , Pinto‐MartinJ , DavisDJ , PadburyJF , et al. Antenatal thyrotropin‐releasing hormone to prevention lung disease in preterm infants. New England Journal of Medicine1998;338:493‐8. ">Ballard 1998</a>; <a href="./references#CD000019-bbs2-0008" title="Collaborative Santiago Surfactant Group. Collaborative trial of prenatal thyrotropin‐releasing hormone and corticosteroids for prevention of respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178:33‐9. MaturanaA , TorresJ , SalinasR , MoyaF , for the Collaborative Group. Controlled trial of prenatal thyrotropin‐releasing hormone (TRH) and betamethasone (B) for prevention of respiratory distress syndrome (RDS). Pediatric Research1997;41:163A. ReyesG , GonzalezAR , GomezG , BlasiniI , RiveraCE . Comparative study of the effectiveness of thyroxine and steroids on reduction of neonatal morbidity: outcome at 20 months follow‐up. Puerto Rico Health Sciences Journal2004;23(1):9‐12. SantiagoR , RomagueraJ . Steroids vs steroids and thyroxine to accelerate fetal maturation of patients in arrested preterm labor. Puerto Rico Health Sciences Journal1999;18:156. ">Chile 1998</a>; <a href="./references#CD000019-bbs2-0010" title="AlfirevicZ , BoerK , BrocklehurstP , BuimerM , ElbourneD , KokJ , et al. Two trials of antenatal thyrotrophin‐releasing hormone for fetal maturation: stopping before the due date. British Journal of Obstetrics and Gynaecology1999;106:898‐906. AlfirevicZ , ElbourneD , BrocklehurstP , TruesdaleA , NeilsonJ . Randomised controlled trial of antenatal administration of thyrotropin releasing hormone (TRH) to women at risk of premature delivery. Prenatal and Neonatal Medicine1996;1(1):10. BrietJM , vanSonderenL , BuimerM , BoerK , KokJH . Neurodevelopmental outcome of children treated with antenatal thyrotropin‐releasing hormone. Pediatrics2002;110(2 Pt 1):249‐53. BrocklehurstP . Antenatal thyrotropin‐releasing hormone for fetal maturity: two concurrent randomised controlled trials (The Antenatal TRH Trial and the Thyroneth Trial). British Journal of Obstetrics and Gynaecology1998;105:81. ">Europe 1999</a>; <a href="./references#CD000019-bbs2-0013" title="KnightDB , LigginsGC , Wealthall SR. A randomised controlled trial of the effect of thyrotropin‐releasing hormone with betamethasone in mothers likely to deliver prematurely on neonatal outcome. Proceedings of the Australian Perinatal Society; 1992; Queensland, Australia. 1992:A9. KnightDB , LigginsGC , Wealthall SR. A randomized, controlled trial of antepartum thyrotropin‐releasing hormone and betamethasone in the prevention of respiratory disease in preterm infants. American Journal of Obstetrics and Gynecology1994;171:11‐6. KnightDB , Wealthall SR, LigginsGC , HowieRN . A randomised double blind controlled trial of antepartum TRH with betamethasone in the prevention of neonatal respiratory disease. New Zealand Medical Journal1989;102:195. LigginsGC , KnightDB , Wealthall SR, HowieRN . A randomized double‐blind trial of antepartum TRH and steroids in the prevention of neonatal respiratory disease. Clinical reproductive medicine ‐ the Liggins years; 1988 July 29‐30; Auckland, New Zealand. 1988. ">Knight 1994</a>), was probably used in three others (<a href="./references#CD000019-bbs2-0006" title="CarlanSJ , ParsonsM , O'BrienWF , KrammerJ . Pharmacologic pulmonary maturation in preterm premature rupture of membranes. American Journal of Obstetrics and Gynecology1991;164:371. ">Carlan 1991</a>; <a href="./references#CD000019-bbs2-0011" title="JikiharaH , SawadaY , ImaiS , MorishigeK , TaniguchiT , NoharaA , et al. Maternal administration of thyrotropin‐releasing hormone for prevention of neonatal respiratory distress syndrome. Proceedings of 6th Congress of the Federation of the Asia‐Oceania Perinatal Societies; 1990 Oct 22‐26; Perth, Western Australia. 1990:87. ">Jikihara 1990</a>; <a href="./references#CD000019-bbs2-0012" title="KimEA , ParkSJ , YoonHS , KimKS , WonHS , LeeIS , et al. Antenatal thyrotropin‐releasing hormone to prevent respiratory distress syndrome in Korean preterm. Pediatric Academic Societies Annual Meeting; 2000 May 12‐16; Boston, MA, USA. 2000. KimEA , ParkSJ , YoonHS , KimKS , WonHS , LeeIS , et al. Antenatal thyrotropin‐releasing hormone to prevent respiratory distress syndrome in Korean preterm. Pediatric Research2000;47:407A. ">Kim 2000</a>) and was not used in <a href="./references#CD000019-bbs2-0003" title="BallardPL , BallardRA , CreasyRK , PadburyJ , PolkDH , BrackenM , et al. Plasma thyroid hormones and prolactin in premature infants and their mothers after treatment with thyrotropin‐releasing hormone. Pediatric Research1992;32(6):673‐8. BallardRA , BallardPL , CreasyR , GrossI , MainD , PadburyJF , et al. Prenatal treatment with thyrotropin releasing hormone plus corticosteroid: absence of maternal, fetal or neonatal side effects. Clinical Research1990;38:192A. BallardRA , BallardPL , CreasyR , GrossI , MainD , PadburyJF , et al. Prenatal treatment with thyrotropin releasing hormone plus corticosteroid: absence of maternal, fetal or neonatal side effects. Pediatric Research1991;29:202A. BallardRA , BallardPL , CreasyR , GrossI , PadburyJF , TRH Study Group. Thyrotropin releasing hormone plus corticosteroids decreases chronic lung disease in very low birth weight infants. Pediatric Research1991;29(4):1828A. BallardRA , BallardPL , CreasyR , PadburyJ , PolkDH , BrackenM , et al. Respiratory disease in very‐low birthweight infants after prenatal thyrotropin‐releasing hormone and glucocorticoid. Lancet1992;339:510‐5. ">Ballard 1992b</a>; <a href="./references#CD000019-bbs2-0005" title="CamposG , HerrmanF , DornerM . Combined hormonal therapy for the prevention of respiratory distress syndrome and its consequences. Seminars in Perinatology1993;17(4):267‐74. ">Campos 1993</a> and <a href="./references#CD000019-bbs2-0014" title="MoralesWJ , O'BrienWF , AngelJL , KnuppelRA , SawaiS . Fetal lung maturation: the combined use of corticosteroids and thyrotropin‐releasing hormone. Obstetrics and Gynecology1989;73:111‐6. ">Morales 1989</a>. </p> </section> <section id="CD000019-sec3-0024"> <h4 class="title">Selective reporting</h4> <p>There was no obvious risk of selective reporting in five of the 15 trials (<a href="./references#CD000019-bbs2-0002" title="CrowtherC , HillerJ , HaslamR , RobinsonJ , the ACTOBAT Study Group. Australian Collaborative Trial of Betamethasone and TRH for the prevention of neonatal respiratory disease (ACTOBAT). International Journal of Gynecology and Obstetrics1994;46:59. CrowtherCA , HillerJE , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial of antenatal thyrotropin‐releasing hormone: Adverse effects at 12‐month follow‐up. Pediatrics1997;99:311‐7. HillerJE , CrowtherCA , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial af antenatal thyrotropin‐releasing hormone (ACTOBAT): 12 month follow‐up. 4th Annual Congress of the Perinatal Society of Australia &amp; New Zealand; 1998 March 30‐April 4; Alice Springs, Australia. Alice Springs, 1998:77. The ACTOBAT Study Group. Australian collaborative trial of betamethasone and thyrotropin releasing hormone (ACTOBAT) for the prevention of neonatal respiratory disease. Lancet1995;345:877‐82. ">ACTOBAT 1995</a>; <a href="./references#CD000019-bbs2-0004" title="BallardPL , BallardRA , NingY , CnannA , BoardmanC , Pinto‐MartinJ , et al. Plasma thyroid hormones in premature infants: effect of gestational age and antenatal thyrotropin‐releasing hormone treatment. Pediatric Research1998;44:642‐9. BallardRA , BallardPL , BoardmanC , CnaanA , DavisDJ , HartMC , et al. Antenatal thyrotropin releasing hormone (TRH) for the prevention of chronic lung disease (CLD) in the preterm infant. Pediatric Research1997;41:246A. BallardRA , BallardPL , CnaanA , Pinto‐MartinJ , DavisDJ , PadburyJF , et al. Antenatal thyrotropin‐releasing hormone to prevention lung disease in preterm infants. New England Journal of Medicine1998;338:493‐8. ">Ballard 1998</a>; <a href="./references#CD000019-bbs2-0008" title="Collaborative Santiago Surfactant Group. Collaborative trial of prenatal thyrotropin‐releasing hormone and corticosteroids for prevention of respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178:33‐9. MaturanaA , TorresJ , SalinasR , MoyaF , for the Collaborative Group. Controlled trial of prenatal thyrotropin‐releasing hormone (TRH) and betamethasone (B) for prevention of respiratory distress syndrome (RDS). Pediatric Research1997;41:163A. ReyesG , GonzalezAR , GomezG , BlasiniI , RiveraCE . Comparative study of the effectiveness of thyroxine and steroids on reduction of neonatal morbidity: outcome at 20 months follow‐up. Puerto Rico Health Sciences Journal2004;23(1):9‐12. SantiagoR , RomagueraJ . Steroids vs steroids and thyroxine to accelerate fetal maturation of patients in arrested preterm labor. Puerto Rico Health Sciences Journal1999;18:156. ">Chile 1998</a>; <a href="./references#CD000019-bbs2-0010" title="AlfirevicZ , BoerK , BrocklehurstP , BuimerM , ElbourneD , KokJ , et al. Two trials of antenatal thyrotrophin‐releasing hormone for fetal maturation: stopping before the due date. British Journal of Obstetrics and Gynaecology1999;106:898‐906. AlfirevicZ , ElbourneD , BrocklehurstP , TruesdaleA , NeilsonJ . Randomised controlled trial of antenatal administration of thyrotropin releasing hormone (TRH) to women at risk of premature delivery. Prenatal and Neonatal Medicine1996;1(1):10. BrietJM , vanSonderenL , BuimerM , BoerK , KokJH . Neurodevelopmental outcome of children treated with antenatal thyrotropin‐releasing hormone. Pediatrics2002;110(2 Pt 1):249‐53. BrocklehurstP . Antenatal thyrotropin‐releasing hormone for fetal maturity: two concurrent randomised controlled trials (The Antenatal TRH Trial and the Thyroneth Trial). British Journal of Obstetrics and Gynaecology1998;105:81. ">Europe 1999</a>; <a href="./references#CD000019-bbs2-0013" title="KnightDB , LigginsGC , Wealthall SR. A randomised controlled trial of the effect of thyrotropin‐releasing hormone with betamethasone in mothers likely to deliver prematurely on neonatal outcome. Proceedings of the Australian Perinatal Society; 1992; Queensland, Australia. 1992:A9. KnightDB , LigginsGC , Wealthall SR. A randomized, controlled trial of antepartum thyrotropin‐releasing hormone and betamethasone in the prevention of respiratory disease in preterm infants. American Journal of Obstetrics and Gynecology1994;171:11‐6. KnightDB , Wealthall SR, LigginsGC , HowieRN . A randomised double blind controlled trial of antepartum TRH with betamethasone in the prevention of neonatal respiratory disease. New Zealand Medical Journal1989;102:195. LigginsGC , KnightDB , Wealthall SR, HowieRN . A randomized double‐blind trial of antepartum TRH and steroids in the prevention of neonatal respiratory disease. Clinical reproductive medicine ‐ the Liggins years; 1988 July 29‐30; Auckland, New Zealand. 1988. ">Knight 1994</a>). In six trials there was insufficient information to make a clear judgement (<a href="./references#CD000019-bbs2-0001" title="AbuhamadA , GreenG , HeylP , deVecianaM . The combined use of corticosteroids and thyrotropin releasing hormone in pregnancies with preterm rupture of membranes: a randomised double blind controlled trial. American Journal of Obstetrics and Gynecology1999;180(1 Pt 2):S96. ">Abuhamad 1999</a>; <a href="./references#CD000019-bbs2-0006" title="CarlanSJ , ParsonsM , O'BrienWF , KrammerJ . Pharmacologic pulmonary maturation in preterm premature rupture of membranes. American Journal of Obstetrics and Gynecology1991;164:371. ">Carlan 1991</a>; <a href="./references#CD000019-bbs2-0007" title="AlthabeF , FustiharaC , AlthabeO , CernadesJMC . Controlled trial of prenatal betamethasone plus TRH vs betamethasone plus placebo for prevention of RDS in preterm infants. Pediatric Research1991;29:200A. Ceriani CernadasJ , FustiharaC , AlthabeF , AlthabeO . Controlled trial of prenatal betamethasone (B) plus TRH for prevention of respiratory distress syndrome (RDS) in preterm infants. Pediatric Research1992;32:738. ">Ceriani 1992</a>; <a href="./references#CD000019-bbs2-0009" title="CrowtherC , HaslamR , HillerJ , McGeeT , RyallR , RobinsonJ . Thyrotropin‐releasing hormone: Does two hundred micrograms provide effective stimulation to the preterm fetal pituitary gland compared with four hundred micrograms?. American Journal of Obstetrics and Gynecology1995;173:719‐23. CrowtherCA , HaslamRR , HillerJE , McGeeT , RobinsonJS . Thyrotrophin releasing hormone (TRH) and lung maturation: does 200mcg TRH provide effective stimulation to the preterm fetal pituitary gland compared with 400mcg TRH?. International Journal of Gynecology and Obstetrics1991;36 Suppl:32. ">Crowther 1995</a>; <a href="./references#CD000019-bbs2-0011" title="JikiharaH , SawadaY , ImaiS , MorishigeK , TaniguchiT , NoharaA , et al. Maternal administration of thyrotropin‐releasing hormone for prevention of neonatal respiratory distress syndrome. Proceedings of 6th Congress of the Federation of the Asia‐Oceania Perinatal Societies; 1990 Oct 22‐26; Perth, Western Australia. 1990:87. ">Jikihara 1990</a>; <a href="./references#CD000019-bbs2-0012" title="KimEA , ParkSJ , YoonHS , KimKS , WonHS , LeeIS , et al. Antenatal thyrotropin‐releasing hormone to prevent respiratory distress syndrome in Korean preterm. Pediatric Academic Societies Annual Meeting; 2000 May 12‐16; Boston, MA, USA. 2000. KimEA , ParkSJ , YoonHS , KimKS , WonHS , LeeIS , et al. Antenatal thyrotropin‐releasing hormone to prevent respiratory distress syndrome in Korean preterm. Pediatric Research2000;47:407A. ">Kim 2000</a>; <a href="./references#CD000019-bbs2-0015" title="VotoL , LedeR , ScagliaH , ZylbersteinC , ZapasterioJ , OrtiJ , et al. Effects of maternal administration of betamethasone, with and without TRH, on serum PRL, TSH and iodothyronine levels in Rh‐isoimmunized fetuses: a randomized clinical trial. Prenatal and Neonatal Medicine1998;3:447‐51. ">Voto 1998</a>). </p> <p>Four trials (<a href="./references#CD000019-bbs2-0003" title="BallardPL , BallardRA , CreasyRK , PadburyJ , PolkDH , BrackenM , et al. Plasma thyroid hormones and prolactin in premature infants and their mothers after treatment with thyrotropin‐releasing hormone. Pediatric Research1992;32(6):673‐8. BallardRA , BallardPL , CreasyR , GrossI , MainD , PadburyJF , et al. Prenatal treatment with thyrotropin releasing hormone plus corticosteroid: absence of maternal, fetal or neonatal side effects. Clinical Research1990;38:192A. BallardRA , BallardPL , CreasyR , GrossI , MainD , PadburyJF , et al. Prenatal treatment with thyrotropin releasing hormone plus corticosteroid: absence of maternal, fetal or neonatal side effects. Pediatric Research1991;29:202A. BallardRA , BallardPL , CreasyR , GrossI , PadburyJF , TRH Study Group. Thyrotropin releasing hormone plus corticosteroids decreases chronic lung disease in very low birth weight infants. Pediatric Research1991;29(4):1828A. BallardRA , BallardPL , CreasyR , PadburyJ , PolkDH , BrackenM , et al. Respiratory disease in very‐low birthweight infants after prenatal thyrotropin‐releasing hormone and glucocorticoid. Lancet1992;339:510‐5. ">Ballard 1992b</a>; <a href="./references#CD000019-bbs2-0005" title="CamposG , HerrmanF , DornerM . Combined hormonal therapy for the prevention of respiratory distress syndrome and its consequences. Seminars in Perinatology1993;17(4):267‐74. ">Campos 1993</a>; <a href="./references#CD000019-bbs2-0007" title="AlthabeF , FustiharaC , AlthabeO , CernadesJMC . Controlled trial of prenatal betamethasone plus TRH vs betamethasone plus placebo for prevention of RDS in preterm infants. Pediatric Research1991;29:200A. Ceriani CernadasJ , FustiharaC , AlthabeF , AlthabeO . Controlled trial of prenatal betamethasone (B) plus TRH for prevention of respiratory distress syndrome (RDS) in preterm infants. Pediatric Research1992;32:738. ">Ceriani 1992</a>; <a href="./references#CD000019-bbs2-0014" title="MoralesWJ , O'BrienWF , AngelJL , KnuppelRA , SawaiS . Fetal lung maturation: the combined use of corticosteroids and thyrotropin‐releasing hormone. Obstetrics and Gynecology1989;73:111‐6. ">Morales 1989</a>) only presented outcomes for a subgroup of participants expected to benefit most from the exposure to prenatal TRH. This led to significant numbers of women who were randomised, being excluded from analysis in <a href="./references#CD000019-bbs2-0014" title="MoralesWJ , O'BrienWF , AngelJL , KnuppelRA , SawaiS . Fetal lung maturation: the combined use of corticosteroids and thyrotropin‐releasing hormone. Obstetrics and Gynecology1989;73:111‐6. ">Morales 1989</a> (148/248; 60% excluded); <a href="./references#CD000019-bbs2-0003" title="BallardPL , BallardRA , CreasyRK , PadburyJ , PolkDH , BrackenM , et al. Plasma thyroid hormones and prolactin in premature infants and their mothers after treatment with thyrotropin‐releasing hormone. Pediatric Research1992;32(6):673‐8. BallardRA , BallardPL , CreasyR , GrossI , MainD , PadburyJF , et al. Prenatal treatment with thyrotropin releasing hormone plus corticosteroid: absence of maternal, fetal or neonatal side effects. Clinical Research1990;38:192A. BallardRA , BallardPL , CreasyR , GrossI , MainD , PadburyJF , et al. Prenatal treatment with thyrotropin releasing hormone plus corticosteroid: absence of maternal, fetal or neonatal side effects. Pediatric Research1991;29:202A. BallardRA , BallardPL , CreasyR , GrossI , PadburyJF , TRH Study Group. Thyrotropin releasing hormone plus corticosteroids decreases chronic lung disease in very low birth weight infants. Pediatric Research1991;29(4):1828A. BallardRA , BallardPL , CreasyR , PadburyJ , PolkDH , BrackenM , et al. Respiratory disease in very‐low birthweight infants after prenatal thyrotropin‐releasing hormone and glucocorticoid. Lancet1992;339:510‐5. ">Ballard 1992b</a> (343/446; 77% infants excluded); probably <a href="./references#CD000019-bbs2-0007" title="AlthabeF , FustiharaC , AlthabeO , CernadesJMC . Controlled trial of prenatal betamethasone plus TRH vs betamethasone plus placebo for prevention of RDS in preterm infants. Pediatric Research1991;29:200A. Ceriani CernadasJ , FustiharaC , AlthabeF , AlthabeO . Controlled trial of prenatal betamethasone (B) plus TRH for prevention of respiratory distress syndrome (RDS) in preterm infants. Pediatric Research1992;32:738. ">Ceriani 1992</a> (percentage not reported); and <a href="./references#CD000019-bbs2-0005" title="CamposG , HerrmanF , DornerM . Combined hormonal therapy for the prevention of respiratory distress syndrome and its consequences. Seminars in Perinatology1993;17(4):267‐74. ">Campos 1993</a> (percentage not reported). <a href="./references#CD000019-bbs2-0014" title="MoralesWJ , O'BrienWF , AngelJL , KnuppelRA , SawaiS . Fetal lung maturation: the combined use of corticosteroids and thyrotropin‐releasing hormone. Obstetrics and Gynecology1989;73:111‐6. ">Morales 1989</a> gave outcome data for infants delivered within one week from the start of therapy. <a href="./references#CD000019-bbs2-0003" title="BallardPL , BallardRA , CreasyRK , PadburyJ , PolkDH , BrackenM , et al. Plasma thyroid hormones and prolactin in premature infants and their mothers after treatment with thyrotropin‐releasing hormone. Pediatric Research1992;32(6):673‐8. BallardRA , BallardPL , CreasyR , GrossI , MainD , PadburyJF , et al. Prenatal treatment with thyrotropin releasing hormone plus corticosteroid: absence of maternal, fetal or neonatal side effects. Clinical Research1990;38:192A. BallardRA , BallardPL , CreasyR , GrossI , MainD , PadburyJF , et al. Prenatal treatment with thyrotropin releasing hormone plus corticosteroid: absence of maternal, fetal or neonatal side effects. Pediatric Research1991;29:202A. BallardRA , BallardPL , CreasyR , GrossI , PadburyJF , TRH Study Group. Thyrotropin releasing hormone plus corticosteroids decreases chronic lung disease in very low birth weight infants. Pediatric Research1991;29(4):1828A. BallardRA , BallardPL , CreasyR , PadburyJ , PolkDH , BrackenM , et al. Respiratory disease in very‐low birthweight infants after prenatal thyrotropin‐releasing hormone and glucocorticoid. Lancet1992;339:510‐5. ">Ballard 1992b</a> reported data for neonates born after full treatment, weighing less than 1500 g at birth and delivering less than 10 days after TRH treatment. <a href="./references#CD000019-bbs2-0007" title="AlthabeF , FustiharaC , AlthabeO , CernadesJMC . Controlled trial of prenatal betamethasone plus TRH vs betamethasone plus placebo for prevention of RDS in preterm infants. Pediatric Research1991;29:200A. Ceriani CernadasJ , FustiharaC , AlthabeF , AlthabeO . Controlled trial of prenatal betamethasone (B) plus TRH for prevention of respiratory distress syndrome (RDS) in preterm infants. Pediatric Research1992;32:738. ">Ceriani 1992</a> reported data for infants born within 10 days of entry who were fully treated (received all doses of TRH or corticosteroids, or both). <a href="./references#CD000019-bbs2-0005" title="CamposG , HerrmanF , DornerM . Combined hormonal therapy for the prevention of respiratory distress syndrome and its consequences. Seminars in Perinatology1993;17(4):267‐74. ">Campos 1993</a> reported data on fully treated infants (received all doses of TRH or corticosteroids, or both) who were born within 48 hours of the last hormonal dose. </p> <p>Neurological outcomes at childhood follow‐up were reported for three trials (<a href="./references#CD000019-bbs2-0002" title="CrowtherC , HillerJ , HaslamR , RobinsonJ , the ACTOBAT Study Group. Australian Collaborative Trial of Betamethasone and TRH for the prevention of neonatal respiratory disease (ACTOBAT). International Journal of Gynecology and Obstetrics1994;46:59. CrowtherCA , HillerJE , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial of antenatal thyrotropin‐releasing hormone: Adverse effects at 12‐month follow‐up. Pediatrics1997;99:311‐7. HillerJE , CrowtherCA , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial af antenatal thyrotropin‐releasing hormone (ACTOBAT): 12 month follow‐up. 4th Annual Congress of the Perinatal Society of Australia &amp; New Zealand; 1998 March 30‐April 4; Alice Springs, Australia. Alice Springs, 1998:77. The ACTOBAT Study Group. Australian collaborative trial of betamethasone and thyrotropin releasing hormone (ACTOBAT) for the prevention of neonatal respiratory disease. Lancet1995;345:877‐82. ">ACTOBAT 1995</a>; <a href="./references#CD000019-bbs2-0008" title="Collaborative Santiago Surfactant Group. Collaborative trial of prenatal thyrotropin‐releasing hormone and corticosteroids for prevention of respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178:33‐9. MaturanaA , TorresJ , SalinasR , MoyaF , for the Collaborative Group. Controlled trial of prenatal thyrotropin‐releasing hormone (TRH) and betamethasone (B) for prevention of respiratory distress syndrome (RDS). Pediatric Research1997;41:163A. ReyesG , GonzalezAR , GomezG , BlasiniI , RiveraCE . Comparative study of the effectiveness of thyroxine and steroids on reduction of neonatal morbidity: outcome at 20 months follow‐up. Puerto Rico Health Sciences Journal2004;23(1):9‐12. SantiagoR , RomagueraJ . Steroids vs steroids and thyroxine to accelerate fetal maturation of patients in arrested preterm labor. Puerto Rico Health Sciences Journal1999;18:156. ">Chile 1998</a>; <a href="./references#CD000019-bbs2-0010" title="AlfirevicZ , BoerK , BrocklehurstP , BuimerM , ElbourneD , KokJ , et al. Two trials of antenatal thyrotrophin‐releasing hormone for fetal maturation: stopping before the due date. British Journal of Obstetrics and Gynaecology1999;106:898‐906. AlfirevicZ , ElbourneD , BrocklehurstP , TruesdaleA , NeilsonJ . Randomised controlled trial of antenatal administration of thyrotropin releasing hormone (TRH) to women at risk of premature delivery. Prenatal and Neonatal Medicine1996;1(1):10. BrietJM , vanSonderenL , BuimerM , BoerK , KokJH . Neurodevelopmental outcome of children treated with antenatal thyrotropin‐releasing hormone. Pediatrics2002;110(2 Pt 1):249‐53. BrocklehurstP . Antenatal thyrotropin‐releasing hormone for fetal maturity: two concurrent randomised controlled trials (The Antenatal TRH Trial and the Thyroneth Trial). British Journal of Obstetrics and Gynaecology1998;105:81. ">Europe 1999</a>). <a href="./references#CD000019-bbs2-0002" title="CrowtherC , HillerJ , HaslamR , RobinsonJ , the ACTOBAT Study Group. Australian Collaborative Trial of Betamethasone and TRH for the prevention of neonatal respiratory disease (ACTOBAT). International Journal of Gynecology and Obstetrics1994;46:59. CrowtherCA , HillerJE , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial of antenatal thyrotropin‐releasing hormone: Adverse effects at 12‐month follow‐up. Pediatrics1997;99:311‐7. HillerJE , CrowtherCA , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial af antenatal thyrotropin‐releasing hormone (ACTOBAT): 12 month follow‐up. 4th Annual Congress of the Perinatal Society of Australia &amp; New Zealand; 1998 March 30‐April 4; Alice Springs, Australia. Alice Springs, 1998:77. The ACTOBAT Study Group. Australian collaborative trial of betamethasone and thyrotropin releasing hormone (ACTOBAT) for the prevention of neonatal respiratory disease. Lancet1995;345:877‐82. ">ACTOBAT 1995</a> assessed neurological outcomes with a questionnaire completed by parents when their infants were 12 months of age. Some data were available for 1022 (81%) of the 1262 infants discharged home alive, but not all outcome data were available for all infants. A subset of 39 of 52 (75%) children recruited at a single centre in <a href="./references#CD000019-bbs2-0010" title="AlfirevicZ , BoerK , BrocklehurstP , BuimerM , ElbourneD , KokJ , et al. Two trials of antenatal thyrotrophin‐releasing hormone for fetal maturation: stopping before the due date. British Journal of Obstetrics and Gynaecology1999;106:898‐906. AlfirevicZ , ElbourneD , BrocklehurstP , TruesdaleA , NeilsonJ . Randomised controlled trial of antenatal administration of thyrotropin releasing hormone (TRH) to women at risk of premature delivery. Prenatal and Neonatal Medicine1996;1(1):10. BrietJM , vanSonderenL , BuimerM , BoerK , KokJH . Neurodevelopmental outcome of children treated with antenatal thyrotropin‐releasing hormone. Pediatrics2002;110(2 Pt 1):249‐53. BrocklehurstP . Antenatal thyrotropin‐releasing hormone for fetal maturity: two concurrent randomised controlled trials (The Antenatal TRH Trial and the Thyroneth Trial). British Journal of Obstetrics and Gynaecology1998;105:81. ">Europe 1999</a> (16% of the infants recruited to the trial overall and alive at end of data collection) were assessed at 12 months and 24 months using the Bayley Scales of Infant Development and by a paediatrician. Similarly, at 18 months, 66 (49%) of the 134 infants enrolled during a 12‐month period (July 1997 to December 1998) of the <a href="./references#CD000019-bbs2-0008" title="Collaborative Santiago Surfactant Group. Collaborative trial of prenatal thyrotropin‐releasing hormone and corticosteroids for prevention of respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178:33‐9. MaturanaA , TorresJ , SalinasR , MoyaF , for the Collaborative Group. Controlled trial of prenatal thyrotropin‐releasing hormone (TRH) and betamethasone (B) for prevention of respiratory distress syndrome (RDS). Pediatric Research1997;41:163A. ReyesG , GonzalezAR , GomezG , BlasiniI , RiveraCE . Comparative study of the effectiveness of thyroxine and steroids on reduction of neonatal morbidity: outcome at 20 months follow‐up. Puerto Rico Health Sciences Journal2004;23(1):9‐12. SantiagoR , RomagueraJ . Steroids vs steroids and thyroxine to accelerate fetal maturation of patients in arrested preterm labor. Puerto Rico Health Sciences Journal1999;18:156. ">Chile 1998</a> study were assessed using the Bayley Scales of Infant Development (2nd edition) by a neonatologist or neonatal fellow. </p> </section> <section id="CD000019-sec3-0025"> <h4 class="title">Other potential sources of bias</h4> <p>Ten of the 15 trials were judged to be at a low risk of other potential bias, with no other obvious sources of bias identified (<a href="./references#CD000019-bbs2-0002" title="CrowtherC , HillerJ , HaslamR , RobinsonJ , the ACTOBAT Study Group. Australian Collaborative Trial of Betamethasone and TRH for the prevention of neonatal respiratory disease (ACTOBAT). International Journal of Gynecology and Obstetrics1994;46:59. CrowtherCA , HillerJE , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial of antenatal thyrotropin‐releasing hormone: Adverse effects at 12‐month follow‐up. Pediatrics1997;99:311‐7. HillerJE , CrowtherCA , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial af antenatal thyrotropin‐releasing hormone (ACTOBAT): 12 month follow‐up. 4th Annual Congress of the Perinatal Society of Australia &amp; New Zealand; 1998 March 30‐April 4; Alice Springs, Australia. Alice Springs, 1998:77. The ACTOBAT Study Group. Australian collaborative trial of betamethasone and thyrotropin releasing hormone (ACTOBAT) for the prevention of neonatal respiratory disease. Lancet1995;345:877‐82. ">ACTOBAT 1995</a>; <a href="./references#CD000019-bbs2-0003" title="BallardPL , BallardRA , CreasyRK , PadburyJ , PolkDH , BrackenM , et al. Plasma thyroid hormones and prolactin in premature infants and their mothers after treatment with thyrotropin‐releasing hormone. Pediatric Research1992;32(6):673‐8. BallardRA , BallardPL , CreasyR , GrossI , MainD , PadburyJF , et al. Prenatal treatment with thyrotropin releasing hormone plus corticosteroid: absence of maternal, fetal or neonatal side effects. Clinical Research1990;38:192A. BallardRA , BallardPL , CreasyR , GrossI , MainD , PadburyJF , et al. Prenatal treatment with thyrotropin releasing hormone plus corticosteroid: absence of maternal, fetal or neonatal side effects. Pediatric Research1991;29:202A. BallardRA , BallardPL , CreasyR , GrossI , PadburyJF , TRH Study Group. Thyrotropin releasing hormone plus corticosteroids decreases chronic lung disease in very low birth weight infants. Pediatric Research1991;29(4):1828A. BallardRA , BallardPL , CreasyR , PadburyJ , PolkDH , BrackenM , et al. Respiratory disease in very‐low birthweight infants after prenatal thyrotropin‐releasing hormone and glucocorticoid. Lancet1992;339:510‐5. ">Ballard 1992b</a>; <a href="./references#CD000019-bbs2-0004" title="BallardPL , BallardRA , NingY , CnannA , BoardmanC , Pinto‐MartinJ , et al. Plasma thyroid hormones in premature infants: effect of gestational age and antenatal thyrotropin‐releasing hormone treatment. Pediatric Research1998;44:642‐9. BallardRA , BallardPL , BoardmanC , CnaanA , DavisDJ , HartMC , et al. Antenatal thyrotropin releasing hormone (TRH) for the prevention of chronic lung disease (CLD) in the preterm infant. Pediatric Research1997;41:246A. BallardRA , BallardPL , CnaanA , Pinto‐MartinJ , DavisDJ , PadburyJF , et al. Antenatal thyrotropin‐releasing hormone to prevention lung disease in preterm infants. New England Journal of Medicine1998;338:493‐8. ">Ballard 1998</a>; <a href="./references#CD000019-bbs2-0005" title="CamposG , HerrmanF , DornerM . Combined hormonal therapy for the prevention of respiratory distress syndrome and its consequences. Seminars in Perinatology1993;17(4):267‐74. ">Campos 1993</a>; <a href="./references#CD000019-bbs2-0008" title="Collaborative Santiago Surfactant Group. Collaborative trial of prenatal thyrotropin‐releasing hormone and corticosteroids for prevention of respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178:33‐9. MaturanaA , TorresJ , SalinasR , MoyaF , for the Collaborative Group. Controlled trial of prenatal thyrotropin‐releasing hormone (TRH) and betamethasone (B) for prevention of respiratory distress syndrome (RDS). Pediatric Research1997;41:163A. ReyesG , GonzalezAR , GomezG , BlasiniI , RiveraCE . Comparative study of the effectiveness of thyroxine and steroids on reduction of neonatal morbidity: outcome at 20 months follow‐up. Puerto Rico Health Sciences Journal2004;23(1):9‐12. SantiagoR , RomagueraJ . Steroids vs steroids and thyroxine to accelerate fetal maturation of patients in arrested preterm labor. Puerto Rico Health Sciences Journal1999;18:156. ">Chile 1998</a>; <a href="./references#CD000019-bbs2-0009" title="CrowtherC , HaslamR , HillerJ , McGeeT , RyallR , RobinsonJ . Thyrotropin‐releasing hormone: Does two hundred micrograms provide effective stimulation to the preterm fetal pituitary gland compared with four hundred micrograms?. American Journal of Obstetrics and Gynecology1995;173:719‐23. CrowtherCA , HaslamRR , HillerJE , McGeeT , RobinsonJS . Thyrotrophin releasing hormone (TRH) and lung maturation: does 200mcg TRH provide effective stimulation to the preterm fetal pituitary gland compared with 400mcg TRH?. International Journal of Gynecology and Obstetrics1991;36 Suppl:32. ">Crowther 1995</a>; <a href="./references#CD000019-bbs2-0010" title="AlfirevicZ , BoerK , BrocklehurstP , BuimerM , ElbourneD , KokJ , et al. Two trials of antenatal thyrotrophin‐releasing hormone for fetal maturation: stopping before the due date. British Journal of Obstetrics and Gynaecology1999;106:898‐906. AlfirevicZ , ElbourneD , BrocklehurstP , TruesdaleA , NeilsonJ . Randomised controlled trial of antenatal administration of thyrotropin releasing hormone (TRH) to women at risk of premature delivery. Prenatal and Neonatal Medicine1996;1(1):10. BrietJM , vanSonderenL , BuimerM , BoerK , KokJH . Neurodevelopmental outcome of children treated with antenatal thyrotropin‐releasing hormone. Pediatrics2002;110(2 Pt 1):249‐53. BrocklehurstP . Antenatal thyrotropin‐releasing hormone for fetal maturity: two concurrent randomised controlled trials (The Antenatal TRH Trial and the Thyroneth Trial). British Journal of Obstetrics and Gynaecology1998;105:81. ">Europe 1999</a>; <a href="./references#CD000019-bbs2-0013" title="KnightDB , LigginsGC , Wealthall SR. A randomised controlled trial of the effect of thyrotropin‐releasing hormone with betamethasone in mothers likely to deliver prematurely on neonatal outcome. Proceedings of the Australian Perinatal Society; 1992; Queensland, Australia. 1992:A9. KnightDB , LigginsGC , Wealthall SR. A randomized, controlled trial of antepartum thyrotropin‐releasing hormone and betamethasone in the prevention of respiratory disease in preterm infants. American Journal of Obstetrics and Gynecology1994;171:11‐6. KnightDB , Wealthall SR, LigginsGC , HowieRN . A randomised double blind controlled trial of antepartum TRH with betamethasone in the prevention of neonatal respiratory disease. New Zealand Medical Journal1989;102:195. LigginsGC , KnightDB , Wealthall SR, HowieRN . A randomized double‐blind trial of antepartum TRH and steroids in the prevention of neonatal respiratory disease. Clinical reproductive medicine ‐ the Liggins years; 1988 July 29‐30; Auckland, New Zealand. 1988. ">Knight 1994</a>; <a href="./references#CD000019-bbs2-0014" title="MoralesWJ , O'BrienWF , AngelJL , KnuppelRA , SawaiS . Fetal lung maturation: the combined use of corticosteroids and thyrotropin‐releasing hormone. Obstetrics and Gynecology1989;73:111‐6. ">Morales 1989</a>; <a href="./references#CD000019-bbs2-0015" title="VotoL , LedeR , ScagliaH , ZylbersteinC , ZapasterioJ , OrtiJ , et al. Effects of maternal administration of betamethasone, with and without TRH, on serum PRL, TSH and iodothyronine levels in Rh‐isoimmunized fetuses: a randomized clinical trial. Prenatal and Neonatal Medicine1998;3:447‐51. ">Voto 1998</a>). For the other five trials, the risk of other potential bias was judged to be unclear, with insufficient information available to make a confident judgement (<a href="./references#CD000019-bbs2-0001" title="AbuhamadA , GreenG , HeylP , deVecianaM . The combined use of corticosteroids and thyrotropin releasing hormone in pregnancies with preterm rupture of membranes: a randomised double blind controlled trial. American Journal of Obstetrics and Gynecology1999;180(1 Pt 2):S96. ">Abuhamad 1999</a>; <a href="./references#CD000019-bbs2-0006" title="CarlanSJ , ParsonsM , O'BrienWF , KrammerJ . Pharmacologic pulmonary maturation in preterm premature rupture of membranes. American Journal of Obstetrics and Gynecology1991;164:371. ">Carlan 1991</a>; <a href="./references#CD000019-bbs2-0007" title="AlthabeF , FustiharaC , AlthabeO , CernadesJMC . Controlled trial of prenatal betamethasone plus TRH vs betamethasone plus placebo for prevention of RDS in preterm infants. Pediatric Research1991;29:200A. Ceriani CernadasJ , FustiharaC , AlthabeF , AlthabeO . Controlled trial of prenatal betamethasone (B) plus TRH for prevention of respiratory distress syndrome (RDS) in preterm infants. Pediatric Research1992;32:738. ">Ceriani 1992</a>; <a href="./references#CD000019-bbs2-0011" title="JikiharaH , SawadaY , ImaiS , MorishigeK , TaniguchiT , NoharaA , et al. Maternal administration of thyrotropin‐releasing hormone for prevention of neonatal respiratory distress syndrome. Proceedings of 6th Congress of the Federation of the Asia‐Oceania Perinatal Societies; 1990 Oct 22‐26; Perth, Western Australia. 1990:87. ">Jikihara 1990</a>; <a href="./references#CD000019-bbs2-0012" title="KimEA , ParkSJ , YoonHS , KimKS , WonHS , LeeIS , et al. Antenatal thyrotropin‐releasing hormone to prevent respiratory distress syndrome in Korean preterm. Pediatric Academic Societies Annual Meeting; 2000 May 12‐16; Boston, MA, USA. 2000. KimEA , ParkSJ , YoonHS , KimKS , WonHS , LeeIS , et al. Antenatal thyrotropin‐releasing hormone to prevent respiratory distress syndrome in Korean preterm. Pediatric Research2000;47:407A. ">Kim 2000</a>). </p> </section> </section> <section id="CD000019-sec2-0006"> <h3 class="title" id="CD000019-sec2-0006">Effects of interventions</h3> <p>Fifteen trials involving over 4600 women were included, although only 13 trials contributed data to the meta‐analyses. All trials used a combination of TRH and antenatal corticosteroids in the intervention group and corticosteroids alone (with or without a placebo) in the control group. </p> <section id="CD000019-sec3-0026"> <h4 class="title">Comparison of TRH with corticosteroids versus corticosteroids alone</h4> </section> <section id="CD000019-sec3-0027"> <h4 class="title">All eligible trials analysed by intention‐to‐treat</h4> <p>Nine trials involving 3833 women contributed data (<a href="./references#CD000019-bbs2-0001" title="AbuhamadA , GreenG , HeylP , deVecianaM . The combined use of corticosteroids and thyrotropin releasing hormone in pregnancies with preterm rupture of membranes: a randomised double blind controlled trial. American Journal of Obstetrics and Gynecology1999;180(1 Pt 2):S96. ">Abuhamad 1999</a>; <a href="./references#CD000019-bbs2-0002" title="CrowtherC , HillerJ , HaslamR , RobinsonJ , the ACTOBAT Study Group. Australian Collaborative Trial of Betamethasone and TRH for the prevention of neonatal respiratory disease (ACTOBAT). International Journal of Gynecology and Obstetrics1994;46:59. CrowtherCA , HillerJE , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial of antenatal thyrotropin‐releasing hormone: Adverse effects at 12‐month follow‐up. Pediatrics1997;99:311‐7. HillerJE , CrowtherCA , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial af antenatal thyrotropin‐releasing hormone (ACTOBAT): 12 month follow‐up. 4th Annual Congress of the Perinatal Society of Australia &amp; New Zealand; 1998 March 30‐April 4; Alice Springs, Australia. Alice Springs, 1998:77. The ACTOBAT Study Group. Australian collaborative trial of betamethasone and thyrotropin releasing hormone (ACTOBAT) for the prevention of neonatal respiratory disease. Lancet1995;345:877‐82. ">ACTOBAT 1995</a>; <a href="./references#CD000019-bbs2-0004" title="BallardPL , BallardRA , NingY , CnannA , BoardmanC , Pinto‐MartinJ , et al. Plasma thyroid hormones in premature infants: effect of gestational age and antenatal thyrotropin‐releasing hormone treatment. Pediatric Research1998;44:642‐9. BallardRA , BallardPL , BoardmanC , CnaanA , DavisDJ , HartMC , et al. Antenatal thyrotropin releasing hormone (TRH) for the prevention of chronic lung disease (CLD) in the preterm infant. Pediatric Research1997;41:246A. BallardRA , BallardPL , CnaanA , Pinto‐MartinJ , DavisDJ , PadburyJF , et al. Antenatal thyrotropin‐releasing hormone to prevention lung disease in preterm infants. New England Journal of Medicine1998;338:493‐8. ">Ballard 1998</a>; <a href="./references#CD000019-bbs2-0006" title="CarlanSJ , ParsonsM , O'BrienWF , KrammerJ . Pharmacologic pulmonary maturation in preterm premature rupture of membranes. American Journal of Obstetrics and Gynecology1991;164:371. ">Carlan 1991</a>; <a href="./references#CD000019-bbs2-0008" title="Collaborative Santiago Surfactant Group. Collaborative trial of prenatal thyrotropin‐releasing hormone and corticosteroids for prevention of respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178:33‐9. MaturanaA , TorresJ , SalinasR , MoyaF , for the Collaborative Group. Controlled trial of prenatal thyrotropin‐releasing hormone (TRH) and betamethasone (B) for prevention of respiratory distress syndrome (RDS). Pediatric Research1997;41:163A. ReyesG , GonzalezAR , GomezG , BlasiniI , RiveraCE . Comparative study of the effectiveness of thyroxine and steroids on reduction of neonatal morbidity: outcome at 20 months follow‐up. Puerto Rico Health Sciences Journal2004;23(1):9‐12. SantiagoR , RomagueraJ . Steroids vs steroids and thyroxine to accelerate fetal maturation of patients in arrested preterm labor. Puerto Rico Health Sciences Journal1999;18:156. ">Chile 1998</a>; <a href="./references#CD000019-bbs2-0010" title="AlfirevicZ , BoerK , BrocklehurstP , BuimerM , ElbourneD , KokJ , et al. Two trials of antenatal thyrotrophin‐releasing hormone for fetal maturation: stopping before the due date. British Journal of Obstetrics and Gynaecology1999;106:898‐906. AlfirevicZ , ElbourneD , BrocklehurstP , TruesdaleA , NeilsonJ . Randomised controlled trial of antenatal administration of thyrotropin releasing hormone (TRH) to women at risk of premature delivery. Prenatal and Neonatal Medicine1996;1(1):10. BrietJM , vanSonderenL , BuimerM , BoerK , KokJH . Neurodevelopmental outcome of children treated with antenatal thyrotropin‐releasing hormone. Pediatrics2002;110(2 Pt 1):249‐53. BrocklehurstP . Antenatal thyrotropin‐releasing hormone for fetal maturity: two concurrent randomised controlled trials (The Antenatal TRH Trial and the Thyroneth Trial). British Journal of Obstetrics and Gynaecology1998;105:81. ">Europe 1999</a>; <a href="./references#CD000019-bbs2-0011" title="JikiharaH , SawadaY , ImaiS , MorishigeK , TaniguchiT , NoharaA , et al. Maternal administration of thyrotropin‐releasing hormone for prevention of neonatal respiratory distress syndrome. Proceedings of 6th Congress of the Federation of the Asia‐Oceania Perinatal Societies; 1990 Oct 22‐26; Perth, Western Australia. 1990:87. ">Jikihara 1990</a>; <a href="./references#CD000019-bbs2-0012" title="KimEA , ParkSJ , YoonHS , KimKS , WonHS , LeeIS , et al. Antenatal thyrotropin‐releasing hormone to prevent respiratory distress syndrome in Korean preterm. Pediatric Academic Societies Annual Meeting; 2000 May 12‐16; Boston, MA, USA. 2000. KimEA , ParkSJ , YoonHS , KimKS , WonHS , LeeIS , et al. Antenatal thyrotropin‐releasing hormone to prevent respiratory distress syndrome in Korean preterm. Pediatric Research2000;47:407A. ">Kim 2000</a>; <a href="./references#CD000019-bbs2-0013" title="KnightDB , LigginsGC , Wealthall SR. A randomised controlled trial of the effect of thyrotropin‐releasing hormone with betamethasone in mothers likely to deliver prematurely on neonatal outcome. Proceedings of the Australian Perinatal Society; 1992; Queensland, Australia. 1992:A9. KnightDB , LigginsGC , Wealthall SR. A randomized, controlled trial of antepartum thyrotropin‐releasing hormone and betamethasone in the prevention of respiratory disease in preterm infants. American Journal of Obstetrics and Gynecology1994;171:11‐6. KnightDB , Wealthall SR, LigginsGC , HowieRN . A randomised double blind controlled trial of antepartum TRH with betamethasone in the prevention of neonatal respiratory disease. New Zealand Medical Journal1989;102:195. LigginsGC , KnightDB , Wealthall SR, HowieRN . A randomized double‐blind trial of antepartum TRH and steroids in the prevention of neonatal respiratory disease. Clinical reproductive medicine ‐ the Liggins years; 1988 July 29‐30; Auckland, New Zealand. 1988. ">Knight 1994</a>). </p> <section id="CD000019-sec4-0015"> <h5 class="title">Primary outcomes</h5> <p>No beneficial effects of prenatal TRH were seen for the primary outcomes: death prior to hospital discharge (risk ratio (RR) 1.05, 95% confidence interval (CI) 0.86 to 1.27, six trials, 3694 infants) (<a href="./references#CD000019-fig-00101" title="">Analysis 1.1</a>), chronic lung disease (RR 1.01, 95% CI 0.85 to 1.19, five trials, 2511 infants) (<a href="./references#CD000019-fig-00102" title="">Analysis 1.2</a>) or respiratory distress syndrome (RDS) (average RR 1.05, 95% CI 0.91 to 1.22, nine trials, 3833 infants) (<a href="./references#CD000019-fig-00103" title="">Analysis 1.3</a>). Moderate statistical heterogeneity was found for the outcome RDS (Tau² = 0.02; I² = 48%), and thus a random‐effects model was used. </p> </section> <section id="CD000019-sec4-0016"> <h5 class="title">Secondary outcomes</h5> <section id="CD000019-sec5-0003"> <h6 class="title">For the infant</h6> <p>No effects of prenatal TRH were shown on the composite outcome of death or chronic lung disease (RR 1.06, 95% CI 0.95 to 1.18, six trials, 3694 infants) (<a href="./references#CD000019-fig-00104" title="">Analysis 1.4</a>), on the need for oxygen therapy (RR 1.05, 95% CI 0.97 to 1.13, four trials, 2387 infants) (<a href="./references#CD000019-fig-00105" title="">Analysis 1.5</a>), or on the outcome severe RDS (average RR 0.88, 95% CI 0.57 to 1.36, three trials, 2119 infants; Tau² = 0.11; I² = 73%) (<a href="./references#CD000019-fig-00106" title="">Analysis 1.6</a>). The need for respiratory support was significantly increased in the TRH treated group (RR 1.16, 95% CI 1.03 to 1.29, three trials, 1969 infants) (<a href="./references#CD000019-fig-00107" title="">Analysis 1.7</a>). </p> <p>No effects of prenatal TRH on gestational age at birth (mean difference (MD) ‐0.43 weeks, 95% CI ‐0.86 to 0.01, two trials, 1563 infants) (<a href="./references#CD000019-fig-00117" title="">Analysis 1.17</a>) or on need for admission to the neonatal intensive care unit (RR 1.04, 95% CI 0.98 to 1.11, two trials, 1637 infants) (<a href="./references#CD000019-fig-00108" title="">Analysis 1.8</a>) were discernible. Similarly, no effects were seen on the risk of intraventricular haemorrhage (RR 1.08, 95% CI 0.93 to 1.26, six trials, 3645 infants) (<a href="./references#CD000019-fig-00109" title="">Analysis 1.9</a>), severe intraventricular haemorrhage (RR 1.13, 95% CI 0.82 to 1.57, five trials, 3313 infants) (<a href="./references#CD000019-fig-00110" title="">Analysis 1.10</a>), air leak syndrome (average RR 1.14, 95% CI 0.71 to 1.83, four trials, 3103 infants) (<a href="./references#CD000019-fig-00111" title="">Analysis 1.11</a>), pulmonary haemorrhage (RR 0.83, 95% CI 0.25 to 2.80, three trials 1969 infants) (<a href="./references#CD000019-fig-00112" title="">Analysis 1.12</a>), necrotising enterocolitis (RR 0.91, 95% CI 0.64 to 1.30, four trials, 3103 infants) (<a href="./references#CD000019-fig-00113" title="">Analysis 1.13</a>), patent ductus arteriosus (average RR 1.00, 95% CI 0.79 to 1.28, six trials, 3645 infants) (<a href="./references#CD000019-fig-00114" title="">Analysis 1.14</a>), or use of surfactant (RR 1.10, 95% CI 0.98 to 1.25, four trials, 3103 infants) (<a href="./references#CD000019-fig-00116" title="">Analysis 1.16</a>). A low Apgar score at five minutes was significantly more common in TRH treated infants (RR 1.48, 95% CI 1.14 to 1.92, three trials, 1969 infants) (<a href="./references#CD000019-fig-00115" title="">Analysis 1.15</a>). Moderate statistical heterogeneity was seen for the outcomes air leak syndrome (Tau² = 0.12; I² = 55%), pulmonary haemorrhage (Tau² = 0.64; I² = 56%) and patent ductus arterious (Tau² = 0.04; I² = 44%), and thus for each outcome, a random‐effects model was used. </p> </section> <section id="CD000019-sec5-0004"> <h6 class="title">For the child</h6> <p>Outcomes for children at 12 months of age or later were available from three trials (<a href="./references#CD000019-bbs2-0002" title="CrowtherC , HillerJ , HaslamR , RobinsonJ , the ACTOBAT Study Group. Australian Collaborative Trial of Betamethasone and TRH for the prevention of neonatal respiratory disease (ACTOBAT). International Journal of Gynecology and Obstetrics1994;46:59. CrowtherCA , HillerJE , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial of antenatal thyrotropin‐releasing hormone: Adverse effects at 12‐month follow‐up. Pediatrics1997;99:311‐7. HillerJE , CrowtherCA , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial af antenatal thyrotropin‐releasing hormone (ACTOBAT): 12 month follow‐up. 4th Annual Congress of the Perinatal Society of Australia &amp; New Zealand; 1998 March 30‐April 4; Alice Springs, Australia. Alice Springs, 1998:77. The ACTOBAT Study Group. Australian collaborative trial of betamethasone and thyrotropin releasing hormone (ACTOBAT) for the prevention of neonatal respiratory disease. Lancet1995;345:877‐82. ">ACTOBAT 1995</a>; <a href="./references#CD000019-bbs2-0008" title="Collaborative Santiago Surfactant Group. Collaborative trial of prenatal thyrotropin‐releasing hormone and corticosteroids for prevention of respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178:33‐9. MaturanaA , TorresJ , SalinasR , MoyaF , for the Collaborative Group. Controlled trial of prenatal thyrotropin‐releasing hormone (TRH) and betamethasone (B) for prevention of respiratory distress syndrome (RDS). Pediatric Research1997;41:163A. ReyesG , GonzalezAR , GomezG , BlasiniI , RiveraCE . Comparative study of the effectiveness of thyroxine and steroids on reduction of neonatal morbidity: outcome at 20 months follow‐up. Puerto Rico Health Sciences Journal2004;23(1):9‐12. SantiagoR , RomagueraJ . Steroids vs steroids and thyroxine to accelerate fetal maturation of patients in arrested preterm labor. Puerto Rico Health Sciences Journal1999;18:156. ">Chile 1998</a>; <a href="./references#CD000019-bbs2-0010" title="AlfirevicZ , BoerK , BrocklehurstP , BuimerM , ElbourneD , KokJ , et al. Two trials of antenatal thyrotrophin‐releasing hormone for fetal maturation: stopping before the due date. British Journal of Obstetrics and Gynaecology1999;106:898‐906. AlfirevicZ , ElbourneD , BrocklehurstP , TruesdaleA , NeilsonJ . Randomised controlled trial of antenatal administration of thyrotropin releasing hormone (TRH) to women at risk of premature delivery. Prenatal and Neonatal Medicine1996;1(1):10. BrietJM , vanSonderenL , BuimerM , BoerK , KokJH . Neurodevelopmental outcome of children treated with antenatal thyrotropin‐releasing hormone. Pediatrics2002;110(2 Pt 1):249‐53. BrocklehurstP . Antenatal thyrotropin‐releasing hormone for fetal maturity: two concurrent randomised controlled trials (The Antenatal TRH Trial and the Thyroneth Trial). British Journal of Obstetrics and Gynaecology1998;105:81. ">Europe 1999</a>). As the three trials followed up infants at different ages (i.e. 18 versus 24 months) and used different methods of assessment, it was difficult to pool these data in meta‐analyses. </p> <p>In the <a href="./references#CD000019-bbs2-0002" title="CrowtherC , HillerJ , HaslamR , RobinsonJ , the ACTOBAT Study Group. Australian Collaborative Trial of Betamethasone and TRH for the prevention of neonatal respiratory disease (ACTOBAT). International Journal of Gynecology and Obstetrics1994;46:59. CrowtherCA , HillerJE , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial of antenatal thyrotropin‐releasing hormone: Adverse effects at 12‐month follow‐up. Pediatrics1997;99:311‐7. HillerJE , CrowtherCA , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial af antenatal thyrotropin‐releasing hormone (ACTOBAT): 12 month follow‐up. 4th Annual Congress of the Perinatal Society of Australia &amp; New Zealand; 1998 March 30‐April 4; Alice Springs, Australia. Alice Springs, 1998:77. The ACTOBAT Study Group. Australian collaborative trial of betamethasone and thyrotropin releasing hormone (ACTOBAT) for the prevention of neonatal respiratory disease. Lancet1995;345:877‐82. ">ACTOBAT 1995</a> trial, an increased risk in the TRH treated group was shown for motor delay (RR 1.31, 95% CI 1.09 to 1.56, 971 infants) (<a href="./references#CD000019-fig-00118" title="">Analysis 1.18</a>), motor impairment (RR 1.51, 95% CI 1.01 to 2.24, 972 infants) (<a href="./references#CD000019-fig-00119" title="">Analysis 1.19</a>), sensory impairment (RR 1.97, 95% CI 1.10 to 3.53, 1004 infants) (<a href="./references#CD000019-fig-00121" title="">Analysis 1.21</a>), and social delay (RR 1.25, 95% CI 1.03 to 1.51, 966 infants) (<a href="./references#CD000019-fig-00123" title="">Analysis 1.23</a>); but not for fine motor delay (RR 1.10, 95% CI 0.91 to 1.32, 926 infants) (<a href="./references#CD000019-fig-00120" title="">Analysis 1.20</a>), or language delay (RR 1.20, 95% CI 0.93 to 1.54, 1004 infants) (<a href="./references#CD000019-fig-00122" title="">Analysis 1.22</a>). </p> <p>While the <a href="./references#CD000019-bbs2-0010" title="AlfirevicZ , BoerK , BrocklehurstP , BuimerM , ElbourneD , KokJ , et al. Two trials of antenatal thyrotrophin‐releasing hormone for fetal maturation: stopping before the due date. British Journal of Obstetrics and Gynaecology1999;106:898‐906. AlfirevicZ , ElbourneD , BrocklehurstP , TruesdaleA , NeilsonJ . Randomised controlled trial of antenatal administration of thyrotropin releasing hormone (TRH) to women at risk of premature delivery. Prenatal and Neonatal Medicine1996;1(1):10. BrietJM , vanSonderenL , BuimerM , BoerK , KokJH . Neurodevelopmental outcome of children treated with antenatal thyrotropin‐releasing hormone. Pediatrics2002;110(2 Pt 1):249‐53. BrocklehurstP . Antenatal thyrotropin‐releasing hormone for fetal maturity: two concurrent randomised controlled trials (The Antenatal TRH Trial and the Thyroneth Trial). British Journal of Obstetrics and Gynaecology1998;105:81. ">Europe 1999</a> trial did not find any difference in neurological abnormality overall between the two groups (RR 4.75, 95% CI 0.61 to 37.01, 39 infants) (<a href="./references#CD000019-fig-00124" title="">Analysis 1.24</a>), at 24 months, the mean Bayley Mental Developmental Index (MDI) was significantly lower (worse) in the TRH exposed children (MD ‐15.70, 95% CI ‐30.86 to ‐0.54, 39 infants). However, in the <a href="./references#CD000019-bbs2-0008" title="Collaborative Santiago Surfactant Group. Collaborative trial of prenatal thyrotropin‐releasing hormone and corticosteroids for prevention of respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178:33‐9. MaturanaA , TorresJ , SalinasR , MoyaF , for the Collaborative Group. Controlled trial of prenatal thyrotropin‐releasing hormone (TRH) and betamethasone (B) for prevention of respiratory distress syndrome (RDS). Pediatric Research1997;41:163A. ReyesG , GonzalezAR , GomezG , BlasiniI , RiveraCE . Comparative study of the effectiveness of thyroxine and steroids on reduction of neonatal morbidity: outcome at 20 months follow‐up. Puerto Rico Health Sciences Journal2004;23(1):9‐12. SantiagoR , RomagueraJ . Steroids vs steroids and thyroxine to accelerate fetal maturation of patients in arrested preterm labor. Puerto Rico Health Sciences Journal1999;18:156. ">Chile 1998</a> trial, at 18 months, no significant difference between groups was shown in the Bayley MDI (MD 0.00, 95% CI ‐8.36 to 8.36, 60 infants); and when the data from the two trials were pooled, no difference was shown overall (MD ‐6.52, 95% CI ‐21.69 to 8.64; Tau² = 84.25; I² = 68%) (<a href="./references#CD000019-fig-00125" title="">Analysis 1.25</a>). The Bayley Psychomotor Developmental Index (PDI) was not shown to be significantly different between groups at follow‐up in either the <a href="./references#CD000019-bbs2-0010" title="AlfirevicZ , BoerK , BrocklehurstP , BuimerM , ElbourneD , KokJ , et al. Two trials of antenatal thyrotrophin‐releasing hormone for fetal maturation: stopping before the due date. British Journal of Obstetrics and Gynaecology1999;106:898‐906. AlfirevicZ , ElbourneD , BrocklehurstP , TruesdaleA , NeilsonJ . Randomised controlled trial of antenatal administration of thyrotropin releasing hormone (TRH) to women at risk of premature delivery. Prenatal and Neonatal Medicine1996;1(1):10. BrietJM , vanSonderenL , BuimerM , BoerK , KokJH . Neurodevelopmental outcome of children treated with antenatal thyrotropin‐releasing hormone. Pediatrics2002;110(2 Pt 1):249‐53. BrocklehurstP . Antenatal thyrotropin‐releasing hormone for fetal maturity: two concurrent randomised controlled trials (The Antenatal TRH Trial and the Thyroneth Trial). British Journal of Obstetrics and Gynaecology1998;105:81. ">Europe 1999</a> trial or the <a href="./references#CD000019-bbs2-0008" title="Collaborative Santiago Surfactant Group. Collaborative trial of prenatal thyrotropin‐releasing hormone and corticosteroids for prevention of respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178:33‐9. MaturanaA , TorresJ , SalinasR , MoyaF , for the Collaborative Group. Controlled trial of prenatal thyrotropin‐releasing hormone (TRH) and betamethasone (B) for prevention of respiratory distress syndrome (RDS). Pediatric Research1997;41:163A. ReyesG , GonzalezAR , GomezG , BlasiniI , RiveraCE . Comparative study of the effectiveness of thyroxine and steroids on reduction of neonatal morbidity: outcome at 20 months follow‐up. Puerto Rico Health Sciences Journal2004;23(1):9‐12. SantiagoR , RomagueraJ . Steroids vs steroids and thyroxine to accelerate fetal maturation of patients in arrested preterm labor. Puerto Rico Health Sciences Journal1999;18:156. ">Chile 1998</a> trial (pooled MD ‐2.73, 95% CI ‐8.58 to 3.12, 99 infants) (<a href="./references#CD000019-fig-00126" title="">Analysis 1.26</a>). The <a href="./references#CD000019-bbs2-0008" title="Collaborative Santiago Surfactant Group. Collaborative trial of prenatal thyrotropin‐releasing hormone and corticosteroids for prevention of respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178:33‐9. MaturanaA , TorresJ , SalinasR , MoyaF , for the Collaborative Group. Controlled trial of prenatal thyrotropin‐releasing hormone (TRH) and betamethasone (B) for prevention of respiratory distress syndrome (RDS). Pediatric Research1997;41:163A. ReyesG , GonzalezAR , GomezG , BlasiniI , RiveraCE . Comparative study of the effectiveness of thyroxine and steroids on reduction of neonatal morbidity: outcome at 20 months follow‐up. Puerto Rico Health Sciences Journal2004;23(1):9‐12. SantiagoR , RomagueraJ . Steroids vs steroids and thyroxine to accelerate fetal maturation of patients in arrested preterm labor. Puerto Rico Health Sciences Journal1999;18:156. ">Chile 1998</a> trial (assessing 60 infants) also found no significant differences on follow‐up between the TRH and corticosteroids and corticosteroids only group for the mean Bayley Behavioural Rating Scale (BRS) (MD 9.00, 95% CI ‐4.88 to 22.88) (<a href="./references#CD000019-fig-00127" title="">Analysis 1.27</a>), the mean Language Developmental Age (LDA) (MD 2.00, 95% CI ‐0.36 to 4.36) (<a href="./references#CD000019-fig-00128" title="">Analysis 1.28</a>), or for the mean Cognitive Developmental Age (CDA) (MD 1.70, 95% CI ‐0.64 to 4.04) (<a href="./references#CD000019-fig-00129" title="">Analysis 1.29</a>). No ophthalmologic or hearing abnormalities were reported at follow‐up for the 60 infants assessed in <a href="./references#CD000019-bbs2-0008" title="Collaborative Santiago Surfactant Group. Collaborative trial of prenatal thyrotropin‐releasing hormone and corticosteroids for prevention of respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178:33‐9. MaturanaA , TorresJ , SalinasR , MoyaF , for the Collaborative Group. Controlled trial of prenatal thyrotropin‐releasing hormone (TRH) and betamethasone (B) for prevention of respiratory distress syndrome (RDS). Pediatric Research1997;41:163A. ReyesG , GonzalezAR , GomezG , BlasiniI , RiveraCE . Comparative study of the effectiveness of thyroxine and steroids on reduction of neonatal morbidity: outcome at 20 months follow‐up. Puerto Rico Health Sciences Journal2004;23(1):9‐12. SantiagoR , RomagueraJ . Steroids vs steroids and thyroxine to accelerate fetal maturation of patients in arrested preterm labor. Puerto Rico Health Sciences Journal1999;18:156. ">Chile 1998</a> (<a href="./references#CD000019-fig-00131" title="">Analysis 1.31</a>), and only one serious neurological abnormality at follow‐up was reported in each group (<a href="./references#CD000019-fig-00130" title="">Analysis 1.30</a>); an infant from the TRH and corticosteroids group was reported to have congential ventriculomegaly, and one infant in the corticosteroids only group was reported to have hypotonia of congenital origin. </p> </section> <section id="CD000019-sec5-0005"> <h6 class="title">For the mother</h6> <p>Maternal side effects were more frequent in the TRH treated women; nausea (RR 3.92, 95% CI 3.13 to 4.92, three trials, 2370 women) (<a href="./references#CD000019-fig-00132" title="">Analysis 1.32</a>), vomiting (RR 2.35, 95% CI 1.35 to 4.09, one trial, 1011 women) (<a href="./references#CD000019-fig-00133" title="">Analysis 1.33</a>), light headedness (RR 1.73, 95% CI 1.36 to 2.22, one trial, 1011 women) (<a href="./references#CD000019-fig-00134" title="">Analysis 1.34</a>), urgency of micturition (RR 2.39, 95% CI 1.75 to 3.27, one trial, 1011 women) (<a href="./references#CD000019-fig-00135" title="">Analysis 1.35</a>), and facial flushing (RR 2.67, 95% CI 2.26 to 3.16, three trials, 2523 women) (<a href="./references#CD000019-fig-00136" title="">Analysis 1.36</a>). In the <a href="./references#CD000019-bbs2-0009" title="CrowtherC , HaslamR , HillerJ , McGeeT , RyallR , RobinsonJ . Thyrotropin‐releasing hormone: Does two hundred micrograms provide effective stimulation to the preterm fetal pituitary gland compared with four hundred micrograms?. American Journal of Obstetrics and Gynecology1995;173:719‐23. CrowtherCA , HaslamRR , HillerJE , McGeeT , RobinsonJS . Thyrotrophin releasing hormone (TRH) and lung maturation: does 200mcg TRH provide effective stimulation to the preterm fetal pituitary gland compared with 400mcg TRH?. International Journal of Gynecology and Obstetrics1991;36 Suppl:32. ">Crowther 1995</a> trial, side effects of nausea, urgency of micturition, or facial flushing occurred in four (of eight) women receiving 200 μg TRH and six (of nine) receiving 400 μg; it was not detailed if any of the nine control women experienced side effects. There was a significant rise in maternal systolic blood pressure (greater than 25 mmHg) (RR 1.80, 95% CI 1.05 to 3.06, one trial, 1011 women) (<a href="./references#CD000019-fig-00137" title="">Analysis 1.37</a>) and maternal diastolic blood pressure (greater than 15 mmHg) (RR 1.62, 95% CI 1.24 to 2.12, 1011 women) (<a href="./references#CD000019-fig-00138" title="">Analysis 1.38</a>) in women given prenatal TRH in the <a href="./references#CD000019-bbs2-0002" title="CrowtherC , HillerJ , HaslamR , RobinsonJ , the ACTOBAT Study Group. Australian Collaborative Trial of Betamethasone and TRH for the prevention of neonatal respiratory disease (ACTOBAT). International Journal of Gynecology and Obstetrics1994;46:59. CrowtherCA , HillerJE , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial of antenatal thyrotropin‐releasing hormone: Adverse effects at 12‐month follow‐up. Pediatrics1997;99:311‐7. HillerJE , CrowtherCA , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial af antenatal thyrotropin‐releasing hormone (ACTOBAT): 12 month follow‐up. 4th Annual Congress of the Perinatal Society of Australia &amp; New Zealand; 1998 March 30‐April 4; Alice Springs, Australia. Alice Springs, 1998:77. The ACTOBAT Study Group. Australian collaborative trial of betamethasone and thyrotropin releasing hormone (ACTOBAT) for the prevention of neonatal respiratory disease. Lancet1995;345:877‐82. ">ACTOBAT 1995</a> trial. </p> </section> </section> </section> <section id="CD000019-sec3-0028"> <h4 class="title">Subgroup analysis based on dose of TRH</h4> <p>Subgroup analyses were performed based on the dose regimen of TRH used (considering dose subgroups 200 μg (x four every 12 hours) versus 400 μg (x four every eight to 12 hours) versus 400 μg (x six every eight hours) versus 500 μg (x four every eight hours)). </p> <p>The subgroup analyses revealed no subgroup differences for the outcomes death prior to hospital discharge for the infant (Chi² = 1.19, P = 0.28, I² = 15.8%) (<a href="./references#CD000019-fig-00201" title="">Analysis 2.1</a>); chronic lung disease (variously defined) (Chi² = 0.31, P = 0.58, I² = 0%) (<a href="./references#CD000019-fig-00202" title="">Analysis 2.2</a>); RDS (Chi² = 3.46, P = 0.33, I² = 13.2%) (<a href="./references#CD000019-fig-00203" title="">Analysis 2.3</a>); chronic lung disease or death (Chi² = 0.11, P = 0.74, I² = 0%) (<a href="./references#CD000019-fig-00204" title="">Analysis 2.4</a>); the need for oxygen therapy (Chi² = 0.00, P = 0.95, I² = 0%) (<a href="./references#CD000019-fig-00205" title="">Analysis 2.5</a>); severe RDS (Chi² = 0.01, P = 0.93, I² = 0%) (<a href="./references#CD000019-fig-00206" title="">Analysis 2.6</a>); or the use of respiratory support (Chi² = 0.05, P = 0.83, I² = 0%) (<a href="./references#CD000019-fig-00207" title="">Analysis 2.7</a>) indicating no differential effects for these primary and other pre‐specified infant outcomes according to the dose regimen administered. </p> </section> <section id="CD000019-sec3-0029"> <h4 class="title">Subgroup analysis based on timing of birth</h4> <p>We also performed subgroup analyses based on the timing of birth, with six trials contributing data (<a href="./references#CD000019-bbs2-0002" title="CrowtherC , HillerJ , HaslamR , RobinsonJ , the ACTOBAT Study Group. Australian Collaborative Trial of Betamethasone and TRH for the prevention of neonatal respiratory disease (ACTOBAT). International Journal of Gynecology and Obstetrics1994;46:59. CrowtherCA , HillerJE , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial of antenatal thyrotropin‐releasing hormone: Adverse effects at 12‐month follow‐up. Pediatrics1997;99:311‐7. HillerJE , CrowtherCA , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial af antenatal thyrotropin‐releasing hormone (ACTOBAT): 12 month follow‐up. 4th Annual Congress of the Perinatal Society of Australia &amp; New Zealand; 1998 March 30‐April 4; Alice Springs, Australia. Alice Springs, 1998:77. The ACTOBAT Study Group. Australian collaborative trial of betamethasone and thyrotropin releasing hormone (ACTOBAT) for the prevention of neonatal respiratory disease. Lancet1995;345:877‐82. ">ACTOBAT 1995</a>; <a href="./references#CD000019-bbs2-0003" title="BallardPL , BallardRA , CreasyRK , PadburyJ , PolkDH , BrackenM , et al. Plasma thyroid hormones and prolactin in premature infants and their mothers after treatment with thyrotropin‐releasing hormone. Pediatric Research1992;32(6):673‐8. BallardRA , BallardPL , CreasyR , GrossI , MainD , PadburyJF , et al. Prenatal treatment with thyrotropin releasing hormone plus corticosteroid: absence of maternal, fetal or neonatal side effects. Clinical Research1990;38:192A. BallardRA , BallardPL , CreasyR , GrossI , MainD , PadburyJF , et al. Prenatal treatment with thyrotropin releasing hormone plus corticosteroid: absence of maternal, fetal or neonatal side effects. Pediatric Research1991;29:202A. BallardRA , BallardPL , CreasyR , GrossI , PadburyJF , TRH Study Group. Thyrotropin releasing hormone plus corticosteroids decreases chronic lung disease in very low birth weight infants. Pediatric Research1991;29(4):1828A. BallardRA , BallardPL , CreasyR , PadburyJ , PolkDH , BrackenM , et al. Respiratory disease in very‐low birthweight infants after prenatal thyrotropin‐releasing hormone and glucocorticoid. Lancet1992;339:510‐5. ">Ballard 1992b</a>; <a href="./references#CD000019-bbs2-0004" title="BallardPL , BallardRA , NingY , CnannA , BoardmanC , Pinto‐MartinJ , et al. Plasma thyroid hormones in premature infants: effect of gestational age and antenatal thyrotropin‐releasing hormone treatment. Pediatric Research1998;44:642‐9. BallardRA , BallardPL , BoardmanC , CnaanA , DavisDJ , HartMC , et al. Antenatal thyrotropin releasing hormone (TRH) for the prevention of chronic lung disease (CLD) in the preterm infant. Pediatric Research1997;41:246A. BallardRA , BallardPL , CnaanA , Pinto‐MartinJ , DavisDJ , PadburyJF , et al. Antenatal thyrotropin‐releasing hormone to prevention lung disease in preterm infants. New England Journal of Medicine1998;338:493‐8. ">Ballard 1998</a>; <a href="./references#CD000019-bbs2-0008" title="Collaborative Santiago Surfactant Group. Collaborative trial of prenatal thyrotropin‐releasing hormone and corticosteroids for prevention of respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178:33‐9. MaturanaA , TorresJ , SalinasR , MoyaF , for the Collaborative Group. Controlled trial of prenatal thyrotropin‐releasing hormone (TRH) and betamethasone (B) for prevention of respiratory distress syndrome (RDS). Pediatric Research1997;41:163A. ReyesG , GonzalezAR , GomezG , BlasiniI , RiveraCE . Comparative study of the effectiveness of thyroxine and steroids on reduction of neonatal morbidity: outcome at 20 months follow‐up. Puerto Rico Health Sciences Journal2004;23(1):9‐12. SantiagoR , RomagueraJ . Steroids vs steroids and thyroxine to accelerate fetal maturation of patients in arrested preterm labor. Puerto Rico Health Sciences Journal1999;18:156. ">Chile 1998</a>; <a href="./references#CD000019-bbs2-0010" title="AlfirevicZ , BoerK , BrocklehurstP , BuimerM , ElbourneD , KokJ , et al. Two trials of antenatal thyrotrophin‐releasing hormone for fetal maturation: stopping before the due date. British Journal of Obstetrics and Gynaecology1999;106:898‐906. AlfirevicZ , ElbourneD , BrocklehurstP , TruesdaleA , NeilsonJ . Randomised controlled trial of antenatal administration of thyrotropin releasing hormone (TRH) to women at risk of premature delivery. Prenatal and Neonatal Medicine1996;1(1):10. BrietJM , vanSonderenL , BuimerM , BoerK , KokJH . Neurodevelopmental outcome of children treated with antenatal thyrotropin‐releasing hormone. Pediatrics2002;110(2 Pt 1):249‐53. BrocklehurstP . Antenatal thyrotropin‐releasing hormone for fetal maturity: two concurrent randomised controlled trials (The Antenatal TRH Trial and the Thyroneth Trial). British Journal of Obstetrics and Gynaecology1998;105:81. ">Europe 1999</a>; <a href="./references#CD000019-bbs2-0013" title="KnightDB , LigginsGC , Wealthall SR. A randomised controlled trial of the effect of thyrotropin‐releasing hormone with betamethasone in mothers likely to deliver prematurely on neonatal outcome. Proceedings of the Australian Perinatal Society; 1992; Queensland, Australia. 1992:A9. KnightDB , LigginsGC , Wealthall SR. A randomized, controlled trial of antepartum thyrotropin‐releasing hormone and betamethasone in the prevention of respiratory disease in preterm infants. American Journal of Obstetrics and Gynecology1994;171:11‐6. KnightDB , Wealthall SR, LigginsGC , HowieRN . A randomised double blind controlled trial of antepartum TRH with betamethasone in the prevention of neonatal respiratory disease. New Zealand Medical Journal1989;102:195. LigginsGC , KnightDB , Wealthall SR, HowieRN . A randomized double‐blind trial of antepartum TRH and steroids in the prevention of neonatal respiratory disease. Clinical reproductive medicine ‐ the Liggins years; 1988 July 29‐30; Auckland, New Zealand. 1988. ">Knight 1994</a>). Babies born less than 24 hours after trial entry made up 13% of the total population, and babies born between 24 hours and 10 days from trial entry accounted for 38% of the total population; while babies born more than 10 days after trial entry accounted for the majority of the population (49%). </p> <p>Considering the timing of birth, the subgroup analyses did not reveal any significant subgroup differences for the outcomes death prior to hospital discharge for the infant (Chi² = 0.45, P = 0.80, I² = 0%) (<a href="./references#CD000019-fig-00301" title="">Analysis 3.1</a>); chronic lung disease (variously defined) (Chi² = 2.76, P = 0.25, I² = 27.6%) (<a href="./references#CD000019-fig-00302" title="">Analysis 3.2</a>); chronic lung disease or death (Chi² = 3.70, P = 0.16, I² = 45.9%) (<a href="./references#CD000019-fig-00304" title="">Analysis 3.4</a>); the need for oxygen therapy (Chi² = 1.37, P = 0.50, I² = 0%) (<a href="./references#CD000019-fig-00305" title="">Analysis 3.5</a>); severe RDS (Chi² = 3.13, P = 0.21, I² = 36.1%) (<a href="./references#CD000019-fig-00306" title="">Analysis 3.6</a>); or the use of respiratory support (Chi² = 2.40, P = 0.30, I² = 16.6%) (<a href="./references#CD000019-fig-00307" title="">Analysis 3.7</a>) indicating no differential effects for these infant outcomes according to timing of birth after trial entry. </p> <p>Considering the outcome RDS, the subgroup interaction test indicated a significant difference (Chi² = 6.39, P = 0.04, I² = 68.7%) (<a href="./references#CD000019-fig-00303" title="">Analysis 3.3</a>), suggesting a possible differential treatment effect based on timing of delivery in favour of corticosteroids alone (as compared with TRH and corticosteroids) for babies born more than 10 days after trial entry (RR 1.33, 95% CI 1.05 to 1.68). This difference was not seen in either of the other two timing of birth subgroups, or in the main analysis. </p> </section> <section id="CD000019-sec3-0030"> <h4 class="title">Analysis restricted to mothers and babies receiving 'optimal treatment'</h4> <p>A secondary analysis was performed in order to allow the additional inclusion of data from three trials (<a href="./references#CD000019-bbs2-0005" title="CamposG , HerrmanF , DornerM . Combined hormonal therapy for the prevention of respiratory distress syndrome and its consequences. Seminars in Perinatology1993;17(4):267‐74. ">Campos 1993</a>; <a href="./references#CD000019-bbs2-0007" title="AlthabeF , FustiharaC , AlthabeO , CernadesJMC . Controlled trial of prenatal betamethasone plus TRH vs betamethasone plus placebo for prevention of RDS in preterm infants. Pediatric Research1991;29:200A. Ceriani CernadasJ , FustiharaC , AlthabeF , AlthabeO . Controlled trial of prenatal betamethasone (B) plus TRH for prevention of respiratory distress syndrome (RDS) in preterm infants. Pediatric Research1992;32:738. ">Ceriani 1992</a>; <a href="./references#CD000019-bbs2-0014" title="MoralesWJ , O'BrienWF , AngelJL , KnuppelRA , SawaiS . Fetal lung maturation: the combined use of corticosteroids and thyrotropin‐releasing hormone. Obstetrics and Gynecology1989;73:111‐6. ">Morales 1989</a>) in which results were reported only for a subgroup of participants regarded as optimally treated by the respective trialists. Overall, 10 trials contributed data (<a href="./references#CD000019-bbs2-0002" title="CrowtherC , HillerJ , HaslamR , RobinsonJ , the ACTOBAT Study Group. Australian Collaborative Trial of Betamethasone and TRH for the prevention of neonatal respiratory disease (ACTOBAT). International Journal of Gynecology and Obstetrics1994;46:59. CrowtherCA , HillerJE , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial of antenatal thyrotropin‐releasing hormone: Adverse effects at 12‐month follow‐up. Pediatrics1997;99:311‐7. HillerJE , CrowtherCA , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial af antenatal thyrotropin‐releasing hormone (ACTOBAT): 12 month follow‐up. 4th Annual Congress of the Perinatal Society of Australia &amp; New Zealand; 1998 March 30‐April 4; Alice Springs, Australia. Alice Springs, 1998:77. The ACTOBAT Study Group. Australian collaborative trial of betamethasone and thyrotropin releasing hormone (ACTOBAT) for the prevention of neonatal respiratory disease. Lancet1995;345:877‐82. ">ACTOBAT 1995</a>; <a href="./references#CD000019-bbs2-0003" title="BallardPL , BallardRA , CreasyRK , PadburyJ , PolkDH , BrackenM , et al. Plasma thyroid hormones and prolactin in premature infants and their mothers after treatment with thyrotropin‐releasing hormone. Pediatric Research1992;32(6):673‐8. BallardRA , BallardPL , CreasyR , GrossI , MainD , PadburyJF , et al. Prenatal treatment with thyrotropin releasing hormone plus corticosteroid: absence of maternal, fetal or neonatal side effects. Clinical Research1990;38:192A. BallardRA , BallardPL , CreasyR , GrossI , MainD , PadburyJF , et al. Prenatal treatment with thyrotropin releasing hormone plus corticosteroid: absence of maternal, fetal or neonatal side effects. Pediatric Research1991;29:202A. BallardRA , BallardPL , CreasyR , GrossI , PadburyJF , TRH Study Group. Thyrotropin releasing hormone plus corticosteroids decreases chronic lung disease in very low birth weight infants. Pediatric Research1991;29(4):1828A. BallardRA , BallardPL , CreasyR , PadburyJ , PolkDH , BrackenM , et al. Respiratory disease in very‐low birthweight infants after prenatal thyrotropin‐releasing hormone and glucocorticoid. Lancet1992;339:510‐5. ">Ballard 1992b</a>; <a href="./references#CD000019-bbs2-0004" title="BallardPL , BallardRA , NingY , CnannA , BoardmanC , Pinto‐MartinJ , et al. Plasma thyroid hormones in premature infants: effect of gestational age and antenatal thyrotropin‐releasing hormone treatment. Pediatric Research1998;44:642‐9. BallardRA , BallardPL , BoardmanC , CnaanA , DavisDJ , HartMC , et al. Antenatal thyrotropin releasing hormone (TRH) for the prevention of chronic lung disease (CLD) in the preterm infant. Pediatric Research1997;41:246A. BallardRA , BallardPL , CnaanA , Pinto‐MartinJ , DavisDJ , PadburyJF , et al. Antenatal thyrotropin‐releasing hormone to prevention lung disease in preterm infants. New England Journal of Medicine1998;338:493‐8. ">Ballard 1998</a>; <a href="./references#CD000019-bbs2-0005" title="CamposG , HerrmanF , DornerM . Combined hormonal therapy for the prevention of respiratory distress syndrome and its consequences. Seminars in Perinatology1993;17(4):267‐74. ">Campos 1993</a>; <a href="./references#CD000019-bbs2-0007" title="AlthabeF , FustiharaC , AlthabeO , CernadesJMC . Controlled trial of prenatal betamethasone plus TRH vs betamethasone plus placebo for prevention of RDS in preterm infants. Pediatric Research1991;29:200A. Ceriani CernadasJ , FustiharaC , AlthabeF , AlthabeO . Controlled trial of prenatal betamethasone (B) plus TRH for prevention of respiratory distress syndrome (RDS) in preterm infants. Pediatric Research1992;32:738. ">Ceriani 1992</a>; <a href="./references#CD000019-bbs2-0008" title="Collaborative Santiago Surfactant Group. Collaborative trial of prenatal thyrotropin‐releasing hormone and corticosteroids for prevention of respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178:33‐9. MaturanaA , TorresJ , SalinasR , MoyaF , for the Collaborative Group. Controlled trial of prenatal thyrotropin‐releasing hormone (TRH) and betamethasone (B) for prevention of respiratory distress syndrome (RDS). Pediatric Research1997;41:163A. ReyesG , GonzalezAR , GomezG , BlasiniI , RiveraCE . Comparative study of the effectiveness of thyroxine and steroids on reduction of neonatal morbidity: outcome at 20 months follow‐up. Puerto Rico Health Sciences Journal2004;23(1):9‐12. SantiagoR , RomagueraJ . Steroids vs steroids and thyroxine to accelerate fetal maturation of patients in arrested preterm labor. Puerto Rico Health Sciences Journal1999;18:156. ">Chile 1998</a>; <a href="./references#CD000019-bbs2-0010" title="AlfirevicZ , BoerK , BrocklehurstP , BuimerM , ElbourneD , KokJ , et al. Two trials of antenatal thyrotrophin‐releasing hormone for fetal maturation: stopping before the due date. British Journal of Obstetrics and Gynaecology1999;106:898‐906. AlfirevicZ , ElbourneD , BrocklehurstP , TruesdaleA , NeilsonJ . Randomised controlled trial of antenatal administration of thyrotropin releasing hormone (TRH) to women at risk of premature delivery. Prenatal and Neonatal Medicine1996;1(1):10. BrietJM , vanSonderenL , BuimerM , BoerK , KokJH . Neurodevelopmental outcome of children treated with antenatal thyrotropin‐releasing hormone. Pediatrics2002;110(2 Pt 1):249‐53. BrocklehurstP . Antenatal thyrotropin‐releasing hormone for fetal maturity: two concurrent randomised controlled trials (The Antenatal TRH Trial and the Thyroneth Trial). British Journal of Obstetrics and Gynaecology1998;105:81. ">Europe 1999</a>; <a href="./references#CD000019-bbs2-0011" title="JikiharaH , SawadaY , ImaiS , MorishigeK , TaniguchiT , NoharaA , et al. Maternal administration of thyrotropin‐releasing hormone for prevention of neonatal respiratory distress syndrome. Proceedings of 6th Congress of the Federation of the Asia‐Oceania Perinatal Societies; 1990 Oct 22‐26; Perth, Western Australia. 1990:87. ">Jikihara 1990</a>; <a href="./references#CD000019-bbs2-0013" title="KnightDB , LigginsGC , Wealthall SR. A randomised controlled trial of the effect of thyrotropin‐releasing hormone with betamethasone in mothers likely to deliver prematurely on neonatal outcome. Proceedings of the Australian Perinatal Society; 1992; Queensland, Australia. 1992:A9. KnightDB , LigginsGC , Wealthall SR. A randomized, controlled trial of antepartum thyrotropin‐releasing hormone and betamethasone in the prevention of respiratory disease in preterm infants. American Journal of Obstetrics and Gynecology1994;171:11‐6. KnightDB , Wealthall SR, LigginsGC , HowieRN . A randomised double blind controlled trial of antepartum TRH with betamethasone in the prevention of neonatal respiratory disease. New Zealand Medical Journal1989;102:195. LigginsGC , KnightDB , Wealthall SR, HowieRN . A randomized double‐blind trial of antepartum TRH and steroids in the prevention of neonatal respiratory disease. Clinical reproductive medicine ‐ the Liggins years; 1988 July 29‐30; Auckland, New Zealand. 1988. ">Knight 1994</a>; <a href="./references#CD000019-bbs2-0014" title="MoralesWJ , O'BrienWF , AngelJL , KnuppelRA , SawaiS . Fetal lung maturation: the combined use of corticosteroids and thyrotropin‐releasing hormone. Obstetrics and Gynecology1989;73:111‐6. ">Morales 1989</a>) to the 'optimal treatment' subgroup. Optimal treatment was described variously by different authors. <a href="./references#CD000019-bbs2-0014" title="MoralesWJ , O'BrienWF , AngelJL , KnuppelRA , SawaiS . Fetal lung maturation: the combined use of corticosteroids and thyrotropin‐releasing hormone. Obstetrics and Gynecology1989;73:111‐6. ">Morales 1989</a> presented outcome data for infants delivered within one week of the start of therapy, which represented only 40% of the total number of babies in the study. <a href="./references#CD000019-bbs2-0007" title="AlthabeF , FustiharaC , AlthabeO , CernadesJMC . Controlled trial of prenatal betamethasone plus TRH vs betamethasone plus placebo for prevention of RDS in preterm infants. Pediatric Research1991;29:200A. Ceriani CernadasJ , FustiharaC , AlthabeF , AlthabeO . Controlled trial of prenatal betamethasone (B) plus TRH for prevention of respiratory distress syndrome (RDS) in preterm infants. Pediatric Research1992;32:738. ">Ceriani 1992</a> reported data for infants fully treated (received all doses of TRH or corticosteroids, or both) and born within 10 days of entry. <a href="./references#CD000019-bbs2-0005" title="CamposG , HerrmanF , DornerM . Combined hormonal therapy for the prevention of respiratory distress syndrome and its consequences. Seminars in Perinatology1993;17(4):267‐74. ">Campos 1993</a> reported the data on fully treated infants (received all doses of TRH or corticosteroids, or both) who were born within 48 hours of the last hormonal dose. The included data from <a href="./references#CD000019-bbs2-0002" title="CrowtherC , HillerJ , HaslamR , RobinsonJ , the ACTOBAT Study Group. Australian Collaborative Trial of Betamethasone and TRH for the prevention of neonatal respiratory disease (ACTOBAT). International Journal of Gynecology and Obstetrics1994;46:59. CrowtherCA , HillerJE , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial of antenatal thyrotropin‐releasing hormone: Adverse effects at 12‐month follow‐up. Pediatrics1997;99:311‐7. HillerJE , CrowtherCA , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial af antenatal thyrotropin‐releasing hormone (ACTOBAT): 12 month follow‐up. 4th Annual Congress of the Perinatal Society of Australia &amp; New Zealand; 1998 March 30‐April 4; Alice Springs, Australia. Alice Springs, 1998:77. The ACTOBAT Study Group. Australian collaborative trial of betamethasone and thyrotropin releasing hormone (ACTOBAT) for the prevention of neonatal respiratory disease. Lancet1995;345:877‐82. ">ACTOBAT 1995</a>; <a href="./references#CD000019-bbs2-0003" title="BallardPL , BallardRA , CreasyRK , PadburyJ , PolkDH , BrackenM , et al. Plasma thyroid hormones and prolactin in premature infants and their mothers after treatment with thyrotropin‐releasing hormone. Pediatric Research1992;32(6):673‐8. BallardRA , BallardPL , CreasyR , GrossI , MainD , PadburyJF , et al. Prenatal treatment with thyrotropin releasing hormone plus corticosteroid: absence of maternal, fetal or neonatal side effects. Clinical Research1990;38:192A. BallardRA , BallardPL , CreasyR , GrossI , MainD , PadburyJF , et al. Prenatal treatment with thyrotropin releasing hormone plus corticosteroid: absence of maternal, fetal or neonatal side effects. Pediatric Research1991;29:202A. BallardRA , BallardPL , CreasyR , GrossI , PadburyJF , TRH Study Group. Thyrotropin releasing hormone plus corticosteroids decreases chronic lung disease in very low birth weight infants. Pediatric Research1991;29(4):1828A. BallardRA , BallardPL , CreasyR , PadburyJ , PolkDH , BrackenM , et al. Respiratory disease in very‐low birthweight infants after prenatal thyrotropin‐releasing hormone and glucocorticoid. Lancet1992;339:510‐5. ">Ballard 1992b</a>; <a href="./references#CD000019-bbs2-0004" title="BallardPL , BallardRA , NingY , CnannA , BoardmanC , Pinto‐MartinJ , et al. Plasma thyroid hormones in premature infants: effect of gestational age and antenatal thyrotropin‐releasing hormone treatment. Pediatric Research1998;44:642‐9. BallardRA , BallardPL , BoardmanC , CnaanA , DavisDJ , HartMC , et al. Antenatal thyrotropin releasing hormone (TRH) for the prevention of chronic lung disease (CLD) in the preterm infant. Pediatric Research1997;41:246A. BallardRA , BallardPL , CnaanA , Pinto‐MartinJ , DavisDJ , PadburyJF , et al. Antenatal thyrotropin‐releasing hormone to prevention lung disease in preterm infants. New England Journal of Medicine1998;338:493‐8. ">Ballard 1998</a>; <a href="./references#CD000019-bbs2-0008" title="Collaborative Santiago Surfactant Group. Collaborative trial of prenatal thyrotropin‐releasing hormone and corticosteroids for prevention of respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178:33‐9. MaturanaA , TorresJ , SalinasR , MoyaF , for the Collaborative Group. Controlled trial of prenatal thyrotropin‐releasing hormone (TRH) and betamethasone (B) for prevention of respiratory distress syndrome (RDS). Pediatric Research1997;41:163A. ReyesG , GonzalezAR , GomezG , BlasiniI , RiveraCE . Comparative study of the effectiveness of thyroxine and steroids on reduction of neonatal morbidity: outcome at 20 months follow‐up. Puerto Rico Health Sciences Journal2004;23(1):9‐12. SantiagoR , RomagueraJ . Steroids vs steroids and thyroxine to accelerate fetal maturation of patients in arrested preterm labor. Puerto Rico Health Sciences Journal1999;18:156. ">Chile 1998</a>; <a href="./references#CD000019-bbs2-0010" title="AlfirevicZ , BoerK , BrocklehurstP , BuimerM , ElbourneD , KokJ , et al. Two trials of antenatal thyrotrophin‐releasing hormone for fetal maturation: stopping before the due date. British Journal of Obstetrics and Gynaecology1999;106:898‐906. AlfirevicZ , ElbourneD , BrocklehurstP , TruesdaleA , NeilsonJ . Randomised controlled trial of antenatal administration of thyrotropin releasing hormone (TRH) to women at risk of premature delivery. Prenatal and Neonatal Medicine1996;1(1):10. BrietJM , vanSonderenL , BuimerM , BoerK , KokJH . Neurodevelopmental outcome of children treated with antenatal thyrotropin‐releasing hormone. Pediatrics2002;110(2 Pt 1):249‐53. BrocklehurstP . Antenatal thyrotropin‐releasing hormone for fetal maturity: two concurrent randomised controlled trials (The Antenatal TRH Trial and the Thyroneth Trial). British Journal of Obstetrics and Gynaecology1998;105:81. ">Europe 1999</a>; <a href="./references#CD000019-bbs2-0011" title="JikiharaH , SawadaY , ImaiS , MorishigeK , TaniguchiT , NoharaA , et al. Maternal administration of thyrotropin‐releasing hormone for prevention of neonatal respiratory distress syndrome. Proceedings of 6th Congress of the Federation of the Asia‐Oceania Perinatal Societies; 1990 Oct 22‐26; Perth, Western Australia. 1990:87. ">Jikihara 1990</a> and <a href="./references#CD000019-bbs2-0013" title="KnightDB , LigginsGC , Wealthall SR. A randomised controlled trial of the effect of thyrotropin‐releasing hormone with betamethasone in mothers likely to deliver prematurely on neonatal outcome. Proceedings of the Australian Perinatal Society; 1992; Queensland, Australia. 1992:A9. KnightDB , LigginsGC , Wealthall SR. A randomized, controlled trial of antepartum thyrotropin‐releasing hormone and betamethasone in the prevention of respiratory disease in preterm infants. American Journal of Obstetrics and Gynecology1994;171:11‐6. KnightDB , Wealthall SR, LigginsGC , HowieRN . A randomised double blind controlled trial of antepartum TRH with betamethasone in the prevention of neonatal respiratory disease. New Zealand Medical Journal1989;102:195. LigginsGC , KnightDB , Wealthall SR, HowieRN . A randomized double‐blind trial of antepartum TRH and steroids in the prevention of neonatal respiratory disease. Clinical reproductive medicine ‐ the Liggins years; 1988 July 29‐30; Auckland, New Zealand. 1988. ">Knight 1994</a> relate to infants born between 24 hours to 10 days after entry into the trial. </p> <p>No beneficial effects of prenatal TRH were seen between groups for death prior to hospital discharge (RR 0.88, 95% CI 0.67 to 1.14, nine trials, 1465 infants) (<a href="./references#CD000019-fig-00401" title="">Analysis 4.1</a>), chronic lung disease (RR 0.87, 95% CI 0.72 to 1.04, eight trials, 1318 infants) (<a href="./references#CD000019-fig-00402" title="">Analysis 4.2</a>), RDS (average RR 0.89, 95% CI 0.77 to 1.03, 10 trials, 1786 infants; Tau² = 0.02; I² = 40%) (<a href="./references#CD000019-fig-00403" title="">Analysis 4.3</a>), chronic lung disease or death (RR 0.96, 95% CI 0.84 to 1.09; five trials, 1317 infants) (<a href="./references#CD000019-fig-00404" title="">Analysis 4.4</a>), the need for oxygen therapy (RR 0.99, 95% CI 0.91 to 1.09; one trial, 506 infants) (<a href="./references#CD000019-fig-00405" title="">Analysis 4.5</a>), or for the use of respiratory support (RR 1.07, 95% CI 0.94 to 1.22; one trial, 506 infants) (<a href="./references#CD000019-fig-00407" title="">Analysis 4.7</a>) for the optimally treated subgroup of infants. A statistically significant reduction in severe RDS was however observed for the infants exposed to TRH as compared corticosteroids alone when considering only optimally treated infants (RR 0.65, 95% CI 0.49 to 0.86; two trials, 694 infants) (<a href="./references#CD000019-fig-00406" title="">Analysis 4.6</a>). </p> <p>When we performed subgroup interaction tests comparing all treated infants versus only those considered 'optimally treated', no significant subgroup differences were observed between the two groups for the outcomes: death (Chi² = 1.12, P = 0.29, I² = 11.0%) (<a href="./references#CD000019-fig-00401" title="">Analysis 4.1</a>), chronic lung disease (Chi² = 1.40, P = 0.24, I² = 28.6%) (<a href="./references#CD000019-fig-00402" title="">Analysis 4.2</a>), RDS (Chi² = 2.47, P = 0.12, I² = 59.5%) (<a href="./references#CD000019-fig-00403" title="">Analysis 4.3</a>), chronic lung disease or death (Chi² = 1.45, P = 0.23, I² = 31.0%) (<a href="./references#CD000019-fig-00404" title="">Analysis 4.4</a>), the need for oxygen therapy (Chi² = 0.79, P = 0.37, I² = 0%) (<a href="./references#CD000019-fig-00405" title="">Analysis 4.5</a>), severe RDS (Chi² = 2.26, P = 0.13, I² = 55.7%) (<a href="./references#CD000019-fig-00406" title="">Analysis 4.6</a>), or for the use of respiratory support (Chi² = 0.74, P = 0.39, I² = 0%) (<a href="./references#CD000019-fig-00407" title="">Analysis 4.7</a>) indicating no clear differential effects based on optimal treatment for these primary and pre‐specified infant outcomes. </p> </section> <section id="CD000019-sec3-0031"> <h4 class="title">Sensitivity analysis by quality rating</h4> <p>Five trials (<a href="./references#CD000019-bbs2-0002" title="CrowtherC , HillerJ , HaslamR , RobinsonJ , the ACTOBAT Study Group. Australian Collaborative Trial of Betamethasone and TRH for the prevention of neonatal respiratory disease (ACTOBAT). International Journal of Gynecology and Obstetrics1994;46:59. CrowtherCA , HillerJE , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial of antenatal thyrotropin‐releasing hormone: Adverse effects at 12‐month follow‐up. Pediatrics1997;99:311‐7. HillerJE , CrowtherCA , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial af antenatal thyrotropin‐releasing hormone (ACTOBAT): 12 month follow‐up. 4th Annual Congress of the Perinatal Society of Australia &amp; New Zealand; 1998 March 30‐April 4; Alice Springs, Australia. Alice Springs, 1998:77. The ACTOBAT Study Group. Australian collaborative trial of betamethasone and thyrotropin releasing hormone (ACTOBAT) for the prevention of neonatal respiratory disease. Lancet1995;345:877‐82. ">ACTOBAT 1995</a>; <a href="./references#CD000019-bbs2-0004" title="BallardPL , BallardRA , NingY , CnannA , BoardmanC , Pinto‐MartinJ , et al. Plasma thyroid hormones in premature infants: effect of gestational age and antenatal thyrotropin‐releasing hormone treatment. Pediatric Research1998;44:642‐9. BallardRA , BallardPL , BoardmanC , CnaanA , DavisDJ , HartMC , et al. Antenatal thyrotropin releasing hormone (TRH) for the prevention of chronic lung disease (CLD) in the preterm infant. Pediatric Research1997;41:246A. BallardRA , BallardPL , CnaanA , Pinto‐MartinJ , DavisDJ , PadburyJF , et al. Antenatal thyrotropin‐releasing hormone to prevention lung disease in preterm infants. New England Journal of Medicine1998;338:493‐8. ">Ballard 1998</a>; <a href="./references#CD000019-bbs2-0008" title="Collaborative Santiago Surfactant Group. Collaborative trial of prenatal thyrotropin‐releasing hormone and corticosteroids for prevention of respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178:33‐9. MaturanaA , TorresJ , SalinasR , MoyaF , for the Collaborative Group. Controlled trial of prenatal thyrotropin‐releasing hormone (TRH) and betamethasone (B) for prevention of respiratory distress syndrome (RDS). Pediatric Research1997;41:163A. ReyesG , GonzalezAR , GomezG , BlasiniI , RiveraCE . Comparative study of the effectiveness of thyroxine and steroids on reduction of neonatal morbidity: outcome at 20 months follow‐up. Puerto Rico Health Sciences Journal2004;23(1):9‐12. SantiagoR , RomagueraJ . Steroids vs steroids and thyroxine to accelerate fetal maturation of patients in arrested preterm labor. Puerto Rico Health Sciences Journal1999;18:156. ">Chile 1998</a>; <a href="./references#CD000019-bbs2-0010" title="AlfirevicZ , BoerK , BrocklehurstP , BuimerM , ElbourneD , KokJ , et al. Two trials of antenatal thyrotrophin‐releasing hormone for fetal maturation: stopping before the due date. British Journal of Obstetrics and Gynaecology1999;106:898‐906. AlfirevicZ , ElbourneD , BrocklehurstP , TruesdaleA , NeilsonJ . Randomised controlled trial of antenatal administration of thyrotropin releasing hormone (TRH) to women at risk of premature delivery. Prenatal and Neonatal Medicine1996;1(1):10. BrietJM , vanSonderenL , BuimerM , BoerK , KokJH . Neurodevelopmental outcome of children treated with antenatal thyrotropin‐releasing hormone. Pediatrics2002;110(2 Pt 1):249‐53. BrocklehurstP . Antenatal thyrotropin‐releasing hormone for fetal maturity: two concurrent randomised controlled trials (The Antenatal TRH Trial and the Thyroneth Trial). British Journal of Obstetrics and Gynaecology1998;105:81. ">Europe 1999</a>; <a href="./references#CD000019-bbs2-0013" title="KnightDB , LigginsGC , Wealthall SR. A randomised controlled trial of the effect of thyrotropin‐releasing hormone with betamethasone in mothers likely to deliver prematurely on neonatal outcome. Proceedings of the Australian Perinatal Society; 1992; Queensland, Australia. 1992:A9. KnightDB , LigginsGC , Wealthall SR. A randomized, controlled trial of antepartum thyrotropin‐releasing hormone and betamethasone in the prevention of respiratory disease in preterm infants. American Journal of Obstetrics and Gynecology1994;171:11‐6. KnightDB , Wealthall SR, LigginsGC , HowieRN . A randomised double blind controlled trial of antepartum TRH with betamethasone in the prevention of neonatal respiratory disease. New Zealand Medical Journal1989;102:195. LigginsGC , KnightDB , Wealthall SR, HowieRN . A randomized double‐blind trial of antepartum TRH and steroids in the prevention of neonatal respiratory disease. Clinical reproductive medicine ‐ the Liggins years; 1988 July 29‐30; Auckland, New Zealand. 1988. ">Knight 1994</a>), considered at a low risk of bias in the domains of sequence generation, allocation concealment, blinding, incomplete outcome data and selective reporting, were included in a sensitivity analysis. </p> <p>No beneficial effects of prenatal TRH were seen for any of the primary infant outcomes of death (RR 1.03, 95% CI 0.84 to 1.25, five trials, 3570 infants) (<a href="./references#CD000019-fig-00501" title="">Analysis 5.1</a>), chronic lung disease (RR 1.00, 95% CI 0.84 to 1.18, four trials, 2387 infants) (<a href="./references#CD000019-fig-00502" title="">Analysis 5.2</a>), and RDS (RR 1.06, 95% CI 0.91 to 1.24, five trials, 3521 infants) (<a href="./references#CD000019-fig-00503" title="">Analysis 5.3</a>), nor for any of the other pre‐specified infant outcomes, including chronic lung disease or death (RR 1.05, 95% CI 0.94 to 1.17, five trials, 3570 infants) (<a href="./references#CD000019-fig-00504" title="">Analysis 5.4</a>), the need for oxygen therapy (RR 1.05, 95% CI 0.97 to 1.13, four trials, 2387 infants) (<a href="./references#CD000019-fig-00505" title="">Analysis 5.5</a>), and severe RDS (average RR 0.88, 95% CI 0.57 to 1.36, three trials, 2119 infants; Tau² = 0.11; I² = 73%) (<a href="./references#CD000019-fig-00506" title="">Analysis 5.6</a>), as in the main analysis. </p> <p>The significant increase in the use of respiratory support for infants exposed to TRH as compared with corticosteroids alone persisted in the sensitivity analysis (with data from the same three trials included: <a href="./references#CD000019-bbs2-0002" title="CrowtherC , HillerJ , HaslamR , RobinsonJ , the ACTOBAT Study Group. Australian Collaborative Trial of Betamethasone and TRH for the prevention of neonatal respiratory disease (ACTOBAT). International Journal of Gynecology and Obstetrics1994;46:59. CrowtherCA , HillerJE , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial of antenatal thyrotropin‐releasing hormone: Adverse effects at 12‐month follow‐up. Pediatrics1997;99:311‐7. HillerJE , CrowtherCA , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial af antenatal thyrotropin‐releasing hormone (ACTOBAT): 12 month follow‐up. 4th Annual Congress of the Perinatal Society of Australia &amp; New Zealand; 1998 March 30‐April 4; Alice Springs, Australia. Alice Springs, 1998:77. The ACTOBAT Study Group. Australian collaborative trial of betamethasone and thyrotropin releasing hormone (ACTOBAT) for the prevention of neonatal respiratory disease. Lancet1995;345:877‐82. ">ACTOBAT 1995</a>; <a href="./references#CD000019-bbs2-0008" title="Collaborative Santiago Surfactant Group. Collaborative trial of prenatal thyrotropin‐releasing hormone and corticosteroids for prevention of respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178:33‐9. MaturanaA , TorresJ , SalinasR , MoyaF , for the Collaborative Group. Controlled trial of prenatal thyrotropin‐releasing hormone (TRH) and betamethasone (B) for prevention of respiratory distress syndrome (RDS). Pediatric Research1997;41:163A. ReyesG , GonzalezAR , GomezG , BlasiniI , RiveraCE . Comparative study of the effectiveness of thyroxine and steroids on reduction of neonatal morbidity: outcome at 20 months follow‐up. Puerto Rico Health Sciences Journal2004;23(1):9‐12. SantiagoR , RomagueraJ . Steroids vs steroids and thyroxine to accelerate fetal maturation of patients in arrested preterm labor. Puerto Rico Health Sciences Journal1999;18:156. ">Chile 1998</a>; <a href="./references#CD000019-bbs2-0010" title="AlfirevicZ , BoerK , BrocklehurstP , BuimerM , ElbourneD , KokJ , et al. Two trials of antenatal thyrotrophin‐releasing hormone for fetal maturation: stopping before the due date. British Journal of Obstetrics and Gynaecology1999;106:898‐906. AlfirevicZ , ElbourneD , BrocklehurstP , TruesdaleA , NeilsonJ . Randomised controlled trial of antenatal administration of thyrotropin releasing hormone (TRH) to women at risk of premature delivery. Prenatal and Neonatal Medicine1996;1(1):10. BrietJM , vanSonderenL , BuimerM , BoerK , KokJH . Neurodevelopmental outcome of children treated with antenatal thyrotropin‐releasing hormone. Pediatrics2002;110(2 Pt 1):249‐53. BrocklehurstP . Antenatal thyrotropin‐releasing hormone for fetal maturity: two concurrent randomised controlled trials (The Antenatal TRH Trial and the Thyroneth Trial). British Journal of Obstetrics and Gynaecology1998;105:81. ">Europe 1999</a>) (RR 1.16, 95% CI 1.03 to 1.29, three trials, 1969 infants) (<a href="./references#CD000019-fig-00507" title="">Analysis 5.7</a>). </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD000019-sec1-0005" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD000019-sec1-0005"></div> <p>This review does not show that prenatal administration of thyrotropin‐releasing hormone (TRH), in addition to corticosteroids, prior to preterm birth reduces the risk of respiratory disease in infants born preterm, or reduces other infant morbidity or mortality. Indeed the data show that this treatment may have adverse effects for women and their infants. All maternal side effects reported in the included trials (nausea, vomiting, light headedness, urgency of micturition, facial flushing) were more likely to occur in women receiving TRH, although their clinical significance and women's perceptions of their importance have not been assessed. For the infants, prenatal TRH increased the risk of infants needing respiratory support, and of having a low Apgar score at five minutes. </p> <p>In one of the three trials with follow‐up data, prenatal TRH was associated with adverse neurodevelopmental outcomes in childhood (such as motor and social delay, and motor and sensory impairment) (<a href="./references#CD000019-bbs2-0002" title="CrowtherC , HillerJ , HaslamR , RobinsonJ , the ACTOBAT Study Group. Australian Collaborative Trial of Betamethasone and TRH for the prevention of neonatal respiratory disease (ACTOBAT). International Journal of Gynecology and Obstetrics1994;46:59. CrowtherCA , HillerJE , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial of antenatal thyrotropin‐releasing hormone: Adverse effects at 12‐month follow‐up. Pediatrics1997;99:311‐7. HillerJE , CrowtherCA , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial af antenatal thyrotropin‐releasing hormone (ACTOBAT): 12 month follow‐up. 4th Annual Congress of the Perinatal Society of Australia &amp; New Zealand; 1998 March 30‐April 4; Alice Springs, Australia. Alice Springs, 1998:77. The ACTOBAT Study Group. Australian collaborative trial of betamethasone and thyrotropin releasing hormone (ACTOBAT) for the prevention of neonatal respiratory disease. Lancet1995;345:877‐82. ">ACTOBAT 1995</a>). However, the other two trials that assessed neurodevelopmental outcomes at follow‐up using an established developmental instrument (Bayley Infant Scales) (<a href="./references#CD000019-bbs2-0008" title="Collaborative Santiago Surfactant Group. Collaborative trial of prenatal thyrotropin‐releasing hormone and corticosteroids for prevention of respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178:33‐9. MaturanaA , TorresJ , SalinasR , MoyaF , for the Collaborative Group. Controlled trial of prenatal thyrotropin‐releasing hormone (TRH) and betamethasone (B) for prevention of respiratory distress syndrome (RDS). Pediatric Research1997;41:163A. ReyesG , GonzalezAR , GomezG , BlasiniI , RiveraCE . Comparative study of the effectiveness of thyroxine and steroids on reduction of neonatal morbidity: outcome at 20 months follow‐up. Puerto Rico Health Sciences Journal2004;23(1):9‐12. SantiagoR , RomagueraJ . Steroids vs steroids and thyroxine to accelerate fetal maturation of patients in arrested preterm labor. Puerto Rico Health Sciences Journal1999;18:156. ">Chile 1998</a>; <a href="./references#CD000019-bbs2-0010" title="AlfirevicZ , BoerK , BrocklehurstP , BuimerM , ElbourneD , KokJ , et al. Two trials of antenatal thyrotrophin‐releasing hormone for fetal maturation: stopping before the due date. British Journal of Obstetrics and Gynaecology1999;106:898‐906. AlfirevicZ , ElbourneD , BrocklehurstP , TruesdaleA , NeilsonJ . Randomised controlled trial of antenatal administration of thyrotropin releasing hormone (TRH) to women at risk of premature delivery. Prenatal and Neonatal Medicine1996;1(1):10. BrietJM , vanSonderenL , BuimerM , BoerK , KokJH . Neurodevelopmental outcome of children treated with antenatal thyrotropin‐releasing hormone. Pediatrics2002;110(2 Pt 1):249‐53. BrocklehurstP . Antenatal thyrotropin‐releasing hormone for fetal maturity: two concurrent randomised controlled trials (The Antenatal TRH Trial and the Thyroneth Trial). British Journal of Obstetrics and Gynaecology1998;105:81. ">Europe 1999</a>), did not show any significant differences between groups on follow‐up, apart from a significantly lower (worse) Mental Developmental Index for infants exposed to prenatal TRH at 24‐month follow‐up in one trial (<a href="./references#CD000019-bbs2-0010" title="AlfirevicZ , BoerK , BrocklehurstP , BuimerM , ElbourneD , KokJ , et al. Two trials of antenatal thyrotrophin‐releasing hormone for fetal maturation: stopping before the due date. British Journal of Obstetrics and Gynaecology1999;106:898‐906. AlfirevicZ , ElbourneD , BrocklehurstP , TruesdaleA , NeilsonJ . Randomised controlled trial of antenatal administration of thyrotropin releasing hormone (TRH) to women at risk of premature delivery. Prenatal and Neonatal Medicine1996;1(1):10. BrietJM , vanSonderenL , BuimerM , BoerK , KokJH . Neurodevelopmental outcome of children treated with antenatal thyrotropin‐releasing hormone. Pediatrics2002;110(2 Pt 1):249‐53. BrocklehurstP . Antenatal thyrotropin‐releasing hormone for fetal maturity: two concurrent randomised controlled trials (The Antenatal TRH Trial and the Thyroneth Trial). British Journal of Obstetrics and Gynaecology1998;105:81. ">Europe 1999</a>), which was not confirmed in the second trial (<a href="./references#CD000019-bbs2-0008" title="Collaborative Santiago Surfactant Group. Collaborative trial of prenatal thyrotropin‐releasing hormone and corticosteroids for prevention of respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178:33‐9. MaturanaA , TorresJ , SalinasR , MoyaF , for the Collaborative Group. Controlled trial of prenatal thyrotropin‐releasing hormone (TRH) and betamethasone (B) for prevention of respiratory distress syndrome (RDS). Pediatric Research1997;41:163A. ReyesG , GonzalezAR , GomezG , BlasiniI , RiveraCE . Comparative study of the effectiveness of thyroxine and steroids on reduction of neonatal morbidity: outcome at 20 months follow‐up. Puerto Rico Health Sciences Journal2004;23(1):9‐12. SantiagoR , RomagueraJ . Steroids vs steroids and thyroxine to accelerate fetal maturation of patients in arrested preterm labor. Puerto Rico Health Sciences Journal1999;18:156. ">Chile 1998</a>). </p> <p>The first two full trial reports published showed promising therapeutic effects of prenatal TRH, but reported neonatal outcome data only in minority subgroups of babies entered into the trials (<a href="./references#CD000019-bbs2-0003" title="BallardPL , BallardRA , CreasyRK , PadburyJ , PolkDH , BrackenM , et al. Plasma thyroid hormones and prolactin in premature infants and their mothers after treatment with thyrotropin‐releasing hormone. Pediatric Research1992;32(6):673‐8. BallardRA , BallardPL , CreasyR , GrossI , MainD , PadburyJF , et al. Prenatal treatment with thyrotropin releasing hormone plus corticosteroid: absence of maternal, fetal or neonatal side effects. Clinical Research1990;38:192A. BallardRA , BallardPL , CreasyR , GrossI , MainD , PadburyJF , et al. Prenatal treatment with thyrotropin releasing hormone plus corticosteroid: absence of maternal, fetal or neonatal side effects. Pediatric Research1991;29:202A. BallardRA , BallardPL , CreasyR , GrossI , PadburyJF , TRH Study Group. Thyrotropin releasing hormone plus corticosteroids decreases chronic lung disease in very low birth weight infants. Pediatric Research1991;29(4):1828A. BallardRA , BallardPL , CreasyR , PadburyJ , PolkDH , BrackenM , et al. Respiratory disease in very‐low birthweight infants after prenatal thyrotropin‐releasing hormone and glucocorticoid. Lancet1992;339:510‐5. ">Ballard 1992b</a>; <a href="./references#CD000019-bbs2-0014" title="MoralesWJ , O'BrienWF , AngelJL , KnuppelRA , SawaiS . Fetal lung maturation: the combined use of corticosteroids and thyrotropin‐releasing hormone. Obstetrics and Gynecology1989;73:111‐6. ">Morales 1989</a>). However, a significant proportion of babies in all of the studies (49%) were born more than 10 days after trial entry. The data in this review show that these babies (born more than 10 days after trial entry), if exposed to prenatal TRH in addition to corticosteroids, were more likely to develop respiratory distress syndrome (RDS) compared with babies in the control group, who received only corticosteroids. This highlights the importance of 'intention‐to‐treat' analyses, and subgroup analyses in this review, since many of the studies excluded categories of babies. Even where data were available for all women who were randomised, results from subgroup analyses (e.g. by timing of treatment) are less reliable than overall analyses. However, it is important to show the data by subgroups since timing of treatment appears to be an important consideration. </p> <p>The expectation was that the greatest beneficial effect of prenatal TRH would be seen in infants born between 24 hours and 10 days of trial entry as shown with antenatal corticosteroids alone (<a href="./references#CD000019-bbs2-0028" title="LigginsGC , HowieRN . A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics1972;50:515‐25. ">Liggins 1972</a>). Infants exposed to TRH in this timed subgroup, and a similar 'optimal' timing subgroup, did show a reduced risk of severe RDS; however, subgroup interaction tests were not significant, and therefore no firm conclusion could be made regarding this particular group of infants. Intention‐to‐treat data for severe RDS were only available from three earlier trials for this timed subgroup (birth more than 24 hours and less than 10 days after first dose) (<a href="./references#CD000019-bbs2-0002" title="CrowtherC , HillerJ , HaslamR , RobinsonJ , the ACTOBAT Study Group. Australian Collaborative Trial of Betamethasone and TRH for the prevention of neonatal respiratory disease (ACTOBAT). International Journal of Gynecology and Obstetrics1994;46:59. CrowtherCA , HillerJE , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial of antenatal thyrotropin‐releasing hormone: Adverse effects at 12‐month follow‐up. Pediatrics1997;99:311‐7. HillerJE , CrowtherCA , HaslamRR , RobinsonJS , the ACTOBAT Study Group. Australian collaborative trial af antenatal thyrotropin‐releasing hormone (ACTOBAT): 12 month follow‐up. 4th Annual Congress of the Perinatal Society of Australia &amp; New Zealand; 1998 March 30‐April 4; Alice Springs, Australia. Alice Springs, 1998:77. The ACTOBAT Study Group. Australian collaborative trial of betamethasone and thyrotropin releasing hormone (ACTOBAT) for the prevention of neonatal respiratory disease. Lancet1995;345:877‐82. ">ACTOBAT 1995</a>; <a href="./references#CD000019-bbs2-0003" title="BallardPL , BallardRA , CreasyRK , PadburyJ , PolkDH , BrackenM , et al. Plasma thyroid hormones and prolactin in premature infants and their mothers after treatment with thyrotropin‐releasing hormone. Pediatric Research1992;32(6):673‐8. BallardRA , BallardPL , CreasyR , GrossI , MainD , PadburyJF , et al. Prenatal treatment with thyrotropin releasing hormone plus corticosteroid: absence of maternal, fetal or neonatal side effects. Clinical Research1990;38:192A. BallardRA , BallardPL , CreasyR , GrossI , MainD , PadburyJF , et al. Prenatal treatment with thyrotropin releasing hormone plus corticosteroid: absence of maternal, fetal or neonatal side effects. Pediatric Research1991;29:202A. BallardRA , BallardPL , CreasyR , GrossI , PadburyJF , TRH Study Group. Thyrotropin releasing hormone plus corticosteroids decreases chronic lung disease in very low birth weight infants. Pediatric Research1991;29(4):1828A. BallardRA , BallardPL , CreasyR , PadburyJ , PolkDH , BrackenM , et al. Respiratory disease in very‐low birthweight infants after prenatal thyrotropin‐releasing hormone and glucocorticoid. Lancet1992;339:510‐5. ">Ballard 1992b</a>; <a href="./references#CD000019-bbs2-0013" title="KnightDB , LigginsGC , Wealthall SR. A randomised controlled trial of the effect of thyrotropin‐releasing hormone with betamethasone in mothers likely to deliver prematurely on neonatal outcome. Proceedings of the Australian Perinatal Society; 1992; Queensland, Australia. 1992:A9. KnightDB , LigginsGC , Wealthall SR. A randomized, controlled trial of antepartum thyrotropin‐releasing hormone and betamethasone in the prevention of respiratory disease in preterm infants. American Journal of Obstetrics and Gynecology1994;171:11‐6. KnightDB , Wealthall SR, LigginsGC , HowieRN . A randomised double blind controlled trial of antepartum TRH with betamethasone in the prevention of neonatal respiratory disease. New Zealand Medical Journal1989;102:195. LigginsGC , KnightDB , Wealthall SR, HowieRN . A randomized double‐blind trial of antepartum TRH and steroids in the prevention of neonatal respiratory disease. Clinical reproductive medicine ‐ the Liggins years; 1988 July 29‐30; Auckland, New Zealand. 1988. ">Knight 1994</a>) and thus it would be important to include any further data on severe RDS from the more recent trials if they became available. </p> </section> </section> <div class="figures-list"> <div class="figure" id="CD000019-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD000019-fig-0001" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/full#CD000019-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD000019-fig-0002" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/full#CD000019-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00101"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 1 Death prior to hospital discharge." data-id="CD000019-fig-00101" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 1 Death prior to hospital discharge. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00101">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00102"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 2 Chronic lung disease." data-id="CD000019-fig-00102" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 2 Chronic lung disease. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00102">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00103"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 3 Respiratory distress syndrome." data-id="CD000019-fig-00103" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 3 Respiratory distress syndrome. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00103">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00104"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 4 Chronic lung disease or death." data-id="CD000019-fig-00104" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 4 Chronic lung disease or death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00104">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00105"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 5 Need for oxygen therapy." data-id="CD000019-fig-00105" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 5 Need for oxygen therapy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00105">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00106"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 6 Severe respiratory distress syndrome." data-id="CD000019-fig-00106" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 6 Severe respiratory distress syndrome. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00106">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00107"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 7 Use of respiratory support." data-id="CD000019-fig-00107" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 7 Use of respiratory support. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00107">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00108"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 8 Admission to neonatal intensive care unit." data-id="CD000019-fig-00108" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 8 Admission to neonatal intensive care unit. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00108">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00109"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 9 Intraventricular haemorrhage." data-id="CD000019-fig-00109" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 9 Intraventricular haemorrhage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00109">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00110"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 10 Severe intraventricular haemorrhage." data-id="CD000019-fig-00110" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 10 Severe intraventricular haemorrhage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00110">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00111"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 11 Air leak syndrome." data-id="CD000019-fig-00111" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 11 Air leak syndrome. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00111">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00112"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 12 Pulmonary haemorrhage." data-id="CD000019-fig-00112" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 12 Pulmonary haemorrhage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00112">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00113"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 13 Necrotising enterocolitis." data-id="CD000019-fig-00113" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 13 Necrotising enterocolitis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00113">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00114"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 14 Patent ductus arteriosus." data-id="CD000019-fig-00114" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 14 Patent ductus arteriosus. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00114">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00115"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 15 Low Apgar score at 5 minutes." data-id="CD000019-fig-00115" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 15 Low Apgar score at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00115">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00116"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-001-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-001-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 16 Use of surfactant." data-id="CD000019-fig-00116" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 16 Use of surfactant. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00116">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00117"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-001-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-001-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 17 Gestational age at birth." data-id="CD000019-fig-00117" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 17 Gestational age at birth. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00117">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00118"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-001-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-001-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 18 Motor delay at follow‐up." data-id="CD000019-fig-00118" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 18 Motor delay at follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00118">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00119"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-001-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-001-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 19 Motor impairment at follow‐up." data-id="CD000019-fig-00119" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 19 Motor impairment at follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00119">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00120"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-001-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-001-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 20 Fine motor delay at follow‐up." data-id="CD000019-fig-00120" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.20</div> <div class="figure-caption"> <p>Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 20 Fine motor delay at follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00120">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00121"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-001-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-001-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 21 Sensory impairment at follow‐up." data-id="CD000019-fig-00121" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.21</div> <div class="figure-caption"> <p>Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 21 Sensory impairment at follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00121">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00122"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-001-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-001-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 22 Language delay at follow‐up." data-id="CD000019-fig-00122" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.22</div> <div class="figure-caption"> <p>Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 22 Language delay at follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00122">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00123"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-001-23" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-001-23.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 23 Social delay at follow‐up." data-id="CD000019-fig-00123" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-23.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.23</div> <div class="figure-caption"> <p>Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 23 Social delay at follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00123">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-23.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00124"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-001-24" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-001-24.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 24 Any neurodevelopmental abnormality at follow‐up." data-id="CD000019-fig-00124" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-24.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.24</div> <div class="figure-caption"> <p>Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 24 Any neurodevelopmental abnormality at follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00124">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-24.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00125"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-001-25" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-001-25.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 25 Bayley Mental Developmental Index." data-id="CD000019-fig-00125" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-25.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.25</div> <div class="figure-caption"> <p>Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 25 Bayley Mental Developmental Index. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00125">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-25.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00126"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-001-26" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-001-26.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 26 Bayley Psychomotor Developmental Index." data-id="CD000019-fig-00126" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-26.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.26</div> <div class="figure-caption"> <p>Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 26 Bayley Psychomotor Developmental Index. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00126">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-26.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00127"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-001-27" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-001-27.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 27 Bayley Behavioural Rating Scales (18 months)." data-id="CD000019-fig-00127" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-27.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.27</div> <div class="figure-caption"> <p>Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 27 Bayley Behavioural Rating Scales (18 months). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00127">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-27.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00128"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-001-28" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-001-28.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 28 Bayley Language Developmental Age (18 months)." data-id="CD000019-fig-00128" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-28.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.28</div> <div class="figure-caption"> <p>Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 28 Bayley Language Developmental Age (18 months). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00128">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-28.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00129"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-001-29" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-001-29.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 29 Bayley Cognitive Developmental Age (18 months)." data-id="CD000019-fig-00129" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-29.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.29</div> <div class="figure-caption"> <p>Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 29 Bayley Cognitive Developmental Age (18 months). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00129">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-29.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00130"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-001-30" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-001-30.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 30 Serious neurological abnormality at follow‐up." data-id="CD000019-fig-00130" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-30.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.30</div> <div class="figure-caption"> <p>Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 30 Serious neurological abnormality at follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00130">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-30.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00131"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-001-31" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-001-31.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 31 Opthalmological or hearing abnormalities at follow‐up." data-id="CD000019-fig-00131" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-31.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.31</div> <div class="figure-caption"> <p>Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 31 Opthalmological or hearing abnormalities at follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00131">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-31.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00132"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-001-32" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-001-32.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 32 Maternal nausea." data-id="CD000019-fig-00132" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-32.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.32</div> <div class="figure-caption"> <p>Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 32 Maternal nausea. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00132">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-32.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00133"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-001-33" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-001-33.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 33 Maternal vomiting." data-id="CD000019-fig-00133" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-33.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.33</div> <div class="figure-caption"> <p>Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 33 Maternal vomiting. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00133">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-33.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00134"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-001-34" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-001-34.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 34 Maternal light headedness." data-id="CD000019-fig-00134" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-34.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.34</div> <div class="figure-caption"> <p>Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 34 Maternal light headedness. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00134">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-34.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00135"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-001-35" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-001-35.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 35 Urgency of micturition." data-id="CD000019-fig-00135" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-35.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.35</div> <div class="figure-caption"> <p>Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 35 Urgency of micturition. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00135">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-35.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00136"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-001-36" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-001-36.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 36 Maternal facial flushing." data-id="CD000019-fig-00136" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-36.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.36</div> <div class="figure-caption"> <p>Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 36 Maternal facial flushing. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00136">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-36.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00137"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-001-37" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-001-37.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 37 Maternal systolic blood pressure rise &gt;= 25 mmHg." data-id="CD000019-fig-00137" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-37.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.37</div> <div class="figure-caption"> <p>Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 37 Maternal systolic blood pressure rise &gt;= 25 mmHg. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00137">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-37.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00138"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-001-38" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-001-38.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 38 Maternal diastolic blood pressure rise &gt;= 15 mmHg." data-id="CD000019-fig-00138" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-38.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.38</div> <div class="figure-caption"> <p>Comparison 1 TRH + steroids versus steroids alone (intention‐to‐treat), Outcome 38 Maternal diastolic blood pressure rise &gt;= 15 mmHg. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00138">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-001-38.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00201"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 TRH + steroids versus steroids alone (dose of TRH subgroups), Outcome 1 Death prior to hospital discharge." data-id="CD000019-fig-00201" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 TRH + steroids versus steroids alone (dose of TRH subgroups), Outcome 1 Death prior to hospital discharge. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00201">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00202"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 TRH + steroids versus steroids alone (dose of TRH subgroups), Outcome 2 Chronic lung disease." data-id="CD000019-fig-00202" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 TRH + steroids versus steroids alone (dose of TRH subgroups), Outcome 2 Chronic lung disease. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00202">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00203"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 TRH + steroids versus steroids alone (dose of TRH subgroups), Outcome 3 Respiratory distress syndrome." data-id="CD000019-fig-00203" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 TRH + steroids versus steroids alone (dose of TRH subgroups), Outcome 3 Respiratory distress syndrome. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00203">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00204"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 TRH + steroids versus steroids alone (dose of TRH subgroups), Outcome 4 Chronic lung disease or death." data-id="CD000019-fig-00204" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 TRH + steroids versus steroids alone (dose of TRH subgroups), Outcome 4 Chronic lung disease or death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00204">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00205"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 TRH + steroids versus steroids alone (dose of TRH subgroups), Outcome 5 Need for oxygen therapy." data-id="CD000019-fig-00205" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 TRH + steroids versus steroids alone (dose of TRH subgroups), Outcome 5 Need for oxygen therapy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00205">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00206"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 TRH + steroids versus steroids alone (dose of TRH subgroups), Outcome 6 Severe respiratory distress syndrome." data-id="CD000019-fig-00206" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 TRH + steroids versus steroids alone (dose of TRH subgroups), Outcome 6 Severe respiratory distress syndrome. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00206">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00207"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 TRH + steroids versus steroids alone (dose of TRH subgroups), Outcome 7 Use of respiratory support." data-id="CD000019-fig-00207" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 TRH + steroids versus steroids alone (dose of TRH subgroups), Outcome 7 Use of respiratory support. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00207">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00301"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 TRH + steroids versus steroids alone (timing of delivery subgroups), Outcome 1 Death prior to hospital discharge." data-id="CD000019-fig-00301" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 TRH + steroids versus steroids alone (timing of delivery subgroups), Outcome 1 Death prior to hospital discharge. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00301">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00302"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 TRH + steroids versus steroids alone (timing of delivery subgroups), Outcome 2 Chronic lung disease." data-id="CD000019-fig-00302" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 TRH + steroids versus steroids alone (timing of delivery subgroups), Outcome 2 Chronic lung disease. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00302">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00303"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 TRH + steroids versus steroids alone (timing of delivery subgroups), Outcome 3 Respiratory distress syndrome." data-id="CD000019-fig-00303" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 TRH + steroids versus steroids alone (timing of delivery subgroups), Outcome 3 Respiratory distress syndrome. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00303">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00304"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 TRH + steroids versus steroids alone (timing of delivery subgroups), Outcome 4 Chronic lung disease or death." data-id="CD000019-fig-00304" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 TRH + steroids versus steroids alone (timing of delivery subgroups), Outcome 4 Chronic lung disease or death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00304">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00305"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 TRH + steroids versus steroids alone (timing of delivery subgroups), Outcome 5 Need for oxygen therapy." data-id="CD000019-fig-00305" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 TRH + steroids versus steroids alone (timing of delivery subgroups), Outcome 5 Need for oxygen therapy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00305">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00306"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-003-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-003-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 TRH + steroids versus steroids alone (timing of delivery subgroups), Outcome 6 Severe respiratory distress syndrome." data-id="CD000019-fig-00306" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-003-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 TRH + steroids versus steroids alone (timing of delivery subgroups), Outcome 6 Severe respiratory distress syndrome. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00306">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-003-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00307"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-003-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-003-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 TRH + steroids versus steroids alone (timing of delivery subgroups), Outcome 7 Use of respiratory support." data-id="CD000019-fig-00307" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-003-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3 TRH + steroids versus steroids alone (timing of delivery subgroups), Outcome 7 Use of respiratory support. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00307">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-003-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00401"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 TRH + steroids versus steroids alone (optimally treated variously defined), Outcome 1 Death prior to hospital discharge." data-id="CD000019-fig-00401" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 TRH + steroids versus steroids alone (optimally treated variously defined), Outcome 1 Death prior to hospital discharge. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00401">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00402"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 TRH + steroids versus steroids alone (optimally treated variously defined), Outcome 2 Chronic lung disease." data-id="CD000019-fig-00402" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 TRH + steroids versus steroids alone (optimally treated variously defined), Outcome 2 Chronic lung disease. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00402">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00403"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 TRH + steroids versus steroids alone (optimally treated variously defined), Outcome 3 Respiratory distress syndrome." data-id="CD000019-fig-00403" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 TRH + steroids versus steroids alone (optimally treated variously defined), Outcome 3 Respiratory distress syndrome. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00403">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00404"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 TRH + steroids versus steroids alone (optimally treated variously defined), Outcome 4 Chronic lung disease or death." data-id="CD000019-fig-00404" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 TRH + steroids versus steroids alone (optimally treated variously defined), Outcome 4 Chronic lung disease or death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00404">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00405"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 TRH + steroids versus steroids alone (optimally treated variously defined), Outcome 5 Need for oxygen therapy." data-id="CD000019-fig-00405" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 TRH + steroids versus steroids alone (optimally treated variously defined), Outcome 5 Need for oxygen therapy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00405">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00406"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-004-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-004-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 TRH + steroids versus steroids alone (optimally treated variously defined), Outcome 6 Severe respiratory distress syndrome." data-id="CD000019-fig-00406" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-004-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.6</div> <div class="figure-caption"> <p>Comparison 4 TRH + steroids versus steroids alone (optimally treated variously defined), Outcome 6 Severe respiratory distress syndrome. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00406">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-004-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00407"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-004-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-004-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 TRH + steroids versus steroids alone (optimally treated variously defined), Outcome 7 Use of respiratory support." data-id="CD000019-fig-00407" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-004-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.7</div> <div class="figure-caption"> <p>Comparison 4 TRH + steroids versus steroids alone (optimally treated variously defined), Outcome 7 Use of respiratory support. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00407">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-004-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00501"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 TRH + steroids versus steroids alone (high‐quality trials), Outcome 1 Death prior to hospital discharge." data-id="CD000019-fig-00501" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 TRH + steroids versus steroids alone (high‐quality trials), Outcome 1 Death prior to hospital discharge. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00501">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00502"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 TRH + steroids versus steroids alone (high‐quality trials), Outcome 2 Chronic lung disease." data-id="CD000019-fig-00502" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 TRH + steroids versus steroids alone (high‐quality trials), Outcome 2 Chronic lung disease. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00502">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00503"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 TRH + steroids versus steroids alone (high‐quality trials), Outcome 3 Respiratory distress syndrome." data-id="CD000019-fig-00503" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 TRH + steroids versus steroids alone (high‐quality trials), Outcome 3 Respiratory distress syndrome. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00503">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00504"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-005-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-005-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 TRH + steroids versus steroids alone (high‐quality trials), Outcome 4 Chronic lung disease or death." data-id="CD000019-fig-00504" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-005-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 TRH + steroids versus steroids alone (high‐quality trials), Outcome 4 Chronic lung disease or death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00504">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-005-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00505"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-005-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-005-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 TRH + steroids versus steroids alone (high‐quality trials), Outcome 5 Need for oxygen therapy." data-id="CD000019-fig-00505" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-005-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5 TRH + steroids versus steroids alone (high‐quality trials), Outcome 5 Need for oxygen therapy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00505">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-005-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00506"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-005-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-005-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 TRH + steroids versus steroids alone (high‐quality trials), Outcome 6 Severe respiratory distress syndrome." data-id="CD000019-fig-00506" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-005-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.6</div> <div class="figure-caption"> <p>Comparison 5 TRH + steroids versus steroids alone (high‐quality trials), Outcome 6 Severe respiratory distress syndrome. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00506">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-005-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000019-fig-00507"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/urn:x-wiley:14651858:media:CD000019:CD000019-CMP-005-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_t/tCD000019-CMP-005-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 TRH + steroids versus steroids alone (high‐quality trials), Outcome 7 Use of respiratory support." data-id="CD000019-fig-00507" src="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-005-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.7</div> <div class="figure-caption"> <p>Comparison 5 TRH + steroids versus steroids alone (high‐quality trials), Outcome 7 Use of respiratory support. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-fig-00507">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/media/CDSR/CD000019/image_n/nCD000019-CMP-005-07.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="comparison" data-id="CD000019-tbl-0001"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">TRH + steroids versus steroids alone (intention‐to‐treat)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Death prior to hospital discharge <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3694</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.86, 1.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Chronic lung disease <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2511</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.85, 1.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Respiratory distress syndrome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3833</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.91, 1.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Chronic lung disease or death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3694</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.95, 1.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Need for oxygen therapy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2387</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.97, 1.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Severe respiratory distress syndrome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.57, 1.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Use of respiratory support <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1969</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.16 [1.03, 1.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Admission to neonatal intensive care unit <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1637</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.98, 1.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Intraventricular haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3645</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.93, 1.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Severe intraventricular haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3313</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.13 [0.82, 1.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Air leak syndrome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.14 [0.71, 1.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Pulmonary haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1969</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.25, 2.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Necrotising enterocolitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.64, 1.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Patent ductus arteriosus <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3645</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.79, 1.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Low Apgar score at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1969</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.48 [1.14, 1.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Use of surfactant <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.98, 1.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Gestational age at birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1563</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.43 [‐0.86, 0.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Motor delay at follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>971</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.31 [1.09, 1.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Motor impairment at follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>972</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.51 [1.01, 2.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Fine motor delay at follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>926</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.91, 1.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Sensory impairment at follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.97 [1.10, 3.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Language delay at follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.20 [0.93, 1.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 Social delay at follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>966</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [1.03, 1.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24 Any neurodevelopmental abnormality at follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.75 [0.61, 37.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">25 Bayley Mental Developmental Index <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.52 [‐21.69, 8.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>25.1 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐15.70 [‐30.86, ‐0.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>25.2 18 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐8.36, 8.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">26 Bayley Psychomotor Developmental Index <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.73 [‐8.58, 3.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>26.1 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.0 [‐13.90, 3.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>26.2 18 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.0 [‐8.77, 6.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">27 Bayley Behavioural Rating Scales (18 months) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.0 [‐4.88, 22.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">28 Bayley Language Developmental Age (18 months) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [‐0.36, 4.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">29 Bayley Cognitive Developmental Age (18 months) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.70 [‐0.64, 4.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">30 Serious neurological abnormality at follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.06, 13.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">31 Opthalmological or hearing abnormalities at follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">32 Maternal nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2370</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.92 [3.13, 4.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">33 Maternal vomiting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.35 [1.35, 4.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">34 Maternal light headedness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.73 [1.36, 2.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">35 Urgency of micturition <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.39 [1.75, 3.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">36 Maternal facial flushing <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2523</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.67 [2.26, 3.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">37 Maternal systolic blood pressure rise &gt;= 25 mmHg <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.80 [1.05, 3.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">38 Maternal diastolic blood pressure rise &gt;= 15 mmHg <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.62 [1.24, 2.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">TRH + steroids versus steroids alone (intention‐to‐treat)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000019-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">TRH + steroids versus steroids alone (dose of TRH subgroups)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Death prior to hospital discharge <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3694</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.86, 1.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 200 μg (x 4 every 12 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1397</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.23 [0.87, 1.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 400 μg (x 4 every 8‐12 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2297</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.77, 1.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Chronic lung disease <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2511</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.85, 1.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 200 μg (x 4 every 12 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1369</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.84, 1.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 400 μg (x 4 every 8‐12 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1142</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.73, 1.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Respiratory distress syndrome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3833</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.91, 1.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 200 μg (x 4 every 12 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1369</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [1.00, 1.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 400 μg (x 4 every 8‐12 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2276</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.78, 1.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 400 μg (x 6 every 8 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.67 [0.87, 3.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4 500 μg (x 4 every 8 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [0.69, 1.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Chronic lung disease or death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3694</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.95, 1.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 200 μg (x 4 every 12 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1397</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.91, 1.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 400 μg (x 4 every 8‐12 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2297</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.92, 1.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Need for oxygen therapy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2387</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.97, 1.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 200 μg (x 4 every 12 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1369</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.95, 1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 400 μg (x 4 every 8‐12 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1018</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.93, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Severe respiratory distress syndrome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.57, 1.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 200 μg (x 4 every 12 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1369</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.66, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 400 μg (x 4 every 8‐12 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>750</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.37, 2.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Use of respiratory support <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1969</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.16 [1.03, 1.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 200 μg (x 4 every 12 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1369</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.15 [1.01, 1.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 400 μg (x 4 every 8‐12 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>600</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.18 [0.95, 1.46]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">TRH + steroids versus steroids alone (dose of TRH subgroups)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000019-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">TRH + steroids versus steroids alone (timing of delivery subgroups)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Death prior to hospital discharge <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2538</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.70, 1.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Birth &lt; 24 hours after first dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>245</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.50, 1.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Birth ≥ 24 hours to ≤ 10 days after first dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1164</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.59, 1.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Birth &gt; 10 days after first dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.47, 3.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Chronic lung disease <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2574</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.81, 1.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Birth &lt; 24 hours after first dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>306</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.54, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Birth ≥ 24 hours to ≤ 10 days after first dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1152</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.77, 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Birth &gt; 10 days after first dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1116</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.30 [0.81, 2.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Respiratory distress syndrome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3535</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.91, 1.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Birth &lt; 24 hours after first dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>495</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.87, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Birth ≥ 24 hours to ≤ 10 days after first dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1485</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.81, 1.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Birth &gt; 10 days after first dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1555</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.33 [1.05, 1.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Chronic lung disease or death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3459</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.84, 1.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Birth &lt; 24 hours after first dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>457</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.75, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Birth ≥ 24 hours to ≤ 10 days after first dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1317</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.77, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Birth &gt; 10 days after first dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1685</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.30 [0.92, 1.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Need for oxygen therapy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1440</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.94, 1.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Birth &lt; 24 hours after first dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.85, 1.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Birth ≥ 24 hours to ≤ 10 days after first dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>577</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.92, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 Birth &gt; 10 days after first dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>708</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [0.88, 1.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Severe respiratory distress syndrome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2031</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.61, 0.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Birth &lt; 24 hours after first dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>270</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.57, 1.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Birth ≥ 24 hours to ≤ 10 days after first dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>874</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.49, 0.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 Birth &gt; 10 days after first dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>887</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.62, 1.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Use of respiratory support <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1440</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.92, 1.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Birth &lt; 24 hours after first dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.82, 1.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Birth ≥ 24 hours to ≤ 10 days after first dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>577</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.87, 1.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 Birth &gt; 10 days after first dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>708</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.34 [0.94, 1.91]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">TRH + steroids versus steroids alone (timing of delivery subgroups)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000019-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">TRH + steroids versus steroids alone (optimally treated variously defined)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Death prior to hospital discharge <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Optimally treated infants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1465</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.67, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 All treated infants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3694</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.86, 1.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Chronic lung disease <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Optimally treated infants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1318</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.72, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 All treated infants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2511</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.85, 1.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Respiratory distress syndrome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Optimally treated infants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1786</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.77, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 All treated infants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3833</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.91, 1.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Chronic lung disease or death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Optimally treated infants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1317</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.84, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 All treated infants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3694</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.95, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Need for oxygen therapy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Optimally treated infants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>506</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.91, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 All treated infants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2387</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.97, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Severe respiratory distress syndrome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Optimally treated infants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>694</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.49, 0.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 All treated infants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.69, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Use of respiratory support <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Optimally treated infants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>506</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.94, 1.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 All treated infants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1969</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.16 [1.03, 1.29]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">TRH + steroids versus steroids alone (optimally treated variously defined)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000019-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">TRH + steroids versus steroids alone (high‐quality trials)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Death prior to hospital discharge <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3570</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.84, 1.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Chronic lung disease <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2387</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.84, 1.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Respiratory distress syndrome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3521</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.91, 1.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Chronic lung disease or death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3570</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.94, 1.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Need for oxygen therapy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2387</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.97, 1.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Severe respiratory distress syndrome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.57, 1.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Use of respiratory support <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1969</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.16 [1.03, 1.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">TRH + steroids versus steroids alone (high‐quality trials)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000019.pub3/references#CD000019-tbl-0005">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD000019.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD000019-note-1207">Español</a> </li> <li class="section-language"> <a class="" href="fr#CD000019-note-1206">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD000019-note-1205">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ru#CD000019-note-1204">Русский</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br/> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000019\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000019\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000019\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000019\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000019\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000019\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000019\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000019\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000019\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000019\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000019\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000019\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000019\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000019\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000019\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000019\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000019\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000019\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=uYcNEb5O&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000019.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD000019.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD000019.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD000019.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000019.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740726896965"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD000019.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740726896968"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD000019.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e9ed86fa5f480',t:'MTc0MDcyNjg5Ny4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 